>pdb|3GBI|B Chain B, The Rational Design and Structural Analysis of a Self-Assembled Three-Dimensional DNA Crystal
NCGTACA
>pdb|3GVN|B Chain B, The 1.2 Angstroem crystal structure of an E.coli tRNASer acceptor stem microhelix reveals two magnesium binding sites
CCTCACC
>pdb|3GVN|A Chain A, The 1.2 Angstroem crystal structure of an E.coli tRNASer acceptor stem microhelix reveals two magnesium binding sites
GGTGAGG
>pdb|3H4D|P Chain P, Ternary complex of human DNA polymerase iota with template U/T and incoming dGTP
AGGACCN
>pdb|3H4B|P Chain P, Ternary complex of human DNA polymerase iota with template U/T and incoming dATP
AGGACCN
>pdb|3H40|P Chain P, Binary complex of human DNA polymerase iota with template U/T
AGGACCN
>pdb|3GV8|P Chain P, Human DNA polymerase iota in complex with T template DNA and incoming dGTP
AGGACCC
>pdb|3GV7|P Chain P, Human DNA polymerase iota in complex with T template DNA and incoming dTTP
AGGACCC
>pdb|3G6Y|P Chain P, Ternary complex of DNA Polymerase iota:DNA:dTTP with an abasic site at the templating position
AGGACCN
>pdb|3G6X|P Chain P, Ternary complex of DNA Polymerase iota:DNA:dGTP with an abasic site at the templating position
AGGACCN
>pdb|3G6V|P Chain P, DNA synthesis across an abasic lesion by human DNA polymerase-iota
AGGACCN
>pdb|2VUQ|B Chain B, Crystal structure of a human tRNAGly acceptor stem microhelix (derived from the gene sequence DG9990) at 1.18 Angstroem resolution
CCAATGC
>pdb|2VUQ|A Chain A, Crystal structure of a human tRNAGly acceptor stem microhelix (derived from the gene sequence DG9990) at 1.18 Angstroem resolution
GCATTGG
>pdb|3G0H|E Chain E, Human dead-box RNA helicase DDX19, in complex with an ATP-analogue and RNA
NTTTTTT
>pdb|3EYI|D Chain D, The crystal structure of the second Z-DNA binding domain of human DAI (ZBP1) in complex with Z-DNA
TCGCGCG
>pdb|3EYI|C Chain C, The crystal structure of the second Z-DNA binding domain of human DAI (ZBP1) in complex with Z-DNA
TCGCGCG
>pdb|2P2R|B Chain B, Crystal structure of the third KH domain of human Poly(C)-Binding Protein-2 in complex with C-rich strand of human telomeric DNA
AACCCTA
>pdb|2VOO|D Chain D, Crystal structure of N-terminal domains of Human La protein complexed with RNA oligomer UUUUUUUU
TTTTTTT
>pdb|2VOO|C Chain C, Crystal structure of N-terminal domains of Human La protein complexed with RNA oligomer UUUUUUUU
TTTTTTT
>pdb|2VOD|D Chain D, Crystal structure of N-terminal domains of Human La protein complexed with RNA oligomer AUAUUUU
ATATTTT
>pdb|2VOD|C Chain C, Crystal structure of N-terminal domains of Human La protein complexed with RNA oligomer AUAUUUU
ATATTTT
>pdb|2V7R|B Chain B, Crystal structure of a human tRNAGly microhelix at 1.2 Angstrom resolution
CCAACGC
>pdb|2V7R|A Chain A, Crystal structure of a human tRNAGly microhelix at 1.2 Angstrom resolution
GCGTTGG
>pdb|2R7Z|N Chain N, Cisplatin lesion containing RNA polymerase II elongation complex
CAAGTAG
>pdb|2V6W|B Chain B, tRNASer acceptor stem: Conformation and hydration of a microhelix in a crystal structure at 1.8 Angstrom resolution
TCTCTCC
>pdb|2V6W|A Chain A, tRNASer acceptor stem: Conformation and hydration of a microhelix in a crystal structure at 1.8 Angstrom resolution
GGAGAGA
>pdb|2VAL|D Chain D, Crystal structure of an Escherichia coli tRNAGly microhelix at 2.0 Angstrom resolution
TTCCCGC
>pdb|2VAL|C Chain C, Crystal structure of an Escherichia coli tRNAGly microhelix at 2.0 Angstrom resolution
TTCCCGC
>pdb|2VAL|B Chain B, Crystal structure of an Escherichia coli tRNAGly microhelix at 2.0 Angstrom resolution
GCGGGAA
>pdb|2VAL|A Chain A, Crystal structure of an Escherichia coli tRNAGly microhelix at 2.0 Angstrom resolution
GCGGGAA
>pdb|2GJW|L Chain L, RNA Recognition and Cleavage by an Splicing Endonuclease
AGGTCGC
>pdb|2GJW|H Chain H, RNA Recognition and Cleavage by an Splicing Endonuclease
AGGTCGC
>pdb|2G4B|B Chain B, Structure of U2AF65 variant with polyuridine tract
NTTTTTT
>pdb|2GXB|F Chain F, Crystal Structure of The Za Domain bound to Z-RNA
NCGCGCG
>pdb|2GXB|E Chain E, Crystal Structure of The Za Domain bound to Z-RNA
NCGCGCG
>pdb|2NVT|N Chain N, RNA Polymerase II Elongation Complex in 150 mM Mg+2 with GMPCPP
GTACTTG
>pdb|2FLL|P Chain P, Ternary complex of human DNA polymerase iota with DNA and dTTP
AGGACCN
>pdb|2FLP|P Chain P, Binary complex of the catalytic core of human DNA polymerase iota with DNA (template G)
AGGACCN
>pdb|2FLN|P Chain P, binary complex of catalytic core of human DNA polymerase iota with DNA (template A)
AGGACCN
>pdb|2DPJ|P Chain P, structure of hPoli with DNA and dTTP
AGGACCN
>pdb|2DPI|P Chain P, Ternary complex of hPoli with DNA and dCTP
AGGACCN
>pdb|2BCU|P Chain P, DNA polymerase lambda in complex with a DNA duplex containing an unpaired Damp and a T:T mismatch
CAGTTCG
>pdb|2BCS|P Chain P, DNA polymerase lambda in complex with a DNA duplex containing an unpaired Dcmp
CAGTACG
>pdb|2BCR|P Chain P, DNA polymerase lambda in complex with a DNA duplex containing an unpaired Damp
CAGTACG
>pdb|2BCQ|P Chain P, DNA polymerase lambda in complex with a DNA duplex containing an unpaired Dtmp
CAGTACG
>pdb|2ALZ|P Chain P, Ternary Complex of hPoli with DNA and dCTP
AGGACCN
>pdb|2BZF|C Chain C, Structural basis for DNA bridging by barrier-to-autointegration factor (BAF)
CCTCCAC
>pdb|2BZF|B Chain B, Structural basis for DNA bridging by barrier-to-autointegration factor (BAF)
GTGGAGG
>pdb|2AXY|H Chain H, Crystal Structure of KH1 domain of human Poly(C)-binding protein-2 with C-rich strand of human telomeric DNA
AACCCTA
>pdb|2AXY|G Chain G, Crystal Structure of KH1 domain of human Poly(C)-binding protein-2 with C-rich strand of human telomeric DNA
AACCCTA
>pdb|2AXY|F Chain F, Crystal Structure of KH1 domain of human Poly(C)-binding protein-2 with C-rich strand of human telomeric DNA
AACCCTA
>pdb|2AXY|E Chain E, Crystal Structure of KH1 domain of human Poly(C)-binding protein-2 with C-rich strand of human telomeric DNA
AACCCTA
>pdb|1Y1Y|T Chain T, RNA Polymerase II-TFIIS-DNA/RNA complex
NACGCCT
>pdb|1Y77|N Chain N, Complete RNA Polymerase II elongation complex with substrate analogue GMPCPP
AAGTACT
>pdb|1Y1W|N Chain N, Complete RNA Polymerase II elongation complex
AAGTACT
>pdb|1XHV|K Chain K, HincII bound to cleaved cognate DNA GTCGAC and Mn2+
GCCGGTC
>pdb|1XHV|I Chain I, HincII bound to cleaved cognate DNA GTCGAC and Mn2+
GCCGGTC
>pdb|1XHV|G Chain G, HincII bound to cleaved cognate DNA GTCGAC and Mn2+
GCCGGTC
>pdb|1XHV|E Chain E, HincII bound to cleaved cognate DNA GTCGAC and Mn2+
GCCGGTC
>pdb|1XHU|K Chain K, HincII bound to cleaved, cognate DNA containing GTCGAC
GCCGGTC
>pdb|1XHU|I Chain I, HincII bound to cleaved, cognate DNA containing GTCGAC
GCCGGTC
>pdb|1XHU|G Chain G, HincII bound to cleaved, cognate DNA containing GTCGAC
GCCGGTC
>pdb|1XHU|E Chain E, HincII bound to cleaved, cognate DNA containing GTCGAC
GCCGGTC
>pdb|1S9B|B Chain B, Crystal Structure Analysis of the B-DNA GAATTCG
GAATTCG
>pdb|1S9B|A Chain A, Crystal Structure Analysis of the B-DNA GAATTCG
GAATTCG
>pdb|1UB8|F Chain F, Crystal structure of d(GCGAAGC), bending duplex with a bulge-in residue
GCGAAGC
>pdb|1UB8|E Chain E, Crystal structure of d(GCGAAGC), bending duplex with a bulge-in residue
GCGAAGC
>pdb|1UB8|D Chain D, Crystal structure of d(GCGAAGC), bending duplex with a bulge-in residue
GCGAAGC
>pdb|1UB8|C Chain C, Crystal structure of d(GCGAAGC), bending duplex with a bulge-in residue
GCGAAGC
>pdb|1UB8|B Chain B, Crystal structure of d(GCGAAGC), bending duplex with a bulge-in residue
GCGAAGC
>pdb|1UB8|A Chain A, Crystal structure of d(GCGAAGC), bending duplex with a bulge-in residue
GCGAAGC
>pdb|1R2O|X Chain X, d(GCATGCT) + Ni2+
GCATGCT
>pdb|1QZL|X Chain X, GCATGCT + Cobalt
GCATGCT
>pdb|1QYL|A Chain A, GCATGCT + Vanadium
GCATGCT
>pdb|1QYK|B Chain B, GCATGCT + Barium
GCATGCT
>pdb|1QYK|A Chain A, GCATGCT + Barium
GCATGCT
>pdb|1MF5|B Chain B, GCATGCT Quadruplex
GCATGCT
>pdb|1MF5|A Chain A, GCATGCT Quadruplex
GCATGCT
>pdb|1M8V|U Chain U, Structure of Pyrococcus abyssii Sm Protein in Complex with a Uridine Heptamer
NTTTTTT
>pdb|1M8V|T Chain T, Structure of Pyrococcus abyssii Sm Protein in Complex with a Uridine Heptamer
NTTTTTT
>pdb|1M8V|S Chain S, Structure of Pyrococcus abyssii Sm Protein in Complex with a Uridine Heptamer
NTTTTTT
>pdb|1M8V|R Chain R, Structure of Pyrococcus abyssii Sm Protein in Complex with a Uridine Heptamer
NTTTTTT
>pdb|1M8V|Q Chain Q, Structure of Pyrococcus abyssii Sm Protein in Complex with a Uridine Heptamer
NTTTTTT
>pdb|1M8V|P Chain P, Structure of Pyrococcus abyssii Sm Protein in Complex with a Uridine Heptamer
NTTTTTT
>pdb|1M8V|O Chain O, Structure of Pyrococcus abyssii Sm Protein in Complex with a Uridine Heptamer
NTTTTTT
>pdb|1M6R|B Chain B, Crystal structure of rGd(CGCGCG) forming hexamer Z-DNA duplex with 5'-(rG) overhang
GCGCGCG
>pdb|1M6R|A Chain A, Crystal structure of rGd(CGCGCG) forming hexamer Z-DNA duplex with 5'-(rG) overhang
GCGCGCG
>pdb|1L3Z|B Chain B, Crystal Structure Analysis of an RNA Heptamer
GTATACA
>pdb|1L3Z|A Chain A, Crystal Structure Analysis of an RNA Heptamer
GTATACA
>pdb|1M8X|D Chain D, Crystal Structure Of The Pumilio-Homology Domain From Human Pumilio1 In Complex With Nre1-14 Rna
NGTATAT
>pdb|1M8W|F Chain F, Crystal Structure Of The Pumilio-Homology Domain From Human Pumilio1 In Complex With Nre1-19 Rna
NGTCCAG
>pdb|1M8W|D Chain D, Crystal Structure Of The Pumilio-Homology Domain From Human Pumilio1 In Complex With Nre1-19 Rna
NGTATAT
>pdb|1FZP|K Chain K, CRYSTAL STRUCTURES OF SARA: A PLEIOTROPIC REGULATOR OF VIRULENCE GENES IN S. AUREUS
NTATATA
>pdb|1FZP|W Chain W, CRYSTAL STRUCTURES OF SARA: A PLEIOTROPIC REGULATOR OF VIRULENCE GENES IN S. AUREUS
NTATATA
>pdb|1FIU|L Chain L, Tetrameric Restriction Endonuclease Ngomiv In Complex With Cleaved Dna
NCGGCGC
>pdb|1FIU|K Chain K, Tetrameric Restriction Endonuclease Ngomiv In Complex With Cleaved Dna
NCGGCGC
>pdb|1FIU|J Chain J, Tetrameric Restriction Endonuclease Ngomiv In Complex With Cleaved Dna
NCGGCGC
>pdb|1FIU|I Chain I, Tetrameric Restriction Endonuclease Ngomiv In Complex With Cleaved Dna
NCGGCGC
>pdb|1QUM|C Chain C, Crystal Structure Of Escherichia Coli Endonuclease Iv In Complex With Damaged Dna
NCGACGA
>pdb|466D|D Chain D, Disorder And Twin Refinement Of Rna Heptamer Double Helix
GGGGCTA
>pdb|466D|C Chain C, Disorder And Twin Refinement Of Rna Heptamer Double Helix
TAGCTCC
>pdb|466D|B Chain B, Disorder And Twin Refinement Of Rna Heptamer Double Helix
GGGGCTA
>pdb|466D|A Chain A, Disorder And Twin Refinement Of Rna Heptamer Double Helix
TAGCTCC
>pdb|464D|D Chain D, Disorder And Twin Refinement Of Rna Heptamer Double Helix
GGGGCNA
>pdb|464D|C Chain C, Disorder And Twin Refinement Of Rna Heptamer Double Helix
TAGCTCC
>pdb|464D|B Chain B, Disorder And Twin Refinement Of Rna Heptamer Double Helix
GGGGCNA
>pdb|464D|A Chain A, Disorder And Twin Refinement Of Rna Heptamer Double Helix
TAGCTCC
>pdb|435D|D Chain D, 5'-R(UpApGpCpCpCpC)-3', 5'-R(GpGpGpGpCpUpA)-3'
GGGGCTA
>pdb|435D|C Chain C, 5'-R(UpApGpCpCpCpC)-3', 5'-R(GpGpGpGpCpUpA)-3'
TAGCCCC
>pdb|435D|B Chain B, 5'-R(UpApGpCpCpCpC)-3', 5'-R(GpGpGpGpCpUpA)-3'
GGGGCTA
>pdb|435D|A Chain A, 5'-R(UpApGpCpCpCpC)-3', 5'-R(GpGpGpGpCpUpA)-3'
TAGCCCC
>pdb|434D|D Chain D, 5'-R(UpApGpCpUpCpC)-3', 5'-R(GpGpGpGpCpUpA)-3'
GGGGCTA
>pdb|434D|C Chain C, 5'-R(UpApGpCpUpCpC)-3', 5'-R(GpGpGpGpCpUpA)-3'
TAGCTCC
>pdb|434D|B Chain B, 5'-R(UpApGpCpUpCpC)-3', 5'-R(GpGpGpGpCpUpA)-3'
GGGGCTA
>pdb|434D|A Chain A, 5'-R(UpApGpCpUpCpC)-3', 5'-R(GpGpGpGpCpUpA)-3'
TAGCTCC
>pdb|1QBJ|F Chain F, Crystal Structure Of The Zalpha Z-Dna Complex
TCGCGCG
>pdb|1QBJ|E Chain E, Crystal Structure Of The Zalpha Z-Dna Complex
TCGCGCG
>pdb|1QBJ|D Chain D, Crystal Structure Of The Zalpha Z-Dna Complex
TCGCGCG
>pdb|313D|B Chain B, Z-Dna Hexamer With 5' Overhangs That Form A Reverse Hoogsteen Base Pair
GNGCGCG
>pdb|313D|A Chain A, Z-Dna Hexamer With 5' Overhangs That Form A Reverse Hoogsteen Base Pair
GNGCGCG
>pdb|312D|B Chain B, Z-Dna Hexamer With 5' Overhangs That Form A Reverse Watson- Crick Base Pair
CCGCGCG
>pdb|312D|A Chain A, Z-Dna Hexamer With 5' Overhangs That Form A Reverse Watson- Crick Base Pair
GCGCGCG
>pdb|331D|B Chain B, Crystal Structure Of D(Gcgcgcg) With 5'-Overhang G's
GCGCGCG
>pdb|331D|A Chain A, Crystal Structure Of D(Gcgcgcg) With 5'-Overhang G's
GCGCGCG
>pdb|314D|B Chain B, Z-Dna Hexamer With 5' Overhangs That Form A Reverse Wobble Base Pair
TCGCGCG
>pdb|314D|A Chain A, Z-Dna Hexamer With 5' Overhangs That Form A Reverse Wobble Base Pair
GCGCGCG
>pdb|1ZQP|P Chain P, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Kcl (75 Millimolar) And Nacl (75 Millimolar)
NCTAATG
>pdb|1ZQO|P Chain P, Dna Polymerase Beta (pol B) (e.c.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Cacl2 (15 Millimolar) And Nacl (15 Millimolar)
NCTAATG
>pdb|1ZQN|P Chain P, Dna Polymerase Beta (pol B) (e.c.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Bacl2 (15 Millimolar) And Nacl (15 Millimolar)
NCTAATG
>pdb|1ZQM|P Chain P, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Mncl2 (15 Millimolar)
NCTAATG
>pdb|1ZQL|P Chain P, Dna Polymerase Beta (pol B) (e.c.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Mncl2 (15 Millimolar) And Mgcl2 (15 Millimolar)
NCTAATG
>pdb|1ZQK|P Chain P, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Kcl (75 Millimolar) And Mgcl2 (75 Millimolar)
NCTAATG
>pdb|1ZQJ|P Chain P, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Cacl2 (15 Millimolar) And Mgcl2 (15 Millimolar)
NCTAATG
>pdb|1ZQI|P Chain P, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Kcl (150 Millimolar)
NCTAATG
>pdb|1ZQH|P Chain P, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of A Sodium-Free Artificial Mother Liquor At Ph 7.5
NCTAATG
>pdb|1ZQG|P Chain P, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of A Sodium-Free Artificial Mother Liquor At Ph 6.5
NCTAATG
>pdb|1ZQF|P Chain P, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Cscl (150 Millimolar)
NCTAATG
>pdb|1ZQE|P Chain P, Dna Polymerase Beta (pol B) (e.c.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Crcl3 (saturated Solution)
NCTAATG
>pdb|1ZQD|P Chain P, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Cacl2 (150 Millimolar)
NCTAATG
>pdb|1ZQC|P Chain P, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Cacl2 (15 Millimolar)
NCTAATG
>pdb|1ZQB|P Chain P, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Bacl2 (150 Millimolar)
NCTAATG
>pdb|1ZQA|P Chain P, Dna Polymerase Beta (pol B) (e.c.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Kcl (150 Millimolar) At Ph 7.5
NCTAATG
>pdb|8ICA|P Chain P, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Datp (1 Millimolar) And Cacl2 (5 Millimolar)
NCTAATG
>pdb|7ICV|T Chain T, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Six Base Pairs Of Dna; Soaked In The Presence Of Mncl2 (0.1 Millimolar) And In The Absence Of Nacl
CATCTGT
>pdb|7ICU|T Chain T, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Six Base Pairs Of Dna; Soaked In The Presence Of Cdcl2 (0.1 Millimolar)
CATCTGT
>pdb|7ICT|T Chain T, Dna Polymerase Beta (E.C.2.7.7.7)DNA COMPLEX, SOAKED IN The Presence Of Zncl2 And Mgcl2
CATCTGT
>pdb|7ICS|T Chain T, Dna Polymerase Beta (E.C.2.7.7.7)DNA COMPLEX, SOAKED IN The Presence Of Zncl2
CATCTGT
>pdb|7ICR|T Chain T, Dna Polymerase Beta (e.c.2.7.7.7)/dna Complex, Soaked In The Presence Of Zncl2
CATCTGT
>pdb|7ICQ|T Chain T, Dna Polymerase Beta (E.C.2.7.7.7)DNA COMPLEX, SOAKED IN The Presence Of Zncl2
CATCTGT
>pdb|7ICP|T Chain T, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Six Base Pairs Of Dna; Soaked In The Presence Of Zncl2 (0.01 Millimolar)
CATCTGT
>pdb|7ICO|T Chain T, Dna Polymerase Beta (E.C.2.7.7.7)DNA COMPLEX, SOAKED IN The Presence Of Zncl2
CATCTGT
>pdb|7ICN|T Chain T, Dna Polymerase Beta (e.c.2.7.7.7)/dna Complex, Soaked In The Presence Of Nicl2
CATCTGT
>pdb|7ICM|T Chain T, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Six Base Pairs Of Dna; Soaked In The Presence Of Mncl2 (1.0 Millimolar)
CATCTGT
>pdb|7ICL|T Chain T, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Six Base Pairs Of Dna; Soaked In The Presence Of Mncl2 (0.1 Millimolar)
CATCTGT
>pdb|7ICK|T Chain T, Dna Polymerase Beta (E.C.2.7.7.7)DNA COMPLEX, SOAKED IN The Presence Of Mgcl2
CATCTGT
>pdb|7ICI|T Chain T, Dna Polymerase Beta (pol B) (e.c.2.7.7.7) Complexed With Six Base Pairs Of Dna; Soaked In The Presence Of Crcl3 (0.1 Millimolar)
CATCTGT
>pdb|7ICH|T Chain T, Dna Polymerase Beta (E.C.2.7.7.7)DNA COMPLEX, SOAKED IN The Presence Of Cocl2
CATCTGT
>pdb|7ICG|T Chain T, Dna Polymerase Beta (e.c.2.7.7.7)/dna Complex, Soaked In The Presence Of Cdcl2
CATCTGT
>pdb|7ICF|T Chain T, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Six Base Pairs Of Dna; Soaked In The Presence Of Cdcl2 (0.1 Millimolar) (Four-Day Soak)
CATCTGT
>pdb|7ICE|T Chain T, Dna Polymerase Beta (E.C.2.7.7.7)DNA COMPLEX, SOAKED IN The Presence Of Cacl2
CATCTGT
>pdb|1ZQT|P Chain P, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Datp (0.01 Millimolar) And Zncl2 (0.02 Millimolar)
NCTAATG
>pdb|1ZQS|P Chain P, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Tlcl (0.5 Millimolar)
NCTAATG
>pdb|1ZQR|P Chain P, Dna Polymerase Beta (E.C.2.7.7.7)DNA COMPLEX, SOAKED IN The Presence Of Nicl2
NCTAATG
>pdb|1ZQQ|P Chain P, Dna Polymerase Beta (pol B) (e.c.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Mncl2 (15 Millimolar) And Nacl (15 Millimolar)
NCTAATG
>pdb|9ICE|P Chain P, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Datp (1 Millimolar) And Cucl2 (0.1 Millimolar)
NCTAATG
>pdb|9ICC|P Chain P, Dna Polymerase Beta (e.c.2.7.7.7)/dna Complex + 2'- Deoxyadenosine-5'-triphosphate, Soaked In The Presence Of Datp And Crcl3
NCTAATG
>pdb|9ICB|P Chain P, Dna Polymerase Beta (E.C.2.7.7.7)DNA COMPLEX + 2'- Deoxyadenosine-5'-Triphosphate, Soaked In The Presence Of Datp And Cocl2
NCTAATG
>pdb|9ICA|P Chain P, Dna Polymerase Beta (E.C.2.7.7.7)DNA COMPLEX + 2'- Deoxyadenosine-5'-O-(1-Thiotriphosphate), Soaked In The Presence Of Datp(Alpha)s And Mncl2
NCTAATG
>pdb|8ICZ|P Chain P, Dna Polymerase Beta (pol B) (e.c.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Of Datp (1 Millimolar), Mncl2 (5 Millimolar), And Lithium Sulfate (75 Millimolar)
NCTAATG
>pdb|8ICX|P Chain P, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Dttp (1 Millimolar) And Mncl2 (5 Millimolar)
NCTAATG
>pdb|8ICT|P Chain P, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Dctp (1 Millimolar) And Mncl2 (5 Millimolar)
NCTAATG
>pdb|8ICS|P Chain P, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Dctp (1 Millimolar) And Mncl2 (5 Millimolar)
NCTAATG
>pdb|8ICQ|P Chain P, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Of Datp (0.1 Millimolar) And Mncl2 (0.5 Millimolar)
NCTAATG
>pdb|8ICO|P Chain P, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Azt-Tp (1 Millimolar) And Mncl2 (5 Millimolar)
NCTAATG
>pdb|8ICM|P Chain P, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Datp (1 Millimolar), Mncl2 (5 Millimolar), And Ammonium Sulfate (75 Millimolar)
NCTAATG
>pdb|8ICL|P Chain P, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Datp (1 Millimolar) And Nicl2 (5 Millimolar)
NCTAATG
>pdb|8ICJ|P Chain P, Dna Polymerase Beta (E.C.2.7.7.7)DNA COMPLEX + THYMIDINE- 5'-Triphosphate, Soaked In The Presence Of Dttp And Mgcl2
NCTAATG
>pdb|8ICI|P Chain P, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Dgtp (1 Millimolar) And Mgcl2 (5 Millimolar)
NCTAATG
>pdb|8ICH|P Chain P, Dna Polymerase Beta (pol B) (e.c.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Dctp (1 Millimolar) And Mgcl2 (5 Millimolar)
NCTAATG
>pdb|8ICG|P Chain P, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Datp (1 Millimolar) And Mgcl2 (5 Millimolar)
NCTAATG
>pdb|8ICF|P Chain P, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Datp (10 Millimolar) And Mgcl2 (50 Millimolar)
NCTAATG
>pdb|8ICC|P Chain P, Dna Polymerase Beta (pol B) (e.c.2.7.7.7) Complexed With Seven Base Pairs Of Dna (no 5'-phosphate)
NCTAATG
>pdb|8ICB|P Chain P, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Artificial Mother Liquor
NCTAATG
>pdb|9ICY|P Chain P, Dna Polymerase Beta (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna (Non Gapped Dna Only)
NCTAATG
>pdb|9ICY|T Chain T, Dna Polymerase Beta (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna (Non Gapped Dna Only)
CATTAGA
>pdb|9ICW|T Chain T, DNA POLYMERASE BETA (POL B) (E.C.2.7.7.7) COMPLEXED WITH SIX BASE PAIRS OF DNA; NATIVE STRUCTURE
CATCTGT
>pdb|9ICU|T Chain T, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Six Base Pairs Of Dna; Soaked In The Presence Of Dttp (1 Millimolar) And Mncl2 (5 Millimolar)
CATCTGT
>pdb|9ICT|T Chain T, Dna Polymerase Beta (E.C.2.7.7.7)DNA COMPLEX + 2'- Deoxyguanosine-5'-Triphosphate, Soaked In The Presence Of Dgtp And Mncl2
CATCTGT
>pdb|9ICS|T Chain T, Dna Polymerase Beta (E.C.2.7.7.7)DNA COMPLEX + 2',3'- Dideoxycytidine-5'-Triphosphate, Soaked In The Presence Of Ddctp And Mncl2
CATCTGT
>pdb|9ICR|T Chain T, Dna Polymerase Beta (E.C.2.7.7.7)DNA COMPLEX + 2'- Deoxycytidine-5'-Triphosphate, Soaked In The Presence Of Dctp And Mncl2
CATCTGT
>pdb|9ICQ|T Chain T, Dna Polymerase Beta (pol B) (e.c.2.7.7.7) Complexed With Six Base Pairs Of Dna; Soaked In The Presence Of Datp (1 Millimolar) And Mncl2 (5 Millimolar)
CATCTGT
>pdb|9ICP|T Chain T, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Six Base Pairs Of Dna; Soaked In The Presence Of Pyrophosphate (1 Millimolar) And Mgcl2 (5 Millimolar)
CATCTGT
>pdb|9ICO|T Chain T, Dna Polymerase Beta (E.C.2.7.7.7)DNA COMPLEX, SOAKED IN The Presence Of Dttp And Mgcl2
CATCTGT
>pdb|9ICN|T Chain T, Dna Polymerase Beta (E.C.2.7.7.7)DNA COMPLEX + 2',3'- Dideoxycytidine-5'-Triphosphate, Soaked In The Presence Of Ddctp And Mgcl2
CATCTGT
>pdb|9ICM|T Chain T, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Six Base Pairs Of Double Stranded Dna (No 5'-Phosphate)
CATCTGT
>pdb|9ICL|T Chain T, Dna Polymerase Beta (E.C.2.7.7.7)DNA COMPLEX, SOAKED IN The Presence Of Pyrophosphate And Mncl2
CATCTGT
>pdb|9ICK|T Chain T, Dna Polymerase Beta (E.C.2.7.7.7)DNA COMPLEX, SOAKED IN The Presence Of Artificial Mother Liquor
CATCTGT
>pdb|9ICJ|P Chain P, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna
NCTAATG
>pdb|9ICH|P Chain P, Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Dgtp (1 Millimolar) And Zncl2 (1 Millimolar)
NCTAATG
>pdb|9ICG|P Chain P, Dna Polymerase Beta (pol B) (e.c.2.7.7.7) Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Dctp (1 Millimolar) And Zncl2 (1 Millimolar)
NCTAATG
>pdb|184D|A Chain A, Self-Association Of A Dna Loop Creates A Quadruplex: Crystal Structure Of D(Gcatgct) At 1.8 Angstroms Resolution
GCATGCT
>pdb|5IP3|E Chain E, Tomato spotted wilt tospovirus nucleocapsid protein-ssDNA complex
NTTTTTT
>pdb|3QSU|P Chain P, Structure of Staphylococcus aureus Hfq in complex with A7 RNA
NAAAAAA
>pdb|3QSU|R Chain R, Structure of Staphylococcus aureus Hfq in complex with A7 RNA
NAAAAAA
>LY804997.1 KR 1020200047207-A/24: Recombinant vector for producing animal model with cardiac hypertrophy, transformed model with cardiac hypertrophy by the recombinant vector and a method of production thereof
GTGCCTT
>LY802113.1 KR 1020200008288-A/40: polypepide for delivery of antigen, Fc-fusion protein comprising thereof and use thereof
ACCATGG
>LY982274.1 KR 1020200035130-A/26: NUCLEIC ACID MOLECULES AND USES THEREOF
AAAAAAA
>LY844836.1 KR 1020200043322-A/6: Method for Diagnosing Alzheimer's disease Using microRNA-485-3p
TGTATGA
>LY977380.1 KR 1020200024305-A/187: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GGCTGCG
>LY977379.1 KR 1020200024305-A/186: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GATCTCG
>LY977378.1 KR 1020200024305-A/185: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
ATAGTAC
>LY977377.1 KR 1020200024305-A/184: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
AGAAGTC
>LY977376.1 KR 1020200024305-A/183: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GATTAGC
>LY977375.1 KR 1020200024305-A/182: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
ATATACG
>LY977374.1 KR 1020200024305-A/181: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
ATTGCCA
>LY977373.1 KR 1020200024305-A/180: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GGAACTA
>LY977372.1 KR 1020200024305-A/179: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CCGCTGG
>LY977371.1 KR 1020200024305-A/178: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GGTCGTT
>LY977370.1 KR 1020200024305-A/177: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
AGGCGGC
>LY977369.1 KR 1020200024305-A/176: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
TATCCGG
>LY977368.1 KR 1020200024305-A/175: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CTAGAGG
>LY977367.1 KR 1020200024305-A/174: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CCTAGAA
>LY977366.1 KR 1020200024305-A/173: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GATGCTG
>LY977365.1 KR 1020200024305-A/172: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
TAATTCT
>LY977364.1 KR 1020200024305-A/171: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CTTCTGC
>LY977363.1 KR 1020200024305-A/170: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
AGGTTGG
>LY977362.1 KR 1020200024305-A/169: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CAAGGCT
>LY977361.1 KR 1020200024305-A/168: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GCTTATT
>LY977360.1 KR 1020200024305-A/167: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
TCATGCA
>LY977359.1 KR 1020200024305-A/166: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
TAGACTA
>LY977358.1 KR 1020200024305-A/165: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GAGTTAA
>LY977357.1 KR 1020200024305-A/164: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GGTTGAA
>LY977356.1 KR 1020200024305-A/163: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CTATGCC
>LY977355.1 KR 1020200024305-A/162: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CGGCCTA
>LY977354.1 KR 1020200024305-A/161: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
AATCGTC
>LY977353.1 KR 1020200024305-A/160: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GCAGGTT
>LY977352.1 KR 1020200024305-A/159: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
ATGATTA
>LY977351.1 KR 1020200024305-A/158: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CGTAGGC
>LY977350.1 KR 1020200024305-A/157: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GCGCTCT
>LY977349.1 KR 1020200024305-A/156: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
AAGCTGA
>LY977348.1 KR 1020200024305-A/155: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GCCGGAC
>LY977347.1 KR 1020200024305-A/154: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GTCTTCT
>LY977346.1 KR 1020200024305-A/153: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CGCCGTC
>LY977345.1 KR 1020200024305-A/152: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
TTAGCTT
>LY977344.1 KR 1020200024305-A/151: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CTAAGTA
>LY977343.1 KR 1020200024305-A/150: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
TCAGTAT
>LY977342.1 KR 1020200024305-A/149: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CATACGT
>LY977341.1 KR 1020200024305-A/148: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GTCGCAG
>LY977340.1 KR 1020200024305-A/147: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GCGCGAG
>LY977339.1 KR 1020200024305-A/146: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GGACTGC
>LY977338.1 KR 1020200024305-A/145: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
TACGCCG
>LY977337.1 KR 1020200024305-A/144: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CTTGGTT
>LY977336.1 KR 1020200024305-A/143: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
ACCGTCG
>LY977335.1 KR 1020200024305-A/142: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GCCATAG
>LY977334.1 KR 1020200024305-A/141: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
TCTAGTT
>LY977333.1 KR 1020200024305-A/140: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
TCTGACT
>LY977332.1 KR 1020200024305-A/139: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CATCATT
>LY977331.1 KR 1020200024305-A/138: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CTTGACC
>LY977330.1 KR 1020200024305-A/137: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CCGGTAC
>LY977329.1 KR 1020200024305-A/136: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
ACCTGCT
>LY977328.1 KR 1020200024305-A/135: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GTCCAGT
>LY977327.1 KR 1020200024305-A/134: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
AGACCTT
>LY977326.1 KR 1020200024305-A/133: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CTGCGCG
>LY977325.1 KR 1020200024305-A/132: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
TTGAATT
>LY977324.1 KR 1020200024305-A/131: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
TTGCGAA
>LY977323.1 KR 1020200024305-A/130: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GCATTCG
>LY977322.1 KR 1020200024305-A/129: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
AGGTATT
>LY977321.1 KR 1020200024305-A/128: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CCTCCTG
>LY977320.1 KR 1020200024305-A/127: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
TATTCCA
>LY977319.1 KR 1020200024305-A/126: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CGGTTCT
>LY977318.1 KR 1020200024305-A/125: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
ACCATGA
>LY977317.1 KR 1020200024305-A/124: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CCGGATG
>LY977316.1 KR 1020200024305-A/123: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
TACTATT
>LY977315.1 KR 1020200024305-A/122: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
AGTACTG
>LY977314.1 KR 1020200024305-A/121: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GCGGCAT
>LY977313.1 KR 1020200024305-A/120: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CAATCGG
>LY977312.1 KR 1020200024305-A/119: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CCTATCT
>LY977311.1 KR 1020200024305-A/118: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GTAATTG
>LY977310.1 KR 1020200024305-A/117: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
TGGCATC
>LY977309.1 KR 1020200024305-A/116: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GACGTCA
>LY977308.1 KR 1020200024305-A/115: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CATATTG
>LY977307.1 KR 1020200024305-A/114: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CGAGATC
>LY977306.1 KR 1020200024305-A/113: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CCAATGC
>LY977305.1 KR 1020200024305-A/112: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GTTGCGT
>LY977304.1 KR 1020200024305-A/111: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GAGCATG
>LY977303.1 KR 1020200024305-A/110: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GAGATTC
>LY977302.1 KR 1020200024305-A/109: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GGACGCA
>LY977301.1 KR 1020200024305-A/108: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GGTACCT
>LY977300.1 KR 1020200024305-A/107: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CGCATTA
>LY977299.1 KR 1020200024305-A/106: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CAGGTCG
>LY977298.1 KR 1020200024305-A/105: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GATCCAA
>LY977296.1 KR 1020200024305-A/103: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
TGATAGT
>LY977294.1 KR 1020200024305-A/101: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
ACTTCAA
>LY977292.1 KR 1020200024305-A/99: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CGGAGTT
>LY977290.1 KR 1020200024305-A/97: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
GTACCGG
>LY977288.1 KR 1020200024305-A/95: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
AGTTGGT
>LY977286.1 KR 1020200024305-A/93: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
TTCGAGC
>LY977284.1 KR 1020200024305-A/91: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CATCGAG
>LY977282.1 KR 1020200024305-A/89: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
TCTCCAT
>LY977280.1 KR 1020200024305-A/87: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
ATCTTGC
>LY977278.1 KR 1020200024305-A/85: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
TTGATCC
>LY977276.1 KR 1020200024305-A/83: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
ACCTAGG
>LY977274.1 KR 1020200024305-A/81: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
TGCAGAG
>LY977272.1 KR 1020200024305-A/79: MULTIPLEXED RECEPTOR-LIGAND INTERACTION SCREENS
CCTGCGA
>LY927624.1 KR 1020200024905-A/2991: NOVEL NUCLEIC ACID MOLECULES
GGTTTGG
>LY823890.1 KR 1020200024127-A/10: ANALYSIS AND PREDICTION OF TRAUMATIC BRAIN INJURY AND CONCUSION SYMPTOMS
GCGGGGC
>LY823889.1 KR 1020200024127-A/9: ANALYSIS AND PREDICTION OF TRAUMATIC BRAIN INJURY AND CONCUSION SYMPTOMS
ATGCCTT
>LY823888.1 KR 1020200024127-A/8: ANALYSIS AND PREDICTION OF TRAUMATIC BRAIN INJURY AND CONCUSION SYMPTOMS
AAAGCTG
>LY823887.1 KR 1020200024127-A/7: ANALYSIS AND PREDICTION OF TRAUMATIC BRAIN INJURY AND CONCUSION SYMPTOMS
GTAAACA
>LY823886.1 KR 1020200024127-A/6: ANALYSIS AND PREDICTION OF TRAUMATIC BRAIN INJURY AND CONCUSION SYMPTOMS
AGCACCA
>LY823885.1 KR 1020200024127-A/5: ANALYSIS AND PREDICTION OF TRAUMATIC BRAIN INJURY AND CONCUSION SYMPTOMS
TCAAGTA
>LY823884.1 KR 1020200024127-A/4: ANALYSIS AND PREDICTION OF TRAUMATIC BRAIN INJURY AND CONCUSION SYMPTOMS
GCTACAT
>LY823883.1 KR 1020200024127-A/3: ANALYSIS AND PREDICTION OF TRAUMATIC BRAIN INJURY AND CONCUSION SYMPTOMS
TTGGCAA
>LY823882.1 KR 1020200024127-A/2: ANALYSIS AND PREDICTION OF TRAUMATIC BRAIN INJURY AND CONCUSION SYMPTOMS
CGAGGAG
>LY823881.1 KR 1020200024127-A/1: ANALYSIS AND PREDICTION OF TRAUMATIC BRAIN INJURY AND CONCUSION SYMPTOMS
GAGGTAG
>LY817330.1 KR 1020200072192-A/6: Novel miRNA mimics and uses thereof
ATGGAGT
>LY817329.1 KR 1020200072192-A/5: Novel miRNA mimics and uses thereof
TGGCCCT
>LY817328.1 KR 1020200072192-A/4: Novel miRNA mimics and uses thereof
GGGTATT
>LY920996.1 KR 1020200038236-A/738: COMPOSITIONS COMPRISING CURONS AND USES THEREOF
CTGCCGC
>LY920978.1 KR 1020200038236-A/720: COMPOSITIONS COMPRISING CURONS AND USES THEREOF
GGGGGCG
>LY920977.1 KR 1020200038236-A/719: COMPOSITIONS COMPRISING CURONS AND USES THEREOF
GCGGCGG
>LY795697.1 KR 1020190142776-A/5: 6-6 FUSED BICYCLIC HETEROARYL COMPOUNDS AND THEIR USE AS LATS INHIBITORS
NNAGAAW
>LY795342.1 KR 1020190141196-A/3: P-ETHOXY NUCLEIC ACIDS FOR BCL2 INHIBITION
TCCTTCC
>LY722252.1 KR 1020190142289-A/6: Method for Diagnosing Alzheimer's disease Using microRNA-485-3p
TGTATGA
>LY720452.1 KR 1020190137019-A/8: Modified nucleic acids suppressing microRNA and use thereof
GTGCCTT
>LY713837.1 KR 1020190096149-A/18: Skin-penetrating Delivery Carrier Comprising Nucleic Acid Complex and Uses thereof
GTCGGTG
>LY748748.1 KR 1020190115019-A/64: OPTIMIZED VECTOR FOR DELIVERY IN MICROBIAL POPULATIONS
GGTNACC
>LY748747.1 KR 1020190115019-A/63: OPTIMIZED VECTOR FOR DELIVERY IN MICROBIAL POPULATIONS
CCTNAGG
>LY748729.1 KR 1020190115019-A/45: OPTIMIZED VECTOR FOR DELIVERY IN MICROBIAL POPULATIONS
CANCATC
>LY748723.1 KR 1020190115019-A/39: OPTIMIZED VECTOR FOR DELIVERY IN MICROBIAL POPULATIONS
RGGNCCY
>LY748718.1 KR 1020190115019-A/34: OPTIMIZED VECTOR FOR DELIVERY IN MICROBIAL POPULATIONS
GAAABCC
>MC403028.1 JP 2018157825-A/6: Compositions and Methods for Regulating Cell Osmolarity
TGACTCA
>MC403025.1 JP 2018157825-A/3: Compositions and Methods for Regulating Cell Osmolarity
TGASTCA
>MC403024.1 JP 2018157825-A/2: Compositions and Methods for Regulating Cell Osmolarity
HGGAASR
>MC402347.1 JP 2019508037-A/156: COMPOSITIONS FOR ENHANCING TARGETED GENE EDITING AND METHODS OF USE THEREOF
AAAGAAA
>MC402345.1 JP 2019508037-A/154: COMPOSITIONS FOR ENHANCING TARGETED GENE EDITING AND METHODS OF USE THEREOF
AGAAAAA
>MC402343.1 JP 2019508037-A/152: COMPOSITIONS FOR ENHANCING TARGETED GENE EDITING AND METHODS OF USE THEREOF
AAAAGGA
>MC402327.1 JP 2019508037-A/136: COMPOSITIONS FOR ENHANCING TARGETED GENE EDITING AND METHODS OF USE THEREOF
TTNNNNT
>MC402325.1 JP 2019508037-A/134: COMPOSITIONS FOR ENHANCING TARGETED GENE EDITING AND METHODS OF USE THEREOF
TCCCCTT
>MC402324.1 JP 2019508037-A/133: COMPOSITIONS FOR ENHANCING TARGETED GENE EDITING AND METHODS OF USE THEREOF
TTCCCCT
>MC402299.1 JP 2019508037-A/108: COMPOSITIONS FOR ENHANCING TARGETED GENE EDITING AND METHODS OF USE THEREOF
TTTNTTT
>MC402297.1 JP 2019508037-A/106: COMPOSITIONS FOR ENHANCING TARGETED GENE EDITING AND METHODS OF USE THEREOF
TNTTTTT
>MC402295.1 JP 2019508037-A/104: COMPOSITIONS FOR ENHANCING TARGETED GENE EDITING AND METHODS OF USE THEREOF
TTTCTTT
>MC402290.1 JP 2019508037-A/99: COMPOSITIONS FOR ENHANCING TARGETED GENE EDITING AND METHODS OF USE THEREOF
TTTTTCT
>MC402289.1 JP 2019508037-A/98: COMPOSITIONS FOR ENHANCING TARGETED GENE EDITING AND METHODS OF USE THEREOF
TCTTTTT
>MC402286.1 JP 2019508037-A/95: COMPOSITIONS FOR ENHANCING TARGETED GENE EDITING AND METHODS OF USE THEREOF
TTTTNNT
>MC402280.1 JP 2019508037-A/89: COMPOSITIONS FOR ENHANCING TARGETED GENE EDITING AND METHODS OF USE THEREOF
TCCTTTT
>MC402279.1 JP 2019508037-A/88: COMPOSITIONS FOR ENHANCING TARGETED GENE EDITING AND METHODS OF USE THEREOF
TTTTCCT
>MC402235.1 JP 2019508037-A/44: COMPOSITIONS FOR ENHANCING TARGETED GENE EDITING AND METHODS OF USE THEREOF
NNTNTTN
>MC402229.1 JP 2019508037-A/38: COMPOSITIONS FOR ENHANCING TARGETED GENE EDITING AND METHODS OF USE THEREOF
TCTCCTT
>MC402228.1 JP 2019508037-A/37: COMPOSITIONS FOR ENHANCING TARGETED GENE EDITING AND METHODS OF USE THEREOF
TTCCTCT
>MC402225.1 JP 2019508037-A/34: COMPOSITIONS FOR ENHANCING TARGETED GENE EDITING AND METHODS OF USE THEREOF
CTTCTCC
>MC402224.1 JP 2019508037-A/33: COMPOSITIONS FOR ENHANCING TARGETED GENE EDITING AND METHODS OF USE THEREOF
CCTCTTC
>MC402211.1 JP 2019508037-A/20: COMPOSITIONS FOR ENHANCING TARGETED GENE EDITING AND METHODS OF USE THEREOF
TTTNTNN
>MC402210.1 JP 2019508037-A/19: COMPOSITIONS FOR ENHANCING TARGETED GENE EDITING AND METHODS OF USE THEREOF
TTTTNNN
>MC402207.1 JP 2019508037-A/16: COMPOSITIONS FOR ENHANCING TARGETED GENE EDITING AND METHODS OF USE THEREOF
CCTCTTT
>MC402206.1 JP 2019508037-A/15: COMPOSITIONS FOR ENHANCING TARGETED GENE EDITING AND METHODS OF USE THEREOF
TTTCTCC
>MC402204.1 JP 2019508037-A/13: COMPOSITIONS FOR ENHANCING TARGETED GENE EDITING AND METHODS OF USE THEREOF
CCCTTTT
>MC402198.1 JP 2019508037-A/7: COMPOSITIONS FOR ENHANCING TARGETED GENE EDITING AND METHODS OF USE THEREOF
AAAAGGG
>MC402196.1 JP 2019508037-A/5: COMPOSITIONS FOR ENHANCING TARGETED GENE EDITING AND METHODS OF USE THEREOF
GGAGAAA
>MC033991.1 JP 2018534950-A/20: THERAPEUTIC TARGETS FOR THE CORRECTION OF THE HUMAN DYSTROPHIN GENE BY GENE EDITING AND METHODS OF USE
NNAGAAW
>MC033695.1 JP 2018533958-A/6: METHOD OF PRODUCING PSICOSE FROM FRUCTOSE-CONTAINING SUBSTRATE
TTACAAA
>MC033694.1 JP 2018533958-A/5: METHOD OF PRODUCING PSICOSE FROM FRUCTOSE-CONTAINING SUBSTRATE
GAAAGGA
>MC184885.1 JP 2018533375-A/32: CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING HERPES SIMPLEX VIRUS
NNAGAAW
>MC183015.1 JP 2019505209-A/124: GENE MODIFICATION ASSAYS
CTGGCCG
>MC029420.1 JP 2018527943-A/69: METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
CTAAGTT
>MC409817.1 JP 2018183155-A/38: RETROVIRAL VECTOR WITH MINI-PROMOTER CASSETTE
RCCATGG
>MC409814.1 JP 2018183155-A/35: RETROVIRAL VECTOR WITH MINI-PROMOTER CASSETTE
CATTGGG
>MP567690.1 Sequence 44 from Patent WO2020056155
CCCCGGC
>MP567487.1 Sequence 44 from Patent WO2020056239
CCCCGGC
>MP563876.1 Sequence 120 from Patent EP3625244
GATACAA
>MP560420.1 Sequence 44 from Patent WO2020056147
CCCCGGC
>MP457040.1 Sequence 61 from Patent EP3594339
TTATGCT
>MP543958.1 Sequence 29 from Patent WO2020033951
TNNTTNT
>MP451218.1 Sequence 144 from Patent WO2019241692
CACAGTG
>MP538430.1 Sequence 44 from Patent WO2020047201
CCCCGGC
>MP353005.1 Sequence 2 from Patent WO2019200171
CCCCGGC
>MP441399.1 Sequence 14 from Patent EP3582790
TTATTTA
>MP434034.1 Sequence 55 from Patent EP3587576
TGATGAC
>MP434010.1 Sequence 31 from Patent EP3587576
GCTTTGG
>MP434008.1 Sequence 29 from Patent EP3587576
CTTTACC
>MP434006.1 Sequence 27 from Patent EP3587576
GCCTCCG
>MP434000.1 Sequence 21 from Patent EP3587576
CCCTCGC
>MP433996.1 Sequence 17 from Patent EP3587576
GTGATGA
>MP433994.1 Sequence 15 from Patent EP3587576
CCAAGTT
>MP433993.1 Sequence 14 from Patent EP3587576
CAAGTTC
>MP433989.1 Sequence 10 from Patent EP3587576
TCTTTAC
>MP522141.1 Sequence 49 from Patent EP3601598
GCTGAGT
>MP340132.1 Sequence 1 from Patent EP3546578
TGASTCA
>MP521868.1 Sequence 10 from Patent EP3600472
GCGGGGC
>MP521864.1 Sequence 6 from Patent EP3600472
AGCACCA
>MP521860.1 Sequence 2 from Patent EP3600472
CGAGGAG
>MP521865.1 Sequence 7 from Patent EP3600472
GTAAACA
>MP521861.1 Sequence 3 from Patent EP3600472
TTGGCAA
>MP521866.1 Sequence 8 from Patent EP3600472
AAAGCTG
>MP521862.1 Sequence 4 from Patent EP3600472
GCTACAT
>MP521867.1 Sequence 9 from Patent EP3600472
ATGCCTT
>MP521863.1 Sequence 5 from Patent EP3600472
TCAAGTA
>MP521859.1 Sequence 1 from Patent EP3600472
GAGGTAG
>MP606094.1 Sequence 30 from Patent WO2020084318
TTCGAAG
>MP338092.1 Sequence 1 from Patent WO2019185732
TGASTCA
>MP604527.1 Sequence 30 from Patent WO2020084319
TTCGAAG
>MP511797.1 Sequence 3 from Patent EP3612160
TCCTTCC
>MP507859.1 Sequence 1 from Patent EP3611262
ACGCGGG
>MP596647.1 Sequence 5 from Patent WO2020074906
ACCATGG
>MP314943.1 Sequence 9 from Patent EP3541934
GAAGAGC
>MP314942.1 Sequence 8 from Patent EP3541934
GCTCTTC
>MP497367.1 Sequence 7 from Patent WO2020025953
TAACTAG
>MP497366.1 Sequence 6 from Patent WO2020025953
TAGCTAG
>MP497365.1 Sequence 5 from Patent WO2020025953
TGACTAG
>MP497361.1 Sequence 1 from Patent WO2020025953
TTTTTTT
>MP400413.1 Sequence 10 from Patent EP3568483
CGCCACC
>MP635568.1 Sequence 26 from Patent WO2020033863
AAAAAAA
>MP398487.1 Sequence 49 from Patent EP3568470
GTAATGC
>MP484845.1 Sequence 44 from Patent WO2020023390
CCCCGGC
>MP579522.1 Sequence 44 from Patent WO2020069169
CCCCGGC
>MP391016.1 Sequence 48 from Patent EP3569252
TCGCCAA
>MP631084.1 Sequence 265 from Patent EP3573448
GAGTGAG
>MP631049.1 Sequence 230 from Patent EP3573448
ANCNANC
>MP631046.1 Sequence 227 from Patent EP3573448
TCCNACC
>MP631045.1 Sequence 226 from Patent EP3573448
ACCNANC
>MP631043.1 Sequence 224 from Patent EP3573448
ACCGACA
>MP631016.1 Sequence 197 from Patent EP3573448
ACACNNG
>MP631004.1 Sequence 185 from Patent EP3573448
CTAACCA
>MP630987.1 Sequence 168 from Patent EP3573448
ACGTGGC
>MP379462.1 Sequence 5 from Patent WO2019202162
ACATTCA
>MP389753.1 Sequence 14 from Patent WO2019209859
TAACAAC
>MB484024.1 JP 2019205446-A/1: EXPRESSION AND PURIFICATION OF CRM197 AND RELATED PROTEINS
GATATAC
>MB483357.1 JP 2019528312-A/18: MRNA-MEDIATED IMMUNIZATION METHODS
ACCATGG
>MB483356.1 JP 2019528312-A/17: MRNA-MEDIATED IMMUNIZATION METHODS
ANNATGG
>MB462063.1 JP 2018522249-A/32: Evaluation of Cas9 molecule/guide RNA molecule complexes
NNAGAAW
>MB453429.1 JP 2018519801-A/60: OPTIMIZED CRISPR/CAS9 SYSTEMS AND METHODS FOR GENE EDITING IN STEM CELLS
NNAGAAW
>MB474340.1 JP 2019526285-A/21: Gold Optimized CAR T-cells
TGGGGAT
>MB474335.1 JP 2019526285-A/16: Gold Optimized CAR T-cells
TTTTTTT
>MB474334.1 JP 2019526285-A/15: Gold Optimized CAR T-cells
TTTATTT
>MB474332.1 JP 2019526285-A/13: Gold Optimized CAR T-cells
TTTGTTT
>MB474330.1 JP 2019526285-A/11: Gold Optimized CAR T-cells
TGGGGAT
>MB430536.1 JP 2019522461-A/20: CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING DUCHENNE MUSCULAR DYSTROPHY
NNAGAAW
>MB430121.1 JP 2019522972-A/6086: Pre-mRNA splice switching or modulating oligonucleotides comprising bicyclic scaffold moieties, with improved characteristics for the treatment of genetic disorders
GGTTCTG
>MB430115.1 JP 2019522972-A/6080: Pre-mRNA splice switching or modulating oligonucleotides comprising bicyclic scaffold moieties, with improved characteristics for the treatment of genetic disorders
GCCCAAT
>MB430113.1 JP 2019522972-A/6078: Pre-mRNA splice switching or modulating oligonucleotides comprising bicyclic scaffold moieties, with improved characteristics for the treatment of genetic disorders
GCCCAAT
>MB422891.1 WO 2019181941-A/5: Method of determining risk of urothelial carcinoma
CGTGAGG
>LY711175.1 KR 1020190065455-A/28: IMMUNE REGULATORY OLIGONUCLEOTIDE(IRO) COMPOUNDS TO MODULATE TOLL-LIKE RECEPTOR BASED IMMUNE RESPONSE
TGTCGTT
>LY711150.1 KR 1020190065455-A/3: IMMUNE REGULATORY OLIGONUCLEOTIDE(IRO) COMPOUNDS TO MODULATE TOLL-LIKE RECEPTOR BASED IMMUNE RESPONSE
TGTCGTT
>LY671554.1 KR 1020190073338-A/2: Pharmaceutical composition inhibiting expression of CCND3 or PAK2 for prevention or treatment of cancer
AGGAGGG
>LY671553.1 KR 1020190073338-A/1: Pharmaceutical composition inhibiting expression of CCND3 or PAK2 for prevention or treatment of cancer
CCCTCCT
>LY670118.1 KR 1020190015385-A/255: APTAMER-BASED ANALYTE ASSAYS
AGGGGTG
>LY670090.1 KR 1020190015385-A/227: APTAMER-BASED ANALYTE ASSAYS
ATGTGGG
>LY670089.1 KR 1020190015385-A/226: APTAMER-BASED ANALYTE ASSAYS
GGTTCAT
>LY670086.1 KR 1020190015385-A/223: APTAMER-BASED ANALYTE ASSAYS
GTTTAGA
>LY670083.1 KR 1020190015385-A/220: APTAMER-BASED ANALYTE ASSAYS
TCGGTAG
>LY670040.1 KR 1020190015385-A/177: APTAMER-BASED ANALYTE ASSAYS
GGATAGT
>LY666259.1 KR 1020190005184-A/13: TLR9-TARGETED SPHERICAL NUCLEIC ACIDS HAVING POTENT ANTITUMOR ACTIVITY
NNGGGNN
>LY665313.1 KR 1020190017751-A/46: COMPOSITIONS AND METHODS FOR TREATMENT OF SKIN DISORDERS
CCGCGCC
>LY663909.1 KR 1020190062290-A/31: miRNA polymer and the method for preparing the same
GTGCTCT
>LY663869.1 KR 1020190062263-A/9: Composition for preventing hair loss or promoting hair growth comprising miRNA
CTGGGAT
>LY663868.1 KR 1020190062263-A/8: Composition for preventing hair loss or promoting hair growth comprising miRNA
AAAGGCG
>LY663867.1 KR 1020190062263-A/7: Composition for preventing hair loss or promoting hair growth comprising miRNA
AGGGCAG
>LY663866.1 KR 1020190062263-A/6: Composition for preventing hair loss or promoting hair growth comprising miRNA
CTCCCTT
>LY663865.1 KR 1020190062263-A/5: Composition for preventing hair loss or promoting hair growth comprising miRNA
GTGACTT
>LY663864.1 KR 1020190062263-A/4: Composition for preventing hair loss or promoting hair growth comprising miRNA
TGGGGGA
>LY663863.1 KR 1020190062263-A/3: Composition for preventing hair loss or promoting hair growth comprising miRNA
GGGTATT
>LY663862.1 KR 1020190062263-A/2: Composition for preventing hair loss or promoting hair growth comprising miRNA
ATGGAGT
>LY663861.1 KR 1020190062263-A/1: Composition for preventing hair loss or promoting hair growth comprising miRNA
TGGCCCT
>LY662127.1 KR 1020190040920-A/18: Expression cassettes for the production of target proteins with high expression and high functionality and use thereof
GCCTCAC
>LY662126.1 KR 1020190040920-A/17: Expression cassettes for the production of target proteins with high expression and high functionality and use thereof
CTCCTAC
>LY662125.1 KR 1020190040920-A/16: Expression cassettes for the production of target proteins with high expression and high functionality and use thereof
TGCTAAC
>LY661154.1 KR 1020190062159-A/9: Composition for wound healing or improving skin comprising miRNA
CTGGGAT
>LY661153.1 KR 1020190062159-A/8: Composition for wound healing or improving skin comprising miRNA
AAAGGCG
>LY661152.1 KR 1020190062159-A/7: Composition for wound healing or improving skin comprising miRNA
AGGGCAG
>LY661151.1 KR 1020190062159-A/6: Composition for wound healing or improving skin comprising miRNA
CTCCCTT
>LY661150.1 KR 1020190062159-A/5: Composition for wound healing or improving skin comprising miRNA
GTGACTT
>LY661149.1 KR 1020190062159-A/4: Composition for wound healing or improving skin comprising miRNA
TGGGGGA
>LY661148.1 KR 1020190062159-A/3: Composition for wound healing or improving skin comprising miRNA
GGGTATT
>LY661147.1 KR 1020190062159-A/2: Composition for wound healing or improving skin comprising miRNA
ATGGAGT
>LY661146.1 KR 1020190062159-A/1: Composition for wound healing or improving skin comprising miRNA
TGGCCCT
>LY693484.1 KR 1020190034344-A/2: METHOD AND SYSTEM FOR SEQUENCING NUCLEIC ACIDS
CAGCAGG
>LY691717.1 KR 1020190034320-A/5: MODIFIED NUCLEOTIDE TRIPHOSPHATES FOR MOLECULAR ELECTRONIC SENSORS
GATTACA
>LY655979.1 KR 1020190051510-A/6: Method for Diagnosing Alzheimer's disease Using microRNA-485-3p
TGTATGA
>LY647160.1 KR 1020190019291-A/10: Promoter of protein regulator of cytokinesis 1 for regulating cancer cell-specific gene expression and recombinant vector comprising the same
GGGATTA
>LY647158.1 KR 1020190019291-A/8: Promoter of protein regulator of cytokinesis 1 for regulating cancer cell-specific gene expression and recombinant vector comprising the same
TTAATTG
>LY647153.1 KR 1020190019291-A/3: Promoter of protein regulator of cytokinesis 1 for regulating cancer cell-specific gene expression and recombinant vector comprising the same
GCGGCAG
>MB197266.1 JP 2019514985-A/13: TLR-TARGETED SPHERICAL NUCLEIC ACIDS HAVING POTENT ANTITUMOR ACTIVITY
NNGGGNN
>MB143980.1 JP 2019514885-A/46: COMPOSITIONS AND METHODS FOR TREATMENT OF SKIN DISORDERS
CCGCGCC
>MB120612.1 JP 2019512260-A/1: Novel minimal UTR sequences
CGCCACC
>LY623773.1 KR 1020180131577-A/1: NOVEL MINIMAL UTR SEQUENCES
CGCCACC
>LY622120.1 KR 1020180120752-A/200: CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING BETA HEMOGLOBINOPATHIES
NNAGAAW
>LY584303.1 KR 1020180137435-A/3: Pharmaceutical composition for prevention or treatment of cancer
GGGTATT
>LY584302.1 KR 1020180137435-A/2: Pharmaceutical composition for prevention or treatment of cancer
ATGGAGT
>LY584301.1 KR 1020180137435-A/1: Pharmaceutical composition for prevention or treatment of cancer
TGGCCCT
>LY578724.1 KR 1020180002776-A/35: ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
GTTTTTG
>LY578703.1 KR 1020180002776-A/14: ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
ATTTGAG
>LY578702.1 KR 1020180002776-A/13: ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
TTTGAGG
>LY578693.1 KR 1020180002776-A/4: ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
ATTTGAG
>LY643651.1 KR 1020180137558-A/98: CONSTRUCT AND VECTOR FOR INTRAGENIC PLANT TRANSFORMATION
CCTCAGC
>LY606975.1 KR 1020180085055-A/6: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
TGACTCA
>LY606971.1 KR 1020180085055-A/2: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
HGGAASR
>LY606972.1 KR 1020180085055-A/3: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
TGASTCA
>LY567167.1 KR 1020180103433-A/13: Arabidopsis BAG genes expressed in response to stress in the Arabidopsis plant
TACGGTC
>MP185291.1 Sequence 35 from Patent EP3528841
AGACTTC
>MP185289.1 Sequence 33 from Patent EP3528841
TCGCAAG
>MP185286.1 Sequence 30 from Patent EP3528841
GAACCGG
>MP185285.1 Sequence 29 from Patent EP3528841
TCGGGAC
>MP185284.1 Sequence 28 from Patent EP3528841
ATTGCGG
>MP185283.1 Sequence 27 from Patent EP3528841
AACGGAC
>MP305484.1 Sequence 3169 from Patent WO2019086510
TTTTTTT
>MP287537.1 Sequence 195 from Patent WO2019104152
CCCCGGC
>MP276675.1 Sequence 50 from Patent WO2019155094
GGAAGAC
>MP276674.1 Sequence 49 from Patent WO2019155094
ACTGGCC
>MP276673.1 Sequence 48 from Patent WO2019155094
TTCAGCC
>MP276672.1 Sequence 47 from Patent WO2019155094
CAGCCAG
>MP276671.1 Sequence 46 from Patent WO2019155094
TTCAGCC
>MP276670.1 Sequence 45 from Patent WO2019155094
TCAGCCA
>MP276669.1 Sequence 44 from Patent WO2019155094
AAGTGCT
>MP276668.1 Sequence 43 from Patent WO2019155094
AGTGCTT
>MP276667.1 Sequence 42 from Patent WO2019155094
GTGAAAC
>MP276666.1 Sequence 41 from Patent WO2019155094
TATCTGT
>MP276665.1 Sequence 40 from Patent WO2019155094
GAAACTG
>MP276664.1 Sequence 39 from Patent WO2019155094
ATCTGTG
>MP276663.1 Sequence 38 from Patent WO2019155094
ATGGTTA
>MP276662.1 Sequence 37 from Patent WO2019155094
TGCTATC
>MP276661.1 Sequence 36 from Patent WO2019155094
CTATCTG
>MP276660.1 Sequence 35 from Patent WO2019155094
CTGTGAA
>MP276659.1 Sequence 34 from Patent WO2019155094
TGAAACT
>MP276658.1 Sequence 33 from Patent WO2019155094
GTGCTAT
>MP276657.1 Sequence 32 from Patent WO2019155094
TGTGAAA
>MP276656.1 Sequence 31 from Patent WO2019155094
GGTGCTA
>MP276655.1 Sequence 30 from Patent WO2019155094
GCTATCT
>MP276654.1 Sequence 29 from Patent WO2019155094
GGGTGCT
>MP276653.1 Sequence 28 from Patent WO2019155094
GTGGTCC
>MP276652.1 Sequence 27 from Patent WO2019155094
AGGTGGT
>MP276651.1 Sequence 26 from Patent WO2019155094
GCTGCTT
>MP276650.1 Sequence 25 from Patent WO2019155094
TGCTTGG
>MP276649.1 Sequence 24 from Patent WO2019155094
CTGCTTG
>MP276648.1 Sequence 23 from Patent WO2019155094
GGAAGAC
>MP276647.1 Sequence 22 from Patent WO2019155094
ACTGGCC
>MP276646.1 Sequence 21 from Patent WO2019155094
TCAGCCA
>MP276645.1 Sequence 20 from Patent WO2019155094
AAGTGCT
>MP276644.1 Sequence 19 from Patent WO2019155094
AGTGCTT
>MP276643.1 Sequence 18 from Patent WO2019155094
GGGGTGC
>MP276642.1 Sequence 17 from Patent WO2019155094
GGTGGTC
>MP264062.1 Sequence 56 from Patent WO2019086603
AGGTAGT
>MP264061.1 Sequence 55 from Patent WO2019086603
TGTAGGG
>MP264060.1 Sequence 54 from Patent WO2019086603
ATGGCTT
>MP264059.1 Sequence 53 from Patent WO2019086603
ATAGGGA
>MP264058.1 Sequence 52 from Patent WO2019086603
ATGGCTT
>MP264057.1 Sequence 51 from Patent WO2019086603
TAGGTAG
>MP264056.1 Sequence 50 from Patent WO2019086603
TTAGGTA
>MP264055.1 Sequence 49 from Patent WO2019086603
TTCATGT
>MP264054.1 Sequence 48 from Patent WO2019086603
GTTTCAT
>MP264053.1 Sequence 47 from Patent WO2019086603
AGTTTCA
>MP264052.1 Sequence 46 from Patent WO2019086603
TAGTTTC
>MP264051.1 Sequence 45 from Patent WO2019086603
GTAGTTT
>MP264050.1 Sequence 44 from Patent WO2019086603
GGTAGTT
>MP264049.1 Sequence 43 from Patent WO2019086603
AGGTAGT
>MP264048.1 Sequence 42 from Patent WO2019086603
GGCTAAA
>MP264047.1 Sequence 41 from Patent WO2019086603
GTAGGGC
>MP264046.1 Sequence 40 from Patent WO2019086603
TGTAGGG
>MP264045.1 Sequence 39 from Patent WO2019086603
TATGGCT
>MP264044.1 Sequence 38 from Patent WO2019086603
TTCATTC
>MP264043.1 Sequence 37 from Patent WO2019086603
TTTCATT
>MP264042.1 Sequence 36 from Patent WO2019086603
TTTTCAT
>MP264041.1 Sequence 35 from Patent WO2019086603
CTTTTCA
>MP264040.1 Sequence 34 from Patent WO2019086603
GGCTTTT
>MP264039.1 Sequence 33 from Patent WO2019086603
TGGCTTT
>MP264038.1 Sequence 32 from Patent WO2019086603
ATGGCTT
>MP252579.1 Sequence 56 from Patent EP3484526
TGTGCTT
>MP246721.1 Sequence 6 from Patent EP3510152
TATAWAW
>MP241128.1 Sequence 44 from Patent WO2019143803
ACCATGG
>MP231390.1 Sequence 5 from Patent EP3491150
GATTACA
>MP225385.1 Sequence 26 from Patent WO2019152692
AAAAAAA
>MP205531.1 Sequence 23 from Patent WO2019081935
CMCACCC
>MP205164.1 Sequence 49 from Patent WO2019086681
AGGAGGT
>MP202480.1 Sequence 23 from Patent WO2019081607
CGGGGAT
>MP202479.1 Sequence 22 from Patent WO2019081607
AACCGTT
>MP202477.1 Sequence 20 from Patent WO2019081607
AGCAGCA
>MP199579.1 Sequence 10 from Patent EP3480320
GGATCCG
>MP199573.1 Sequence 4 from Patent EP3480320
CCCGGGG
>MP290179.1 Sequence 44 from Patent WO2019104160
CCCCGGC
>MP288812.1 Sequence 195 from Patent WO2019104195
CCCCGGC
>MP264037.1 Sequence 31 from Patent WO2019086603
TAGGGAT
>MP264036.1 Sequence 30 from Patent WO2019086603
ATATAGG
>MP264035.1 Sequence 29 from Patent WO2019086603
TATAGGG
>MP264034.1 Sequence 28 from Patent WO2019086603
ATAGGGA
>MP264033.1 Sequence 27 from Patent WO2019086603
TTATTCC
>MP264031.1 Sequence 25 from Patent WO2019086603
TTTTATT
>MP264030.1 Sequence 24 from Patent WO2019086603
TTTTTAT
>MP264027.1 Sequence 21 from Patent WO2019086603
GGCTTTT
>MP264026.1 Sequence 20 from Patent WO2019086603
TGGCTTT
>MP264024.1 Sequence 18 from Patent WO2019086603
AGGTAGT
>MP264021.1 Sequence 15 from Patent WO2019086603
ATAGGGA
>MP264032.1 Sequence 26 from Patent WO2019086603
TTTATTC
>MP264029.1 Sequence 23 from Patent WO2019086603
CTTTTTA
>MP264028.1 Sequence 22 from Patent WO2019086603
GCTTTTT
>MP264025.1 Sequence 19 from Patent WO2019086603
ATGGCTT
>MP264023.1 Sequence 17 from Patent WO2019086603
TGTAGGG
>MP264022.1 Sequence 16 from Patent WO2019086603
ATGGCTT
>MP264020.1 Sequence 14 from Patent WO2019086603
ATGGCTT
>MP264356.1 Sequence 350 from Patent WO2019086603
GTGTTCA
>MP264355.1 Sequence 349 from Patent WO2019086603
AAGGCAC
>MP254720.1 Sequence 21 from Patent EP3518976
ACTTCCT
>MP254719.1 Sequence 20 from Patent EP3518976
ACTTCCT
>MP254713.1 Sequence 14 from Patent EP3518976
CCATTTT
>MP254703.1 Sequence 4 from Patent EP3518976
AAAATGG
>MB029146.1 JP 2019511216-A/10: AAV VECTORS FOR TREATMENT OF DOMINANT RETINITIS PIGMENTOSA
TGTGCTT
>MB029145.1 JP 2019511216-A/9: AAV VECTORS FOR TREATMENT OF DOMINANT RETINITIS PIGMENTOSA
TCAAGAG
>MA993111.1 JP 2017531437-A/2: Expression system for psicose epimerase and production for psicose using the same
GAAAGGA
>MB003719.1 JP 2017537641-A/3: EXPRESSION ELEMENT, EXPRESSION CASSETTE, AND VECTOR CONTAINING THE SAME
AGGAGGT
>MB022289.1 WO 2019077887-A/7: Logical engineering of D- and T-arms of tRNA that enhances D-amino acid and beta amino acid incorporation
TTCGAAT
>MB001620.1 JP 2017533733-A/196: HYBRIDIZATION PROBES AND METHODS
GAACGAC
>MB001619.1 JP 2017533733-A/195: HYBRIDIZATION PROBES AND METHODS
CACAGTG
>MA997057.1 JP 2017532979-A/37: PEPTIDE-MEDIATED DELIVERY OF RNA-GUIDED ENDONUCLEASE INTO CELLS
NNAGAAW
>MB013115.1 JP 2018500311-A/3: GENE THERAPY FOR JUVENILE BATTEN DISEASE
CAATAAA
>MB013060.1 JP 2017538418-A/31: Methods and Compositions for Detecting Antibiotic Resistant Bacteria
AATAAAT
>MA993120.1 JP 2017531437-A/11: Expression system for psicose epimerase and production for psicose using the same
GGACAAA
>MA993119.1 JP 2017531437-A/10: Expression system for psicose epimerase and production for psicose using the same
GCACAAA
>MA993118.1 JP 2017531437-A/9: Expression system for psicose epimerase and production for psicose using the same
GTACAAA
>MA993117.1 JP 2017531437-A/8: Expression system for psicose epimerase and production for psicose using the same
GAACAAA
>MA993116.1 JP 2017531437-A/7: Expression system for psicose epimerase and production for psicose using the same
TTACAAA
>MA851681.1 JP 2019030297-A/116: Single-Chain Multivalent Binding Proteins
CTCGAGT
>MA851680.1 JP 2019030297-A/115: Single-Chain Multivalent Binding Proteins
TGATCAG
>MP150586.1 Sequence 35 from Patent EP3446714
GCATGCT
>MP117168.1 Sequence 14 from Patent EP3456831
TGCTGAG
>MP112111.1 Sequence 18 from Patent WO2019043234
TCTAACT
>MP111507.1 Sequence 182 from Patent WO2019046817
AAATGGT
>MP111506.1 Sequence 181 from Patent WO2019046817
AATTGGT
>MP180234.1 Sequence 154 from Patent WO2019068880
TNCTATC
>MP180233.1 Sequence 153 from Patent WO2019068880
CNCTATC
>MP180232.1 Sequence 152 from Patent WO2019068880
ANCTATC
>MP180231.1 Sequence 151 from Patent WO2019068880
GNCTATC
>MP176511.1 Sequence 164 from Patent WO2019051470
GGNNNGG
>MP176510.1 Sequence 163 from Patent WO2019051470
GGNNNGG
>MP163277.1 Sequence 14 from Patent EP3460063
TGCTGAG
>MP155550.1 Sequence 17 from Patent EP3445448
CCGCGCC
>MP055698.1 Sequence 3 from Patent EP3406267
AGGAGAT
>MP055350.1 Sequence 81 from Patent EP3406722
AAGGAGG
>MP055349.1 Sequence 80 from Patent EP3406722
AGGAGGT
>MP042910.1 Sequence 3 from Patent WO2018213789
CCCCGGC
>MP021485.1 Sequence 2 from Patent WO2018200884
CGAGAAG
>MP021484.1 Sequence 1 from Patent WO2018200884
GCTCTTC
>MP016217.1 Sequence 11 from Patent WO2019018551
TTTTTTT
>MP075803.1 Sequence 10 from Patent EP3423582
TGTGCTT
>MP075802.1 Sequence 9 from Patent EP3423582
TCAAGAG
>MP067581.1 Sequence 66 from Patent WO2018232006
CCCCGGC
>LQ998296.1 Sequence 9 from Patent EP3428290
SWWWWWW
>LQ998295.1 Sequence 8 from Patent EP3428290
WSWWWWW
>LQ998294.1 Sequence 7 from Patent EP3428290
WWSWWWW
>LQ998293.1 Sequence 6 from Patent EP3428290
WWWSWWW
>LQ998292.1 Sequence 5 from Patent EP3428290
WWWWSWW
>LQ998291.1 Sequence 4 from Patent EP3428290
WWWWWSW
>LQ998290.1 Sequence 3 from Patent EP3428290
WWWWWWS
>LQ998289.1 Sequence 2 from Patent EP3428290
WWWWWWW
>FI617290.1 Wang-Penn1-June-203-week14-Avr-064354_3520_0467 Carl June Integration Site Library Homo sapiens genomic, genomic survey sequence
TGGCGGC
>CZ290577.1 cp70g07.f Candida parapsilosis Random Genomic Library Candida parapsilosis genomic clone cp70g07, genomic survey sequence
GATCACT
>CZ283869.1 cp32c03.f Candida parapsilosis Random Genomic Library Candida parapsilosis genomic clone cp32c03, genomic survey sequence
GATCAAC
>ET418670.1 S0253I16_SP6 CHORI-214 Salmo salar genomic clone S0253I16 3', genomic survey sequence
CTGGAAC
>ET417439.1 S0058L14_SP6 CHORI-214 Salmo salar genomic clone S0058L14 3', genomic survey sequence
TTTCTGG
>ET403464.1 S0231N22_SP6 CHORI-214 Salmo salar genomic clone S0231N22 3', genomic survey sequence
CCCTTCC
>ET394208.1 S0033M08_SP6 CHORI-214 Salmo salar genomic clone S0033M08 3', genomic survey sequence
CTGTTCT
>ET388065.1 S0026I23_SP6 CHORI-214 Salmo salar genomic clone S0026I23 3', genomic survey sequence
CCCTTAA
>ET353305.1 S0164K15_SP6 CHORI-214 Salmo salar genomic clone S0164K15 3', genomic survey sequence
TCCCTAT
>ET349023.1 S0239N02_SP6 CHORI-214 Salmo salar genomic clone S0239N02 3', genomic survey sequence
GTCCTGC
>ET331558.1 S0155M24_SP6 CHORI-214 Salmo salar genomic clone S0155M24 3', genomic survey sequence
TCTCAAC
>ET318374.1 S0213K13_SP6 CHORI-214 Salmo salar genomic clone S0213K13 3', genomic survey sequence
TCCTTTT
>ET296693.1 S0226G23_SP6 CHORI-214 Salmo salar genomic clone S0226G23 3', genomic survey sequence
TGGGATG
>ET278559.1 S0282J02_SP6 CHORI-214 Salmo salar genomic clone S0282J02 3', genomic survey sequence
CAAAGCC
>ET272509.1 S0131A03_SP6 CHORI-214 Salmo salar genomic clone S0131A03 3', genomic survey sequence
TTTTGTC
>ET252296.1 S0021M17_SP6 CHORI-214 Salmo salar genomic clone S0021M17 3', genomic survey sequence
CACGAGA
>ET250336.1 S0256G20_SP6 CHORI-214 Salmo salar genomic clone S0256G20 3', genomic survey sequence
TGCGTGG
>ED565534.1 AUAC-aax81f01.b1 Ascaris suum whole genome shotgun library (PMAJ_4 GSS) Ascaris suum genomic, genomic survey sequence
GGATTCG
>CL902929.1 CSHC2304 1188HC library Triticum aestivum genomic clone 1188HC01D02, genomic survey sequence
GCCGCCG
>CL692060.1 PRI0158a_D07_2 - PRI0158a.BR (7) Mixed stage fosmid library of P. pacificus var. California Pristionchus pacificus genomic, genomic survey sequence
CTCTCTC
>CL686739.1 PRI0145a_B02_2 - PRI0145a.BR (7) Mixed stage fosmid library of P. pacificus var. California Pristionchus pacificus genomic, genomic survey sequence
CGTTCTC
>CL686722.1 PRI0144d_H09_2 - PRI0144d.BR (7) Mixed stage fosmid library of P. pacificus var. California Pristionchus pacificus genomic, genomic survey sequence
ATCGACC
>CL686516.1 PRI0144b_G05_2 - PRI0144b.BR (7) Mixed stage fosmid library of P. pacificus var. California Pristionchus pacificus genomic, genomic survey sequence
ATTCAAT
>CL682672.1 PRI0134c_G06_2 - PRI0134c.BR (7) Mixed stage fosmid library of P. pacificus var. California Pristionchus pacificus genomic, genomic survey sequence
TTTGTCT
>CL681806.1 PRI0132a_F07_2 - PRI0132a.BR (7) Mixed stage fosmid library of P. pacificus var. California Pristionchus pacificus genomic, genomic survey sequence
AACCCAC
>CL669695.1 PRI0160a_D07 - PRI0160a.B21 (7) Mixed stage fosmid library of P. pacificus var. California Pristionchus pacificus genomic, genomic survey sequence
CGATGGG
>CL423859.1 01S0750-04C1-B12 UniformMu MuTAIL Library Zea mays genomic clone 01S0750-04C1-B12, genomic survey sequence
GTCAGTC
>CL423561.1 01S0557-03B1-E05 UniformMu MuTAIL Library Zea mays genomic clone 01S0557-03B1-E05, genomic survey sequence
TCCTTTG
>MA760182.1 JP 2017517261-A/156: NUCLEIC ACID COMPOUNDS FOR BINDING TO COMPLEMENT COMPONENT 3 PROTEIN
GNACRNN
>MA760158.1 JP 2017517261-A/132: NUCLEIC ACID COMPOUNDS FOR BINDING TO COMPLEMENT COMPONENT 3 PROTEIN
GNACGNN
>MA797661.1 JP 2018527020-A/2: Nucleic Acid Sequencing Methods and Systems
CAGCAGG
>MA796737.1 JP 2018525000-A/115: PATHOGEN-RESISTANT ANIMALS HAVING MODIFIED CD163 GENES
TACTACT
>DU672212.1 Bst004754 lambda03 Boechera stricta genomic clone SAD-EX-06-T3_B01, genomic survey sequence
GAAGAGC
>DU671466.1 Bst004008 lambda03 Boechera stricta genomic clone SAD-EX-05-T3_A12, genomic survey sequence
AAANGCC
>DU671146.1 Bst003688 lambda03 Boechera stricta genomic clone SAD-EX-04-T7_C06, genomic survey sequence
TCNTCTC
>DU670860.1 Bst003402 lambda03 Boechera stricta genomic clone SAD-EX-04-T3_F24, genomic survey sequence
CTTTNNC
>DU670775.1 Bst003317 lambda03 Boechera stricta genomic clone SAD-EX-04-T3_C11, genomic survey sequence
CGGATGC
>DU669788.1 Bst002330 lambda03 Boechera stricta genomic clone SAD-EX-02-T7_I03, genomic survey sequence
TCACGAT
>DU669786.1 Bst002328 lambda03 Boechera stricta genomic clone SAD-EX-02-T7_I01, genomic survey sequence
ACTCNTC
>DU766203.1 ANIW13337.g2 HF4000_12-21-03 uncultured marine microorganism HF4000_12-21-03 genomic clone HF4000_[384]035A24, genomic survey sequence
CAACTAA
>DU759278.1 ASNG2462.b2 HF200_10-06-02 uncultured marine microorganism HF200_10-06-02 genomic clone HF0200_085F08, genomic survey sequence
CCCGGAA
>DU756274.1 HF130_48_84TR HF130_10-06-02 uncultured marine microorganism HF130_10-06-02 genomic clone HF130_48_84TR, genomic survey sequence
AACGCCA
>DU743175.1 ASNC1596.b2 HF10_10-07-02 uncultured marine microorganism HF10_10-07-02 genomic clone HF0010_017D08, genomic survey sequence
GTTTGTT
>DU739683.1 APKI5354.g2 HF70_10-07-02 uncultured marine microorganism HF70_10-07-02 genomic clone HF0070_062B10, genomic survey sequence
CCCGGGG
>MA765078.1 JP 2017522897-A/48: GENETIC TARGETING IN NON-CONVENTIONAL YEAST USING AN RNA-GUIDED ENDONUCLEASE
NNAGAAW
>MA638260.1 JP 2017070307-A/1: Stabilization method of functional nucleic acid
GCGAAGC
>AM160294.1 AM160294 Xenoturbella bocki library Xenoturbella bocki cDNA clone Xet12_B11 5', mRNA sequence
CTGAATC
>CR554359.1 DKFZp468J184_r1 468 (synonym: phrt1) Pongo abelii cDNA clone DKFZp468J184 5', mRNA sequence
TAAATCG
>AL042652.1 DKFZp434N1921_r1 434 (synonym: htes3) Homo sapiens cDNA clone DKFZp434N1921, mRNA sequence
CGGTTTG
>AL042562.1 DKFZp434J1721_r1 434 (synonym: htes3) Homo sapiens cDNA clone DKFZp434J1721, mRNA sequence
CGGAATT
>GW794049.1 AmnE011001P0022A06.y_phred13_vc Alexandrium minutum normalized EST library Alexandrium minutum cDNA, mRNA sequence
GGGAACA
>GW793936.1 AmnE011001P0020H01.y_phred13_vc Alexandrium minutum normalized EST library Alexandrium minutum cDNA, mRNA sequence
CAAGGCG
>GW796295.1 AmnE011001P0045C04.y_phred13_vc Alexandrium minutum normalized EST library Alexandrium minutum cDNA, mRNA sequence
GGGGGGC
>GW792707.1 AmnE011001P0008A04.y_phred13_vc Alexandrium minutum normalized EST library Alexandrium minutum cDNA, mRNA sequence
GGGACGA
>GW792634.1 AmnE011001P0007C03.x_phred13_vc Alexandrium minutum normalized EST library Alexandrium minutum cDNA, mRNA sequence
ATAAGCT
>GW853628.1 CMi2083-2005-12-09 CMI Gadus morhua cDNA, mRNA sequence
TCCTCCC
>GW857667.1 CPY545-2005-10-12 CPY Gadus morhua cDNA, mRNA sequence
GGAACCC
>GW860377.1 Cta141-2005-06-08 CTA Gadus morhua cDNA, mRNA sequence
AAATAAG
>GW854946.1 COV341r1-2007-09-03 COV Gadus morhua cDNA, mRNA sequence
CGTATAT
>GW849503.1 CLE1238-2005-04-05 CLE Gadus morhua cDNA, mRNA sequence
TTCCCCC
>GW849452.1 CLE1001-2005-03-29 CLE Gadus morhua cDNA, mRNA sequence
CCAGTGC
>GW852339.1 CLU1723-2007-12-28 CLU Gadus morhua cDNA, mRNA sequence
CCCCCCC
>GW852335.1 CLU1719-2007-12-28 CLU Gadus morhua cDNA, mRNA sequence
CCCCCCC
>GW846282.1 CHO1203-2005-11-11 CHO Gadus morhua cDNA, mRNA sequence
CCTATTC
>GW843560.1 CE385-2005-01-14 CEM Gadus morhua cDNA, mRNA sequence
TTGACGC
>GW844172.1 CEM5368-2005-10-05 CEM Gadus morhua cDNA, mRNA sequence
CGCTTAA
>GW844022.1 CEM4325-2005-06-20 CEM Gadus morhua cDNA, mRNA sequence
GGGCCCA
>JZ144621.1 M0806176 Monochamus alternatus cDNA library Monochamus alternatus cDNA, mRNA sequence
TCGACAC
>JZ144520.1 M0806070 Monochamus alternatus cDNA library Monochamus alternatus cDNA, mRNA sequence
TCGACAC
>JG446737.1 03488 (Cs-2011) Coleochaete scutata cDNA library Coleochaete scutata cDNA clone Coleo-C-a-42n17.t7, mRNA sequence
GGGGAAG
>JG446490.1 03235 (Cs-2011) Coleochaete scutata cDNA library Coleochaete scutata cDNA clone Coleo-C-a-40d12.t7, mRNA sequence
AATTAGG
>HS076733.1 KYERRC001_08-G02-T3.ab1 Panax ginseng in vitro-cultured adventitious root cDNA library Panax ginseng cDNA, mRNA sequence
GCACGAG
>HS077917.1 KYERRC001_21-H04-T3.ab1 Panax ginseng in vitro-cultured adventitious root cDNA library Panax ginseng cDNA, mRNA sequence
GCACGAG
>HS079977.1 KYERRC001_43-F10-T3.ab1 Panax ginseng in vitro-cultured adventitious root cDNA library Panax ginseng cDNA, mRNA sequence
GCACGAG
>HS079954.1 KYERRC001_43-D11-T3.ab1 Panax ginseng in vitro-cultured adventitious root cDNA library Panax ginseng cDNA, mRNA sequence
GCACGAG
>HS079053.1 KYERRC001_33-H04-T3.ab1 Panax ginseng in vitro-cultured adventitious root cDNA library Panax ginseng cDNA, mRNA sequence
GCACGAG
>HS079044.1 KYERRC001_33-G07-T3.ab1 Panax ginseng in vitro-cultured adventitious root cDNA library Panax ginseng cDNA, mRNA sequence
GCACGAG
>HS078970.1 KYERRC001_33-A03-T3.ab1 Panax ginseng in vitro-cultured adventitious root cDNA library Panax ginseng cDNA, mRNA sequence
GCACGAG
>HS078500.1 KYERRC001_28-A06-T3.ab1 Panax ginseng in vitro-cultured adventitious root cDNA library Panax ginseng cDNA, mRNA sequence
GCACGAG
>HS078259.1 KYERRC001_25-E03-T3.ab1 Panax ginseng in vitro-cultured adventitious root cDNA library Panax ginseng cDNA, mRNA sequence
GCACGAG
>HS076611.1 KYERRC001_07-C12-T3.ab1 Panax ginseng in vitro-cultured adventitious root cDNA library Panax ginseng cDNA, mRNA sequence
GCACGAG
>EV286050.1 Tdi-CNS_20_M20.g Central Nervous System (CNS) from one juvenile Tritonia diomedea Tritonia diomedea cDNA, mRNA sequence
GCGGGAT
>HO698288.1 NLG1279-2007-06-29.ab1 Lepeophtheirus salmonis NLG Lepeophtheirus salmonis cDNA, mRNA sequence
ATAAAAA
>HO698026.1 292_CC515_G02_017.ab1 Lepeophtheirus salmonis CC Lepeophtheirus salmonis cDNA, mRNA sequence
TATCCTG
>HO701224.1 NLG4102-2009-02-24.ab1 Lepeophtheirus salmonis NLG Lepeophtheirus salmonis cDNA, mRNA sequence
ATTTTTC
>HO701072.1 NLG3864-2009-02-17.ab1 Lepeophtheirus salmonis NLG Lepeophtheirus salmonis cDNA, mRNA sequence
TATGGGA
>HO701017.1 NLG3766-2009-02-17.ab1 Lepeophtheirus salmonis NLG Lepeophtheirus salmonis cDNA, mRNA sequence
AATTGAA
>HO700858.1 NLG3548-2009-02-09.ab1 Lepeophtheirus salmonis NLG Lepeophtheirus salmonis cDNA, mRNA sequence
CAATAAA
>HO700741.1 NLG3375-2009-02-09.ab1 Lepeophtheirus salmonis NLG Lepeophtheirus salmonis cDNA, mRNA sequence
TTACTGG
>HO697895.1 NA501-2003-05-30.ab1 Lepeophtheirus salmonis NA Lepeophtheirus salmonis cDNA, mRNA sequence
AAAAAAA
>HO699575.1 NLG2959-2007-09-20.ab1 Lepeophtheirus salmonis NLG Lepeophtheirus salmonis cDNA, mRNA sequence
TGGGGGG
>HO687096.1 zslaa0_007264.z1.scf Lepeophtheirus salmonis LNO Lepeophtheirus salmonis cDNA, mRNA sequence
ATTTATA
>HO689054.1 zslaa0_009530.z1.scf Lepeophtheirus salmonis LNO Lepeophtheirus salmonis cDNA, mRNA sequence
CATTATA
>HO692812.1 zslaa0_013794.z1.scf Lepeophtheirus salmonis LNO Lepeophtheirus salmonis cDNA, mRNA sequence
AGGAAGC
>HO683931.1 zslaa0_002283.z1.scf Lepeophtheirus salmonis LNO Lepeophtheirus salmonis cDNA, mRNA sequence
GAGGAAG
>HO680637.1 LNO2478-2007-02-14.ab1 Lepeophtheirus salmonis LNO Lepeophtheirus salmonis cDNA, mRNA sequence
AAAAGGT
>HO680633.1 LNO2472-2007-02-14.ab1 Lepeophtheirus salmonis LNO Lepeophtheirus salmonis cDNA, mRNA sequence
CTGCAAA
>HO684794.1 zslaa0_003548.z1.scf Lepeophtheirus salmonis LNO Lepeophtheirus salmonis cDNA, mRNA sequence
AAGCGGC
>HO684764.1 zslaa0_003517.z1.scf Lepeophtheirus salmonis LNO Lepeophtheirus salmonis cDNA, mRNA sequence
TGCCCGG
>HO671841.1 345_FN456_SC11_T7.ab1 Lepeophtheirus salmonis SB Lepeophtheirus salmonis cDNA, mRNA sequence
GAAAAAA
>HO666966.1 482_FN1209_A02_005.ab1 Lepeophtheirus salmonis FB Lepeophtheirus salmonis cDNA, mRNA sequence
TTTTTTT
>HO666957.1 481_FN1192_D12_094.ab1 Lepeophtheirus salmonis FB Lepeophtheirus salmonis cDNA, mRNA sequence
TGGGAAG
>HO668811.1 542_FN1732_H04_011.ab1 Lepeophtheirus salmonis ME Lepeophtheirus salmonis cDNA, mRNA sequence
GGGGGCG
>HO668191.1 FN3403-2002-03-08.ab1 Lepeophtheirus salmonis ME Lepeophtheirus salmonis cDNA, mRNA sequence
GGGGGGG
>GT299727.1 FOAA-aaa10e10.g1 First instar Frankliniella occidentalis library Frankliniella occidentalis cDNA 5', mRNA sequence
GGGGTAC
>GW350709.1 CCASHALF07a02R Pigeonpea Asha leaf cDNA Library Cajanus cajan cDNA, mRNA sequence
AGACAGG
>GR470790.1 ICP7035_CS06_D01 Sterility mosaic disease (SMD) challenged (45 DAS) pigeonpea genotype ICP7035 leaf cDNA library Cajanus cajan cDNA clone ICP7035_CS06_D01 5', mRNA sequence
TTTCACG
>GR393895.1 CABB016TF ICC1882 field drought stressed root cDNA library Cicer arietinum cDNA clone CABB016TF 5', mRNA sequence
GCGGGGA
>GR283374.1 895556 Chlamydomonas reinhardtii (CC-503 strain) cells grown in liquid culture under constant light Chlamydomonas reinhardtii cDNA clone 9136_D08_3RACE 5' similar to EC 2.3.1.61, dihydrolipoyllysine-residue succinyltransferase, estExt_fgenesh2_pg.C_160090, mRNA sequence
GGGCTGC
>GH703630.1 galice5P0002F02_F.ab1_0_0_0_vc Fucus vesiculosus desiccation/rehydration library Fucus vesiculosus cDNA 5', mRNA sequence
CCCCCCC
>GO322728.1 FCMI-PM-2505 WSSV infected Penaeus monodon cDNA library Penaeus monodon cDNA clone FCMI-PM-2505 3', mRNA sequence
CGGGGGA
>GO322656.1 FCMI-PM-2699 WSSV infected Penaeus monodon cDNA library Penaeus monodon cDNA clone FCMI-PM-2699 3', mRNA sequence
TAGGCTG
>GO253154.1 Gpa_EST_P1_17-04M13F_E05_E05_020 Parasitic stage nematodes 7 days post infection Globodera pallida cDNA, mRNA sequence
CCCTTTT
>GO252955.1 Gpa_EST_P1_17-02M13F_B11_B11_047 Parasitic stage nematodes 7 days post infection Globodera pallida cDNA, mRNA sequence
CCCTTCA
>GO253162.1 Gpa_EST_P1_17-04M13F_F06_F06_019 Parasitic stage nematodes 7 days post infection Globodera pallida cDNA, mRNA sequence
CCCCCCT
>GO074590.1 PmTwI87G07.ab1_Seeing_2nd_1398 PmTwI Penaeus monodon cDNA 5', mRNA sequence
GCACAAG
>GO074567.1 PmTwI85E05.ab1_Seeing_2nd_1398 PmTwI Penaeus monodon cDNA 5', mRNA sequence
GCACGAG
>GO074563.1 PmTwI85D01.ab1_Seeing_2nd_1398 PmTwI Penaeus monodon cDNA 5', mRNA sequence
GCACGAG
>GH196711.1 FCMI-PM-352 WSSV infected Penaeus monodon cDNA library Penaeus monodon cDNA clone FCMI-PM-352 3', mRNA sequence
TTTTTTT
>GD196548.1 G1045P344RN3.T1 Aplysia californica Pooled Normalized Library Aplysia californica cDNA, mRNA sequence
ATAAAAA
>ES128125.1 154151_0532_1272 Arabidopsis ovule high throughput cDNA library Arabidopsis thaliana cDNA, mRNA sequence
AAGTTCC
>EL978248.1 012279_1620_2390 Arabidopsis ovule high throughput cDNA library Arabidopsis thaliana cDNA, mRNA sequence
AAAAAAC
>EV504545.1 GIARDIA013B07.G1 Giardia lamblia trophozoite Giardia intestinalis cDNA, mRNA sequence
TGATGAC
>EL934350.1 Centeaurea_plate-010_K14.trimmed.seq Centaurea normalized cDNA library Centaurea maculosa cDNA 5', mRNA sequence
CGCGGCT
>EL934254.1 Centeaurea_plate-010_G11.trimmed.seq Centaurea normalized cDNA library Centaurea maculosa cDNA 5', mRNA sequence
CCCGTTC
>EL934236.1 Centeaurea_plate-010_F17.trimmed.seq Centaurea normalized cDNA library Centaurea maculosa cDNA 5', mRNA sequence
CGATCTG
>EL932581.1 Centeaurea_plate-006_A13.trimmed.seq Centaurea normalized cDNA library Centaurea maculosa cDNA 5', mRNA sequence
GTGTTGG
>EL930916.1 Centeaurea_plate-001_K15.trimmed.seq Centaurea normalized cDNA library Centaurea maculosa cDNA 5', mRNA sequence
GACGCGC
>ES455212.1 piTE008xA16.b1.ab1 PiTE - Interaction library between Potato tuber and Phytophthora infestans Phytophthora infestans cDNA, mRNA sequence
GCGTGGC
>ES290068.1 PZ002H4.R germinating cysts of P. brassicae Phytophthora brassicae cDNA, mRNA sequence
CTGGTGC
>ES281772.1 pq007-a10.T7.187790.ab1 non-sporulating culture of P. brassicae Phytophthora brassicae cDNA, mRNA sequence
GGGCGGG
>FG707563.1 G1144P329RD13.T0 Anolis carolinensis pooled normalized embryo cDNA library Anolis carolinensis cDNA, mRNA sequence
AAAAAGG
>FG650614.1 G1142P310RC11.T0 Anolis carolinensis pooled normalized Brain cDNA Library Anolis carolinensis cDNA, mRNA sequence
AATTTTT
>FD933038.1 05_FB-C6_E04_10S Colonial bentgrass EST Agrostis capillaris cDNA, mRNA sequence
GGGGNCC
>EE487910.1 SD2MrC4 YG/PR Prunus cerasus cDNA, mRNA sequence
GCACGAG
>EY422482.1 YesTrp1127_Bco3_A05_2656 Aplysia kurodai nervous system random primed library Aplysia kurodai cDNA, mRNA sequence
ATTCCTT
>EY422481.1 YesTrp1127_Bco3_A05_2560 Aplysia kurodai nervous system random primed library Aplysia kurodai cDNA, mRNA sequence
TTTAAAG
>EY421251.1 YESTrp01_F09_069 Aplysia kurodai nervous system random primed library Aplysia kurodai cDNA, mRNA sequence
ATTCCAT
>FD476499.1 3P5T7RIP_E12_T7_087 frumisis3 Triticum turgidum subsp. durum cDNA clone 3P5T7RIP_E12_T7_087, mRNA sequence
CACGCTA
>EC611605.1 VDSF_10_fwd_Run02_Cp357_MD1/ C01.esd VDSF Euglena gracilis UTEX Euglena gracilis cDNA, mRNA sequence
CGGTATT
>EC611316.1 VDSF_7_rev_Run01_Cp357_MD1/ E11.esd VDSF Euglena gracilis UTEX Euglena gracilis cDNA, mRNA sequence
CATAGGG
>EC611161.1 VDSF_7_fwd_Run01_Cp357_MD1/ B06.esd VDSF Euglena gracilis UTEX Euglena gracilis cDNA, mRNA sequence
GTGTAGA
>EC610815.1 VDSF_5_fwd_Run01_Cp357_MD1/ C01.esd VDSF Euglena gracilis UTEX Euglena gracilis cDNA, mRNA sequence
GCCTTTG
>EC610733.1 VDSF_5_fwd_Run01_Cp357_MD1/ A08.esd VDSF Euglena gracilis UTEX Euglena gracilis cDNA, mRNA sequence
TCATTGG
>EC610255.1 VDSF_1_fwd_Run01_Cp357_MD1/ G09.esd VDSF Euglena gracilis UTEX Euglena gracilis cDNA, mRNA sequence
AAATNAC
>EC610254.1 VDSF_1_rev_Run01_Cp357_MD1/ G08.esd VDSF Euglena gracilis UTEX Euglena gracilis cDNA, mRNA sequence
CTAGGAG
>EC610203.1 VDSF_1_rev_Run01_Cp357_MD1/ F06.esd VDSF Euglena gracilis UTEX Euglena gracilis cDNA, mRNA sequence
ACTTCGC
>EC610110.1 VDSF_1_fwd_Run01_Cp357_MD1/ D08.esd VDSF Euglena gracilis UTEX Euglena gracilis cDNA, mRNA sequence
CCGGTCG
>EC610022.1 VDSF_1_fwd_Run01_Cp357_MD1/ B12.esd VDSF Euglena gracilis UTEX Euglena gracilis cDNA, mRNA sequence
CATTTTA
>EC609941.1 VDSF_11_R_Run01_Cp357_MD1/ H07.esd VDSF Euglena gracilis UTEX Euglena gracilis cDNA, mRNA sequence
CGTGGAG
>EC609925.1 VDSF_11_R_Run01_Cp357_MD1/ G11.esd VDSF Euglena gracilis UTEX Euglena gracilis cDNA, mRNA sequence
TCTGCTG
>EC429969.1 133232721 Sea Urchin Tube Foot DH5 cDNA library Strongylocentrotus purpuratus cDNA clone DH5TFSP-5O4 3', mRNA sequence
CGACATG
>EW691225.1 TFI_005_C9.T3 Torpedo californica electric organ Tetronarce californica cDNA, mRNA sequence
TGNCCNA
>EX947159.1 lj69a07.g7 Gnetum gnemon leaf (NYBG) Gnetum gnemon cDNA 3', mRNA sequence
GAACTAG
>EX927269.1 lk98c10.g7 Cycas ovule - normalized (NYBG) Cycas rumphii cDNA 3', mRNA sequence
TTAAGTT
>EX918030.1 lj14d11.g7 Cycas sporophyll (w/o ovule) (NYBG) Cycas rumphii cDNA 3', mRNA sequence
TCAACGG
>EX809551.1 iq15d07.g1 Cycas ovule (NYBG) Cycas rumphii cDNA 3', mRNA sequence
GGCACGA
>DV736463.1 AOyst.F3M3.ful02.aa.A010h05 Pacific oyster 3X3 MPSS QC library Crassostrea gigas cDNA, mRNA sequence
AAAAAAA
>DR026258.1 Osmo00125 F. cylindrus osmotic stress library Fragilariopsis cylindrus cDNA clone FcylESTa35d12.s1, mRNA sequence
CCCTTTT
>CK608378.1 IFN_N24 Interferon Stimulated Chicken PBL Macrophage Gallus gallus cDNA clone IFN_N24 5', mRNA sequence
GCGCGCA
>CK588427.1 IST_WI5_37509 AD-ORFeome1.0 library Caenorhabditis elegans cDNA 5' similar to K08E7.5, mRNA sequence
GAATCTT
>CB846672.2 M2PN-2422 MOUSE POST-NATAL DAY 2 EYE Mus musculus cDNA 5', mRNA sequence
CCACGCG
>CA853917.1 B13G06.seq cDNA Peking library 12hr SCN3 Glycine max cDNA clone B13G06 5', mRNA sequence
AGCTGCC
>CA851975.1 D19F10_K22_11.ab1 cDNA Peking library 2, 4 day SCN3 Glycine max cDNA clone D19F10 5', mRNA sequence
AANGGNG
>CA851776.1 D17D10_G22_07.ab1 cDNA Peking library 2, 4 day SCN3 Glycine max cDNA clone D17D10 5', mRNA sequence
ATACAAC
>CA850933.1 D08C12_F24_06.ab1 cDNA Peking library 2, 4 day SCN3 Glycine max cDNA clone D08C12 5', mRNA sequence
CCNGAAC
>CA850888.1 D07G02_M14_13.ab1 cDNA Peking library 2, 4 day SCN3 Glycine max cDNA clone D07G02 5', mRNA sequence
GANNTGC
>CA850834.1 D07A08_A20_02.ab1 cDNA Peking library 2, 4 day SCN3 Glycine max cDNA clone D07A08 5', mRNA sequence
NNGGGGG
>CA850763.1 D06C07_C07_05.ab1 cDNA Peking library 2, 4 day SCN3 Glycine max cDNA clone D06C07 5', mRNA sequence
NNCNGCC
>MA631865.1 JP 2018523977-A/32: CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR IMPROVING TRANSPLANTATION
NNAGAAW
>MA625821.1 JP 2018138590-A/1: METHODS FOR TAGGING DNA-ENCODED LIBRARIES
GTGCTGC
>MA427834.1 JP 2018143208-A/23: METHOD FOR INTRODUCING SINGLE BASE SUBSTITUTION INTO A TARGET DOUBLE-STRANDED POLYNUCLEOTIDE
NNNNACA
>MA427825.1 JP 2018143208-A/14: METHOD FOR INTRODUCING SINGLE BASE SUBSTITUTION INTO A TARGET DOUBLE-STRANDED POLYNUCLEOTIDE
TTGCGTC
>MA427824.1 JP 2018143208-A/13: METHOD FOR INTRODUCING SINGLE BASE SUBSTITUTION INTO A TARGET DOUBLE-STRANDED POLYNUCLEOTIDE
AGCAACA
>MA427823.1 JP 2018143208-A/12: METHOD FOR INTRODUCING SINGLE BASE SUBSTITUTION INTO A TARGET DOUBLE-STRANDED POLYNUCLEOTIDE
TGTGATC
>MA427822.1 JP 2018143208-A/11: METHOD FOR INTRODUCING SINGLE BASE SUBSTITUTION INTO A TARGET DOUBLE-STRANDED POLYNUCLEOTIDE
CCTGGCC
>MA427816.1 JP 2018143208-A/5: METHOD FOR INTRODUCING SINGLE BASE SUBSTITUTION INTO A TARGET DOUBLE-STRANDED POLYNUCLEOTIDE
NNNVACA
>MA427815.1 JP 2018143208-A/4: METHOD FOR INTRODUCING SINGLE BASE SUBSTITUTION INTO A TARGET DOUBLE-STRANDED POLYNUCLEOTIDE
NNNVRYA
>MA427812.1 JP 2018143208-A/1: METHOD FOR INTRODUCING SINGLE BASE SUBSTITUTION INTO A TARGET DOUBLE-STRANDED POLYNUCLEOTIDE
NNNVRYM
>MA410985.1 JP 2018517674-A/62: mRNA containing composition for treatment of tumor disease
GGTTTGG
>MA405258.1 WO 2018155427-A/32: A probe with reduced false positive binding, a method to desing the probe, and the use thereof
CCNCNCN
>MA405257.1 WO 2018155427-A/31: A probe with reduced false positive binding, a method to desing the probe, and the use thereof
CNCCNCN
>MA405256.1 WO 2018155427-A/30: A probe with reduced false positive binding, a method to desing the probe, and the use thereof
CNCNCCN
>MA405255.1 WO 2018155427-A/29: A probe with reduced false positive binding, a method to desing the probe, and the use thereof
CNCNCNC
>MA405254.1 WO 2018155427-A/28: A probe with reduced false positive binding, a method to desing the probe, and the use thereof
NCCNCCN
>MA405253.1 WO 2018155427-A/27: A probe with reduced false positive binding, a method to desing the probe, and the use thereof
NCCNCNC
>MA405252.1 WO 2018155427-A/26: A probe with reduced false positive binding, a method to desing the probe, and the use thereof
NCNCCNC
>MA405251.1 WO 2018155427-A/25: A probe with reduced false positive binding, a method to desing the probe, and the use thereof
NCNCNCC
>MA405250.1 WO 2018155427-A/24: A probe with reduced false positive binding, a method to desing the probe, and the use thereof
CCNCCNC
>MA405249.1 WO 2018155427-A/23: A probe with reduced false positive binding, a method to desing the probe, and the use thereof
CCNCNCC
>MA405248.1 WO 2018155427-A/22: A probe with reduced false positive binding, a method to desing the probe, and the use thereof
CNCCNCC
>MA405247.1 WO 2018155427-A/21: A probe with reduced false positive binding, a method to desing the probe, and the use thereof
GGNGNGN
>MA405246.1 WO 2018155427-A/20: A probe with reduced false positive binding, a method to desing the probe, and the use thereof
GNGNGGN
>MA405245.1 WO 2018155427-A/19: A probe with reduced false positive binding, a method to desing the probe, and the use thereof
GNGGNGN
>MA405244.1 WO 2018155427-A/18: A probe with reduced false positive binding, a method to desing the probe, and the use thereof
GNGNGNG
>MA405243.1 WO 2018155427-A/17: A probe with reduced false positive binding, a method to desing the probe, and the use thereof
NGGNGGN
>MA405242.1 WO 2018155427-A/16: A probe with reduced false positive binding, a method to desing the probe, and the use thereof
NGGNGNG
>MA405241.1 WO 2018155427-A/15: A probe with reduced false positive binding, a method to desing the probe, and the use thereof
NGNGGNG
>MA405240.1 WO 2018155427-A/14: A probe with reduced false positive binding, a method to desing the probe, and the use thereof
NGNGNGG
>MA405239.1 WO 2018155427-A/13: A probe with reduced false positive binding, a method to desing the probe, and the use thereof
GGNGGNG
>MA405238.1 WO 2018155427-A/12: A probe with reduced false positive binding, a method to desing the probe, and the use thereof
GGNGNGG
>MA405237.1 WO 2018155427-A/11: A probe with reduced false positive binding, a method to desing the probe, and the use thereof
GNGGNGG
>MA405228.1 WO 2018155427-A/2: A probe with reduced false positive binding, a method to desing the probe, and the use thereof
CCCCCCC
>MA405227.1 WO 2018155427-A/1: A probe with reduced false positive binding, a method to desing the probe, and the use thereof
GGGGGGG
>MA404818.1 WO 2018143477-A/92: Method for enginerring genome of dicotyledonous plants
ACAGTTC
>LQ935889.1 Sequence 2 from Patent EP2802655
GAAGAGC
>LQ935888.1 Sequence 1 from Patent EP2802655
GCTCTTC
>LQ993089.1 Sequence 114 from Patent EP2580329
KTWGTTT
>LQ993072.1 Sequence 97 from Patent EP2580329
MGGAWGT
>LQ993060.1 Sequence 85 from Patent EP2580329
TYAAGTG
>LQ993050.1 Sequence 75 from Patent EP2580329
GNCNGTT
>LQ993041.1 Sequence 66 from Patent EP2580329
AWTTTCC
>LQ993038.1 Sequence 63 from Patent EP2580329
AAGTGAA
>LQ993010.1 Sequence 35 from Patent EP2580329
GTNTGCT
>LQ992009.1 Sequence 51 from Patent WO2013049135
CTCGCAA
>LQ991982.1 Sequence 24 from Patent WO2013049135
CTGCGGA
>LQ991318.1 Sequence 16 from Patent WO2013048583
TTTTTTT
>LQ945620.1 Sequence 18 from Patent EP2692862
TCTGCCA
>LQ945610.1 Sequence 8 from Patent EP2692862
TGGCAGA
>LQ925725.1 Sequence 17 from Patent EP3394262
GCGCNCG
>LQ927087.1 Sequence 460 from Patent WO2018189382
TTACGTT
>LQ927080.1 Sequence 453 from Patent WO2018189382
TTACGTT
>LQ923733.1 Sequence 21 from Patent EP3394261
GCANNCC
>LQ915238.1 Sequence 1 from Patent EP3392338
GTGCTGC
>MA388973.1 JP 2018513685-A/12: Method for Blocking miRNA
AGCAGCA
>MA402282.1 JP 2018515138-A/35: ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
GTTTTTG
>MA402261.1 JP 2018515138-A/14: ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
ATTTGAG
>MA402260.1 JP 2018515138-A/13: ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
TTTGAGG
>MA402251.1 JP 2018515138-A/4: ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
ATTTGAG
>MA402139.1 JP 2018514233-A/6: Mixed sugar granule and method of preparing the same
TTACAAA
>MA402138.1 JP 2018514233-A/5: Mixed sugar granule and method of preparing the same
GAAAGGA
>MA402131.1 JP 2018514232-A/6: Saccharide mixture containing psicose with improved sweetness quality and crystallization
TTACAAA
>MA402130.1 JP 2018514232-A/5: Saccharide mixture containing psicose with improved sweetness quality and crystallization
GAAAGGA
>LQ902968.1 Sequence 6 from Patent EP3378943
TTACAAA
>LQ902967.1 Sequence 5 from Patent EP3378943
GAAAGGA
>LY549857.1 KR 1020170138548-A/351: RNA CONTAINING COMPOSITION FOR TREATMENT OF TUMOR DISEASES
GGTTTGG
>LY535013.1 KR 1020170102056-A/14: METHODS AND COMPOSITIONS FOR THE TARGETED MODIFICATION OF A GENOME
TGCTGAG
>LQ893871.1 Sequence 367 from Patent EP3369818
CAGCCAG
>LQ893870.1 Sequence 366 from Patent EP3369818
TTCAGCC
>LQ893867.1 Sequence 363 from Patent EP3369818
TCAGCCA
>LQ893611.1 Sequence 107 from Patent EP3369818
TCAAACT
>LQ893610.1 Sequence 106 from Patent EP3369818
GCCGCCA
>LQ893609.1 Sequence 105 from Patent EP3369818
TGCCGCC
>LQ893608.1 Sequence 104 from Patent EP3369818
GTGCCGC
>LQ893607.1 Sequence 103 from Patent EP3369818
CCTGAAC
>LQ893606.1 Sequence 102 from Patent EP3369818
CCCTGAA
>LQ893605.1 Sequence 101 from Patent EP3369818
GACTCCT
>LQ893604.1 Sequence 100 from Patent EP3369818
TGACTCC
>LQ893603.1 Sequence 99 from Patent EP3369818
GTGAAAC
>LQ893602.1 Sequence 98 from Patent EP3369818
TATCTGT
>LQ893601.1 Sequence 97 from Patent EP3369818
GAAACTG
>LQ893600.1 Sequence 96 from Patent EP3369818
ATCTGTG
>LQ893599.1 Sequence 95 from Patent EP3369818
ATGGTTA
>LQ893598.1 Sequence 94 from Patent EP3369818
TGCTATC
>LQ893597.1 Sequence 93 from Patent EP3369818
CTATCTG
>LQ893596.1 Sequence 92 from Patent EP3369818
CTGTGAA
>LQ893595.1 Sequence 91 from Patent EP3369818
TGAAACT
>LQ893594.1 Sequence 90 from Patent EP3369818
GTGCTAT
>LQ893593.1 Sequence 89 from Patent EP3369818
TGTGAAA
>LQ893592.1 Sequence 88 from Patent EP3369818
GGTGCTA
>LQ893591.1 Sequence 87 from Patent EP3369818
GCTATCT
>LQ893590.1 Sequence 86 from Patent EP3369818
GGGTGCT
>LQ893589.1 Sequence 85 from Patent EP3369818
TCTCACA
>LQ893588.1 Sequence 84 from Patent EP3369818
ACAGAAA
>LQ893587.1 Sequence 83 from Patent EP3369818
CAGAAAT
>LQ893586.1 Sequence 82 from Patent EP3369818
CACAGAA
>LQ893585.1 Sequence 81 from Patent EP3369818
ACACAGA
>LQ893584.1 Sequence 80 from Patent EP3369818
TCACACA
>LQ893583.1 Sequence 79 from Patent EP3369818
CACACAG
>LQ893582.1 Sequence 78 from Patent EP3369818
TGAAGGC
>LQ893581.1 Sequence 77 from Patent EP3369818
GAGGCAG
>LQ893580.1 Sequence 76 from Patent EP3369818
CCCGAGG
>LQ893579.1 Sequence 75 from Patent EP3369818
CATCTGT
>LQ893578.1 Sequence 74 from Patent EP3369818
TCATCTG
>LQ893577.1 Sequence 73 from Patent EP3369818
GCCTCAT
>LQ893576.1 Sequence 72 from Patent EP3369818
CTCATCT
>LQ893575.1 Sequence 71 from Patent EP3369818
CCTCATC
>LQ893574.1 Sequence 70 from Patent EP3369818
GTGGTCC
>LQ893573.1 Sequence 69 from Patent EP3369818
AGGTGGT
>LQ893572.1 Sequence 68 from Patent EP3369818
GCTGCTT
>LQ893571.1 Sequence 67 from Patent EP3369818
TGCTTGG
>LQ893570.1 Sequence 66 from Patent EP3369818
CTGCTTG
>LQ893569.1 Sequence 65 from Patent EP3369818
GCACATT
>LQ893568.1 Sequence 64 from Patent EP3369818
TATGGCG
>LQ893567.1 Sequence 63 from Patent EP3369818
ATTACAC
>LQ893566.1 Sequence 62 from Patent EP3369818
CATTACA
>LQ893565.1 Sequence 61 from Patent EP3369818
CACATTA
>LQ893564.1 Sequence 60 from Patent EP3369818
AAAAACC
>LQ893563.1 Sequence 59 from Patent EP3369818
AAAAAAC
>LQ893562.1 Sequence 58 from Patent EP3369818
TGGGGTC
>LQ893561.1 Sequence 57 from Patent EP3369818
CTGACCG
>LQ893560.1 Sequence 56 from Patent EP3369818
ACTGACC
>LQ893559.1 Sequence 55 from Patent EP3369818
CACTGAC
>LQ893558.1 Sequence 54 from Patent EP3369818
ACCACTG
>LQ893557.1 Sequence 53 from Patent EP3369818
CAAAACC
>LQ893556.1 Sequence 52 from Patent EP3369818
TCAAAAC
>LQ893555.1 Sequence 51 from Patent EP3369818
TCGACCG
>LQ893554.1 Sequence 50 from Patent EP3369818
AAACCAT
>LQ893553.1 Sequence 49 from Patent EP3369818
CATCGAC
>LQ893552.1 Sequence 48 from Patent EP3369818
AACCATC
>LQ893551.1 Sequence 47 from Patent EP3369818
ACCATCG
>LQ893550.1 Sequence 46 from Patent EP3369818
GCCAGCC
>LQ893549.1 Sequence 45 from Patent EP3369818
CTTCAGA
>LQ893548.1 Sequence 44 from Patent EP3369818
ACGCTGT
>LQ893547.1 Sequence 43 from Patent EP3369818
AACGCTG
>LQ893546.1 Sequence 42 from Patent EP3369818
CCTTCAG
>LQ893545.1 Sequence 41 from Patent EP3369818
CAACGCT
>LQ893544.1 Sequence 40 from Patent EP3369818
TCAACGC
>LQ893543.1 Sequence 39 from Patent EP3369818
AACATTC
>LQ893542.1 Sequence 38 from Patent EP3369818
TTCAACG
>LQ893541.1 Sequence 37 from Patent EP3369818
ATTCAAC
>LQ893540.1 Sequence 36 from Patent EP3369818
CATTCAA
>LQ893522.1 Sequence 18 from Patent EP3369818
AGTGCCG
>LQ893521.1 Sequence 17 from Patent EP3369818
CTCAAAC
>LQ893520.1 Sequence 16 from Patent EP3369818
CTGACTC
>LQ893519.1 Sequence 15 from Patent EP3369818
CTCACAC
>LQ893518.1 Sequence 14 from Patent EP3369818
GGGGTGC
>LQ893517.1 Sequence 13 from Patent EP3369818
CTCTGGG
>LQ893516.1 Sequence 12 from Patent EP3369818
ACATTAC
>LQ893515.1 Sequence 11 from Patent EP3369818
GGTGGTC
>LQ893514.1 Sequence 10 from Patent EP3369818
CCACTGA
>LQ893513.1 Sequence 9 from Patent EP3369818
CCATCGA
>LQ893512.1 Sequence 8 from Patent EP3369818
ACATTCA
>LQ885515.1 Sequence 183 from Patent EP3369817
AATACTG
>LQ885514.1 Sequence 182 from Patent EP3369817
AAACCAC
>LQ885513.1 Sequence 181 from Patent EP3369817
AGCAGCA
>LQ885512.1 Sequence 180 from Patent EP3369817
ACTGCAG
>LQ885511.1 Sequence 179 from Patent EP3369817
ACTGCAG
>LQ885510.1 Sequence 178 from Patent EP3369817
GATTGGT
>LQ885522.1 Sequence 190 from Patent EP3369817
GAGCTAA
>LQ885521.1 Sequence 189 from Patent EP3369817
ACTGGCC
>LQ885520.1 Sequence 188 from Patent EP3369817
ACTGGCC
>LQ885519.1 Sequence 187 from Patent EP3369817
GGTTCTA
>LQ885518.1 Sequence 186 from Patent EP3369817
TTGGCAA
>LQ885517.1 Sequence 185 from Patent EP3369817
TCAACGG
>LQ885516.1 Sequence 184 from Patent EP3369817
GTCTTAC
>LQ885509.1 Sequence 177 from Patent EP3369817
TTGGTCC
>LQ885508.1 Sequence 176 from Patent EP3369817
CAATATT
>LQ885507.1 Sequence 175 from Patent EP3369817
CAGTATT
>LQ885506.1 Sequence 174 from Patent EP3369817
AGCAGCA
>LQ885505.1 Sequence 173 from Patent EP3369817
TCAGCCA
>LQ885504.1 Sequence 172 from Patent EP3369817
TGAAATG
>LQ885503.1 Sequence 171 from Patent EP3369817
GATATGT
>LQ885502.1 Sequence 170 from Patent EP3369817
GGACGGA
>LQ885501.1 Sequence 169 from Patent EP3369817
AGCCCTT
>LQ885500.1 Sequence 168 from Patent EP3369817
AGCCCTT
>LQ885499.1 Sequence 167 from Patent EP3369817
TTTTTGC
>LQ885498.1 Sequence 166 from Patent EP3369817
CACAGTG
>LQ885497.1 Sequence 165 from Patent EP3369817
ATCATGT
>LQ885496.1 Sequence 164 from Patent EP3369817
TTGGCAC
>LQ885495.1 Sequence 163 from Patent EP3369817
GCCCTAA
>LQ885494.1 Sequence 162 from Patent EP3369817
AAGGTGC
>LQ885493.1 Sequence 161 from Patent EP3369817
CAGATTC
>LQ885492.1 Sequence 160 from Patent EP3369817
ACCCTGT
>LQ885491.1 Sequence 159 from Patent EP3369817
AACAAAT
>LQ885490.1 Sequence 158 from Patent EP3369817
AACAAAT
>LQ885489.1 Sequence 157 from Patent EP3369817
GGAAGAC
>LQ875942.1 Sequence 53 from Patent EP3362571
TTTTTTT
>LQ858810.1 Sequence 381 from Patent EP3360966
TCTTTGG
>LQ858809.1 Sequence 380 from Patent EP3360966
TTGGTTA
>LQ858808.1 Sequence 379 from Patent EP3360966
TTTGGTT
>LQ858807.1 Sequence 378 from Patent EP3360966
TAAAGCT
>LQ858806.1 Sequence 377 from Patent EP3360966
CTTTGGT
>LQ858805.1 Sequence 376 from Patent EP3360966
GTAGTGT
>LQ858804.1 Sequence 375 from Patent EP3360966
ATAAAGT
>LQ858803.1 Sequence 374 from Patent EP3360966
GATATGT
>LQ858802.1 Sequence 373 from Patent EP3360966
TCAGTAG
>LQ858801.1 Sequence 372 from Patent EP3360966
GCTACAT
>LQ858800.1 Sequence 371 from Patent EP3360966
CCTGGCA
>LQ858799.1 Sequence 370 from Patent EP3360966
GCTACAT
>LQ858798.1 Sequence 369 from Patent EP3360966
TGTACAG
>LQ858797.1 Sequence 368 from Patent EP3360966
TATACAA
>LQ858796.1 Sequence 367 from Patent EP3360966
GAGGTAG
>LQ858795.1 Sequence 366 from Patent EP3360966
GATTCCT
>LQ858794.1 Sequence 365 from Patent EP3360966
TCCAGTT
>LQ858793.1 Sequence 364 from Patent EP3360966
AACACCA
>LQ858792.1 Sequence 363 from Patent EP3360966
AGCTTAT
>LQ858791.1 Sequence 362 from Patent EP3360966
ATTATTA
>LQ858790.1 Sequence 361 from Patent EP3360966
CGTACCG
>LQ858789.1 Sequence 360 from Patent EP3360966
CCGTGGC
>LQ858788.1 Sequence 359 from Patent EP3360966
AACAGTC
>LQ858787.1 Sequence 358 from Patent EP3360966
GGTTGGG
>LQ858786.1 Sequence 357 from Patent EP3360966
ATTGCAC
>LQ858785.1 Sequence 356 from Patent EP3360966
GGGCTTA
>LQ858784.1 Sequence 355 from Patent EP3360966
TCACAGT
>LQ858783.1 Sequence 354 from Patent EP3360966
ACGCTCA
>LQ858782.1 Sequence 353 from Patent EP3360966
GAGTGTG
>LQ858781.1 Sequence 352 from Patent EP3360966
CTGTTCT
>LQ858780.1 Sequence 351 from Patent EP3360966
TCAAGTA
>LQ858779.1 Sequence 350 from Patent EP3360966
AACAAAT
>LQ858778.1 Sequence 349 from Patent EP3360966
AACAAAT
>LQ858777.1 Sequence 348 from Patent EP3360966
GGAAGAC
>LQ858544.1 Sequence 115 from Patent EP3360966
AAGCTAG
>LQ858543.1 Sequence 114 from Patent EP3360966
AAAGCTA
>LQ858542.1 Sequence 113 from Patent EP3360966
TAAAGCT
>LQ858541.1 Sequence 112 from Patent EP3360966
CTTTGGT
>LQ858540.1 Sequence 111 from Patent EP3360966
GTAGTGT
>LQ858539.1 Sequence 110 from Patent EP3360966
TGTAGTG
>LQ858538.1 Sequence 109 from Patent EP3360966
TGAGTGT
>LQ858537.1 Sequence 108 from Patent EP3360966
GAGTGTA
>LQ858536.1 Sequence 107 from Patent EP3360966
GTGTTTC
>LQ858535.1 Sequence 106 from Patent EP3360966
AGTGTTT
>LQ858534.1 Sequence 105 from Patent EP3360966
TAGTGTT
>LQ858533.1 Sequence 104 from Patent EP3360966
AAGTAGA
>LQ858532.1 Sequence 103 from Patent EP3360966
AGTAGAA
>LQ858531.1 Sequence 102 from Patent EP3360966
CCCATAA
>LQ858530.1 Sequence 101 from Patent EP3360966
AAAGTAG
>LQ858529.1 Sequence 100 from Patent EP3360966
CATAAAG
>LQ858528.1 Sequence 99 from Patent EP3360966
TAAAGTA
>LQ858527.1 Sequence 98 from Patent EP3360966
ATAAAGT
>LQ858526.1 Sequence 97 from Patent EP3360966
CCATAAA
>LQ858525.1 Sequence 96 from Patent EP3360966
ATATGTT
>LQ858524.1 Sequence 95 from Patent EP3360966
GATATGT
>LQ858523.1 Sequence 94 from Patent EP3360966
GAGGTAG
>LQ858522.1 Sequence 93 from Patent EP3360966
GCTACAT
>LQ858521.1 Sequence 92 from Patent EP3360966
GCTACAT
>LQ858520.1 Sequence 91 from Patent EP3360966
TCCAGTT
>LQ858519.1 Sequence 90 from Patent EP3360966
AGCTTAT
>LQ858518.1 Sequence 89 from Patent EP3360966
GTACCGT
>LQ858517.1 Sequence 88 from Patent EP3360966
ACAGTCT
>LQ858516.1 Sequence 87 from Patent EP3360966
AACAGTC
>LQ858515.1 Sequence 86 from Patent EP3360966
ATTGCAC
>LQ858514.1 Sequence 85 from Patent EP3360966
TCACAGT
>LQ858513.1 Sequence 84 from Patent EP3360966
CACGCTC
>LQ858512.1 Sequence 83 from Patent EP3360966
GCTCATG
>LQ858511.1 Sequence 82 from Patent EP3360966
CGCTCAT
>LQ858510.1 Sequence 81 from Patent EP3360966
ACGCTCA
>LQ858509.1 Sequence 80 from Patent EP3360966
TGCGTGG
>LQ858508.1 Sequence 79 from Patent EP3360966
TGAGTGT
>LQ858507.1 Sequence 78 from Patent EP3360966
AGTGTGT
>LQ858506.1 Sequence 77 from Patent EP3360966
GAGTGTG
>LQ858505.1 Sequence 76 from Patent EP3360966
CAAGTAA
>LQ858504.1 Sequence 75 from Patent EP3360966
TCAAGTA
>LQ858503.1 Sequence 74 from Patent EP3360966
ACAAGTC
>LQ858502.1 Sequence 73 from Patent EP3360966
AACAAGT
>LQ858501.1 Sequence 72 from Patent EP3360966
ACAAATC
>LQ858500.1 Sequence 71 from Patent EP3360966
CAAATCA
>LQ858499.1 Sequence 70 from Patent EP3360966
AACAAAT
>LQ858498.1 Sequence 69 from Patent EP3360966
GTGGAAG
>LQ858497.1 Sequence 68 from Patent EP3360966
TGGAAGA
>LQ858496.1 Sequence 67 from Patent EP3360966
CTAGTGA
>LQ858495.1 Sequence 66 from Patent EP3360966
ACTAGTG
>LQ858494.1 Sequence 65 from Patent EP3360966
GACTAGT
>LQ858493.1 Sequence 64 from Patent EP3360966
AGACTAG
>LQ858492.1 Sequence 63 from Patent EP3360966
AAGACTA
>LQ858491.1 Sequence 62 from Patent EP3360966
GAAGACT
>LQ858490.1 Sequence 61 from Patent EP3360966
GGAAGAC
>LQ839670.1 Sequence 81 from Patent EP3354740
AAGGAGG
>LQ839669.1 Sequence 80 from Patent EP3354740
AGGAGGT
>LQ826801.1 Sequence 1 from Patent EP3351631
GTGCTGC
>MA262162.1 JP 2016538001-A/5: SOMATIC HAPLOID HUMAN CELL LINE
NNAGAAN
>MA258565.1 JP 2017503169-A/70: DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS USING OLIGONUCLEOTIDES ANTIGENS
CGTTCTG
>MA258566.1 JP 2017503169-A/71: DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS USING OLIGONUCLEOTIDES ANTIGENS
GCTTCTG
>MA258512.1 JP 2017503169-A/17: DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS USING OLIGONUCLEOTIDES ANTIGENS
GGGGGGG
>MA258504.1 JP 2017503169-A/9: DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS USING OLIGONUCLEOTIDES ANTIGENS
TTTTTTT
>MA154287.1 JP 2016198110-A/13: Methods and Compositions for the Targeted Modification of a Genome
TGCTGAG
>MA257842.1 JP 2016539655-A/13: Methods and Compositions for the Targeted Modification of a Genome
TGCTGAG
>MA265100.1 JP 2017502661-A/15: Covered Sequence Conversion DNA and Detection Methods
CCTCAGC
>MA264549.1 JP 2017507955-A/12: SORAFENIB-MICRORNA COMBINATION THERAPY FOR LIVER CANCER
TGACCTA
>MA264546.1 JP 2017507955-A/9: SORAFENIB-MICRORNA COMBINATION THERAPY FOR LIVER CANCER
GGCAGTG
>MA142465.1 WO 2018038234-A/26: stress responsive promoter
ATGTNTG
>MA134113.1 JP 2018038372-A/11: Circular single-strand nucleic acid and preparation and use thereof
CGTCGCG
>MA134112.1 JP 2018038372-A/10: Circular single-strand nucleic acid and preparation and use thereof
CGCGACG
>MA134111.1 JP 2018038372-A/9: Circular single-strand nucleic acid and preparation and use thereof
CGAGCTA
>MA134110.1 JP 2018038372-A/8: Circular single-strand nucleic acid and preparation and use thereof
GATAGCG
>MA134109.1 JP 2018038372-A/7: Circular single-strand nucleic acid and preparation and use thereof
CACGCTA
>MA134108.1 JP 2018038372-A/6: Circular single-strand nucleic acid and preparation and use thereof
GTATCGC
>MA134107.1 JP 2018038372-A/5: Circular single-strand nucleic acid and preparation and use thereof
CTAGCGC
>MA134106.1 JP 2018038372-A/4: Circular single-strand nucleic acid and preparation and use thereof
CGCTAGC
>MA134105.1 JP 2018038372-A/3: Circular single-strand nucleic acid and preparation and use thereof
GTACGCT
>MA134104.1 JP 2018038372-A/2: Circular single-strand nucleic acid and preparation and use thereof
ATACGCG
>LQ777401.1 Sequence 115 from Patent EP3331355
TACTACT
>LQ770786.1 Sequence 4151 from Patent EP3328873
ACAATCC
>LQ746450.1 Sequence 5 from Patent EP3310169
GAGTRNG
>LQ746446.1 Sequence 1 from Patent EP3310169
GAGTRNG
>LQ717975.1 Sequence 81 from Patent EP3323881
AAGGAGG
>LQ717974.1 Sequence 80 from Patent EP3323881
AGGAGGT
>LQ716014.1 Sequence 1 from Patent EP3327123
ACGCGGG
>MA056371.1 JP 2018019697-A/37: Method for producing nucleic acid aptamer
GCGAAGC
>MA047716.1 JP 2018019694-A/151: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
CCACGCT
>MA047714.1 JP 2018019694-A/149: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
CCACGCT
>MA047712.1 JP 2018019694-A/147: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
CCACGCT
>MA047710.1 JP 2018019694-A/145: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
CCACGCT
>MA047708.1 JP 2018019694-A/143: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
CCACGCT
>MA047706.1 JP 2018019694-A/141: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
CCACGCT
>MA047704.1 JP 2018019694-A/139: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
CCACGCT
>MA047702.1 JP 2018019694-A/137: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
CCACGCT
>MA047700.1 JP 2018019694-A/135: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
CCACGCT
>MA047698.1 JP 2018019694-A/133: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
CCACGCT
>MA091915.1 JP 2018016633-A/45: Production and Utilization of A Novel Anti-Cancer Drug In Therapy
TACTTAT
>MA091914.1 JP 2018016633-A/44: Production and Utilization of A Novel Anti-Cancer Drug In Therapy
TACTAAC
>MA091910.1 JP 2018016633-A/40: Production and Utilization of A Novel Anti-Cancer Drug In Therapy
CTRAYNG
>MA091908.1 JP 2018016633-A/38: Production and Utilization of A Novel Anti-Cancer Drug In Therapy
GTAGAGT
>MA091876.1 JP 2018016633-A/6: Production and Utilization of A Novel Anti-Cancer Drug In Therapy
TACTWAY
>LQ707905.1 Sequence 26 from Patent WO2017136358
AAAAAAA
>LQ706657.1 Sequence 11 from Patent EP3214176
GGACAAA
>LQ706656.1 Sequence 10 from Patent EP3214176
GCACAAA
>LQ706655.1 Sequence 9 from Patent EP3214176
GTACAAA
>LQ706654.1 Sequence 8 from Patent EP3214176
GAACAAA
>LQ706653.1 Sequence 7 from Patent EP3214176
TTACAAA
>LQ706648.1 Sequence 2 from Patent EP3214176
GAAAGGA
>LP898602.1 Sequence 196 from Patent EP3218482
GAACGAC
>LP898601.1 Sequence 195 from Patent EP3218482
CACAGTG
>LP769089.1 Sequence 6 from Patent EP3295807
TTACAAA
>LP769088.1 Sequence 5 from Patent EP3295807
GAAAGGA
>LP893499.1 Sequence 2 from Patent EP3254109
CCTNAGG
>LP767873.1 Sequence 6 from Patent EP3295808
TTACAAA
>LP767872.1 Sequence 5 from Patent EP3295808
GAAAGGA
>LP945779.1 Sequence 133 from Patent EP3239302
CGCGCGG
>LP888254.1 Sequence 23 from Patent WO2017199041
CTGAGGC
>LP888252.1 Sequence 21 from Patent WO2017199041
CTGAGGC
>LP888251.1 Sequence 20 from Patent WO2017199041
CACCCAC
>LP762855.1 Sequence 35 from Patent EP3291839
GCATGCT
>LP756802.1 Sequence 78 from Patent WO2018007530
GGTGTAT
>LP756565.1 Sequence 35 from Patent WO2018026958
GCATGCT
>LP754444.1 Sequence 12 from Patent EP3280805
AGCAGCA
>LP751484.1 Sequence 31 from Patent EP3287528
CAGGAAC
>LP751476.1 Sequence 23 from Patent EP3287528
CAGGAAC
>LP933861.1 Sequence 125 from Patent WO2017122096
CTGGCCG
>LP870116.1 Sequence 37 from Patent EP3222727
GCGAAGC
>LP869633.1 Sequence 6 from Patent EP3222723
TACTWAY
>LP746485.1 Sequence 78 from Patent WO2018007767
GGTGTAT
>LP808195.1 Sequence 19 from Patent EP3283630
GCCCAGC
>LP808189.1 Sequence 13 from Patent EP3283630
GCCCAGC
>LP744493.1 Sequence 9 from Patent EP3273971
AAGCACA
>LP744492.1 Sequence 8 from Patent EP3273971
AGCACAA
>LP806546.1 Sequence 24 from Patent EP3266871
GCGNAGC
>LP805451.1 Sequence 21 from Patent EP3265561
AAAGAGA
>LP918277.1 Sequence 5 from Patent EP3241900
GTCCAGA
>LP918276.1 Sequence 4 from Patent EP3241900
GACCAGA
>LP983137.1 Sequence 168 from Patent WO2017143042
AAAGAAA
>LP983135.1 Sequence 166 from Patent WO2017143042
AGAAAAA
>LP983133.1 Sequence 164 from Patent WO2017143042
AAAAGGA
>LP983117.1 Sequence 148 from Patent WO2017143042
TTNNNNT
>LP983115.1 Sequence 146 from Patent WO2017143042
TCCCCTT
>LP983114.1 Sequence 145 from Patent WO2017143042
TTCCCCT
>LP983089.1 Sequence 120 from Patent WO2017143042
TTTNTTT
>LP983087.1 Sequence 118 from Patent WO2017143042
TNTTTTT
>LP983085.1 Sequence 116 from Patent WO2017143042
TTTCTTT
>LP983080.1 Sequence 111 from Patent WO2017143042
TTTTTCT
>LP983079.1 Sequence 110 from Patent WO2017143042
TCTTTTT
>LP983076.1 Sequence 107 from Patent WO2017143042
TTTTNNT
>LP983070.1 Sequence 101 from Patent WO2017143042
TCCTTTT
>LP983069.1 Sequence 100 from Patent WO2017143042
TTTTCCT
>LP983019.1 Sequence 50 from Patent WO2017143042
TCTCCTT
>LP983018.1 Sequence 49 from Patent WO2017143042
TTCCTCT
>LP983015.1 Sequence 46 from Patent WO2017143042
CTTCTCC
>LP983014.1 Sequence 45 from Patent WO2017143042
CCTCTTC
>LP983009.1 Sequence 40 from Patent WO2017143042
TNNTTNT
>LP982997.1 Sequence 28 from Patent WO2017143042
CCTCTTT
>LP982996.1 Sequence 27 from Patent WO2017143042
TTTCTCC
>LP982994.1 Sequence 25 from Patent WO2017143042
CCCTTTT
>LP982988.1 Sequence 19 from Patent WO2017143042
AAAAGGG
>LP982986.1 Sequence 17 from Patent WO2017143042
GGAGAAA
>LP982963.1 Sequence 168 from Patent WO2017143061
AAAGAAA
>LP982961.1 Sequence 166 from Patent WO2017143061
AGAAAAA
>LP982943.1 Sequence 148 from Patent WO2017143061
TTNNNNT
>LP982941.1 Sequence 146 from Patent WO2017143061
TCCCCTT
>LP982940.1 Sequence 145 from Patent WO2017143061
TTCCCCT
>LP982915.1 Sequence 120 from Patent WO2017143061
TTTNTTT
>LP982913.1 Sequence 118 from Patent WO2017143061
TNTTTTT
>LP982911.1 Sequence 116 from Patent WO2017143061
TTTCTTT
>LP982906.1 Sequence 111 from Patent WO2017143061
TTTTTCT
>LP982905.1 Sequence 110 from Patent WO2017143061
TCTTTTT
>LP982902.1 Sequence 107 from Patent WO2017143061
TTTTNNT
>LP982896.1 Sequence 101 from Patent WO2017143061
TCCTTTT
>LP982895.1 Sequence 100 from Patent WO2017143061
TTTTCCT
>LP982846.1 Sequence 50 from Patent WO2017143061
TCTCCTT
>LP982845.1 Sequence 49 from Patent WO2017143061
TTCCTCT
>LP982842.1 Sequence 46 from Patent WO2017143061
CTTCTCC
>LP982841.1 Sequence 45 from Patent WO2017143061
CCTCTTC
>LP982836.1 Sequence 40 from Patent WO2017143061
TNNTTNT
>LP982824.1 Sequence 28 from Patent WO2017143061
CCTCTTT
>LP982823.1 Sequence 27 from Patent WO2017143061
TTTCTCC
>LP982821.1 Sequence 25 from Patent WO2017143061
CCCTTTT
>LP982815.1 Sequence 19 from Patent WO2017143061
AAAAGGG
>LP982813.1 Sequence 17 from Patent WO2017143061
GGAGAAA
>LP800997.1 Sequence 11 from Patent EP3307786
CTTCCAA
>LP800996.1 Sequence 10 from Patent EP3307786
TTTTAAA
>LP800995.1 Sequence 9 from Patent EP3307786
TTCGTAA
>LP800994.1 Sequence 8 from Patent EP3307786
AGGTGAA
>LP800993.1 Sequence 7 from Patent EP3307786
TTTATAC
>LP909446.1 Sequence 107 from Patent EP3214174
AAGGCGC
>LP909445.1 Sequence 106 from Patent EP3214174
TACAAAG
>LP909444.1 Sequence 105 from Patent EP3214174
AAGTGCT
>LP909443.1 Sequence 104 from Patent EP3214174
AGTGCTT
>LP909442.1 Sequence 103 from Patent EP3214174
AAAGCGC
>LP909441.1 Sequence 102 from Patent EP3214174
GGAATGT
>LP909440.1 Sequence 101 from Patent EP3214174
AATACTG
>LP909439.1 Sequence 100 from Patent EP3214174
ATTTCAG
>LP909438.1 Sequence 99 from Patent EP3214174
CCTTCAT
>LP909437.1 Sequence 98 from Patent EP3214174
GTCTTAC
>LP909436.1 Sequence 97 from Patent EP3214174
AATACTG
>LP909435.1 Sequence 96 from Patent EP3214174
ATCTTAC
>LP909434.1 Sequence 95 from Patent EP3214174
AATACTG
>LP909433.1 Sequence 94 from Patent EP3214174
ATCTTAC
>LP909432.1 Sequence 93 from Patent EP3214174
AACACTG
>LP909431.1 Sequence 92 from Patent EP3214174
ATCTTCC
>LP909430.1 Sequence 91 from Patent EP3214174
AACACTG
>LP909429.1 Sequence 90 from Patent EP3214174
CCATCGA
>LP909428.1 Sequence 89 from Patent EP3214174
ACATTCA
>LP909427.1 Sequence 88 from Patent EP3214174
GTGTTCA
>LP909426.1 Sequence 87 from Patent EP3214174
AAGGCAC
>LP970707.1 Sequence 142 from Patent WO2017207979
GCCGCTT
>LP970705.1 Sequence 140 from Patent WO2017207979
TCGAGGA
>LP970703.1 Sequence 138 from Patent WO2017207979
GCCGTCG
>LP970701.1 Sequence 136 from Patent WO2017207979
ATGCGGC
>LP970699.1 Sequence 134 from Patent WO2017207979
TCGATGT
>LP970697.1 Sequence 132 from Patent WO2017207979
TCGTAAT
>LP970695.1 Sequence 130 from Patent WO2017207979
TCGTTGT
>LP970693.1 Sequence 128 from Patent WO2017207979
GGTCGAT
>LP970691.1 Sequence 126 from Patent WO2017207979
ATACATC
>LP970689.1 Sequence 124 from Patent WO2017207979
CATAGGT
>LP970687.1 Sequence 122 from Patent WO2017207979
CTTTAAA
>LP970685.1 Sequence 120 from Patent WO2017207979
CCATCTC
>LP970683.1 Sequence 118 from Patent WO2017207979
GCATAAC
>LP970681.1 Sequence 116 from Patent WO2017207979
GAATACG
>LP970679.1 Sequence 114 from Patent WO2017207979
TTTAAAT
>LP970677.1 Sequence 112 from Patent WO2017207979
CTTCTTT
>LP970675.1 Sequence 110 from Patent WO2017207979
GATGCGG
>LP970673.1 Sequence 108 from Patent WO2017207979
TAAGTTA
>LP793294.1 Sequence 2 from Patent WO2018035134
CAGCAGG
>LP729355.1 Sequence 10 from Patent EP3263707
CCCTCCC
>LP964335.1 Sequence 42 from Patent WO2017177131
CTCCCTC
>LP902016.1 Sequence 1 from Patent EP3180450
GAGACAG
>LZ993542.1 JP 2017534246-A/19: OLIGONUCLEOTIDE FRAGMENT, AND METHOD AS WELL AS APPLICATION OF SELECTIVE AMPLIFICTION OF VARIANT OF TARGET NUCLEIC ACID SEQUENCE USING THE SAME
GCCCAGC
>LZ993536.1 JP 2017534246-A/13: OLIGONUCLEOTIDE FRAGMENT, AND METHOD AS WELL AS APPLICATION OF SELECTIVE AMPLIFICTION OF VARIANT OF TARGET NUCLEIC ACID SEQUENCE USING THE SAME
GCCCAGC
>LZ991527.1 WO 2017221875-A/8: COMPLEX AND USE THEREOF
GCAATCA
>LZ991526.1 WO 2017221875-A/7: COMPLEX AND USE THEREOF
TGATTGC
>LZ991079.1 JP 2017213003-A/134: Sequences and their use for detection of Salmonella
GGCGCCT
>LZ991077.1 JP 2017213003-A/132: Sequences and their use for detection of Salmonella
AGGCGCC
>LZ991070.1 JP 2017213003-A/125: Sequences and their use for detection of Salmonella
GGGGCCC
>LZ991067.1 JP 2017213003-A/122: Sequences and their use for detection of Salmonella
GGGTCCT
>LZ991066.1 JP 2017213003-A/121: Sequences and their use for detection of Salmonella
GGGTCCC
>LZ991058.1 JP 2017213003-A/113: Sequences and their use for detection of Salmonella
AGGACCC
>LZ990011.1 JP 2017221207-A/81: COMPOSITIONS AND METHODS FOR PRODUCING ISOPRENE FREE OF C5 HYDROCARBONS UNDER DECOUPLING CONDITIONS AND/OR SAFE OPERATING RANGES
AAGGAGG
>LZ990010.1 JP 2017221207-A/80: COMPOSITIONS AND METHODS FOR PRODUCING ISOPRENE FREE OF C5 HYDROCARBONS UNDER DECOUPLING CONDITIONS AND/OR SAFE OPERATING RANGES
AGGAGGT
>LZ986406.1 JP 2017225396-A/8: Complex and use thereof
GCAATCA
>LZ986405.1 JP 2017225396-A/7: Complex and use thereof
TGATTGC
>LY495563.1 KR 1020170059948-A/6: Beverage with improved taste including fragment of fruit or plant and method of preparing the same
TTACAAA
>LY495562.1 KR 1020170059948-A/5: Beverage with improved taste including fragment of fruit or plant and method of preparing the same
GAAAGGA
>LY491507.1 KR 1020170057078-A/6: METHOD OF PREPARING PSICOSE FROM FRUCTOSE-CONTAINING SUBSTRATE
TTACAAA
>LY491506.1 KR 1020170057078-A/5: METHOD OF PREPARING PSICOSE FROM FRUCTOSE-CONTAINING SUBSTRATE
GAAAGGA
>LY508206.1 KR 1020170036792-A/49: GENETIC TARGETING IN NON-CONVENTIONAL YEAST USING AN RNA-GUIDED ENDONUCLEASE
NNAGAAW
>LZ952342.1 JP 2017200908-A/69: POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF FOR TREATMENT OF IMMUNE RELATED DISORDERS AND CANCER
AGAAAKA
>LZ228099.1 JP 2017522005-A/18: HUNTINGTON'S DISEASE THERAPEUTIC COMPOUNDS
CGCCTAC
>LZ228098.1 JP 2017522005-A/17: HUNTINGTON'S DISEASE THERAPEUTIC COMPOUNDS
CGCYTAC
>LZ177372.1 JP 2017145222-A/1: Prophylactic and therapeutic agent for liver fibrosis
TAGCACC
>LX281020.1 JP 2016508367-A/58: LNA OLIGONUCLEOTIDE CARBOHYDRATE CONJUGATES
ACACTCC
>LX281010.1 JP 2016508367-A/48: LNA OLIGONUCLEOTIDE CARBOHYDRATE CONJUGATES
ATGTAGC
>LX281005.1 JP 2016508367-A/43: LNA OLIGONUCLEOTIDE CARBOHYDRATE CONJUGATES
ATAAGCT
>LX281000.1 JP 2016508367-A/38: LNA OLIGONUCLEOTIDE CARBOHYDRATE CONJUGATES
CAATGCA
>LX279293.1 JP 2016105724-A/54: Complexation of nucleic acids with disulfide-linked cationic polymers for transfection and immunostimulation
GGTTTGG
>LZ099266.1 JP 2017123856-A/81: COMPOSITIONS AND METHODS FOR PRODUCING ISOPRENE
AAGGAGG
>LZ099265.1 JP 2017123856-A/80: COMPOSITIONS AND METHODS FOR PRODUCING ISOPRENE
AGGAGGT
>LX295427.1 JP 2015529449-A/1: DNA-ENCODED LIBRARIES HAVING ENCODING OLIGONUCLEOTIDE LINKAGES NOT READABLE BY POLYMERASES
GTGCTGC
>LY409567.1 KR 1020160122850-A/12: SORAFENIB-MICRORNA COMBINATION THERAPY FOR LIVER CANCER
TGACCTA
>LY409564.1 KR 1020160122850-A/9: SORAFENIB-MICRORNA COMBINATION THERAPY FOR LIVER CANCER
GGCAGTG
>LY268252.1 KR 1020160142130-A/6: Premix composition for preparing cookie with soft and wet taste and cookie prepared from the premix composition
TTACAAA
>LY268251.1 KR 1020160142130-A/5: Premix composition for preparing cookie with soft and wet taste and cookie prepared from the premix composition
GAAAGGA
>LY268981.1 KR 1020170003260-A/6: fermented alcoholic beverage of grains with improved storage stability and sweetness quality and method of preparing the same
TTACAAA
>LY268980.1 KR 1020170003260-A/5: fermented alcoholic beverage of grains with improved storage stability and sweetness quality and method of preparing the same
GAAAGGA
>LY268864.1 KR 1020170001153-A/6: Ice cream composition with low calories and low fat and method of preparing the same
TTACAAA
>LY268863.1 KR 1020170001153-A/5: Ice cream composition with low calories and low fat and method of preparing the same
GAAAGGA
>LY410798.1 KR 1020160135754-A/72: COMPOSITIONS AND METHODS FOR ENHANCED GENE EXPRESSION IN CONE CELLS
ACCATGG
>LY342739.1 KR 1020160095150-A/14: METHODS AND COMPOSITIONS FOR THE TARGETED MODIFICATION OF A GENOME
TGCTGAG
>LY268399.1 KR 1020160143444-A/6: The low calorie lactic-acid fermented milk with an enhanced storage stability and method for preparing the same
TTACAAA
>LY268398.1 KR 1020160143444-A/5: The low calorie lactic-acid fermented milk with an enhanced storage stability and method for preparing the same
GAAAGGA
>LY268369.1 KR 1020160143076-A/6: Hard candy having low calory, good sweetness and formability
TTACAAA
>LY268368.1 KR 1020160143076-A/5: Hard candy having low calory, good sweetness and formability
GAAAGGA
>LY268361.1 KR 1020160143075-A/6: Frozen bread dough and method of preparing the same
TTACAAA
>LY268360.1 KR 1020160143075-A/5: Frozen bread dough and method of preparing the same
GAAAGGA
>LY268353.1 KR 1020160143070-A/6: Gummy candy with improved mold releasing property and good taste and preparation method
TTACAAA
>LY268352.1 KR 1020160143070-A/5: Gummy candy with improved mold releasing property and good taste and preparation method
GAAAGGA
>LY268131.1 KR 1020160139849-A/5: Pharmaceutical composition comprising miR-7, miR-18a or miR-18b for prevention or treatment of metabolic disease
GCACCTT
>LY267998.1 KR 1020160139288-A/6: The semisolid yoghurt with an enhanced storage stability and method for preparing the same
TTACAAA
>LY267997.1 KR 1020160139288-A/5: The semisolid yoghurt with an enhanced storage stability and method for preparing the same
GAAAGGA
>LY267826.1 KR 1020160136861-A/6: microbial growth inhibitor comprising psicose
TTACAAA
>LY267825.1 KR 1020160136861-A/5: microbial growth inhibitor comprising psicose
GAAAGGA
>LY267648.1 KR 1020160134362-A/6: Saccharide mixture containing psicose with improved sweetness quality and crystallization
TTACAAA
>LY267647.1 KR 1020160134362-A/5: Saccharide mixture containing psicose with improved sweetness quality and crystallization
GAAAGGA
>LY267533.1 KR 1020160133314-A/6: Premix composition for preparing muffin with soft and wet taste and muffin prepared from the premix composition
TTACAAA
>LY267532.1 KR 1020160133314-A/5: Premix composition for preparing muffin with soft and wet taste and muffin prepared from the premix composition
GAAAGGA
>LY284976.1 KR 1020160075467-A/6: Ginseng food including psicose and method of preparing the same
TTACAAA
>LY284975.1 KR 1020160075467-A/5: Ginseng food including psicose and method of preparing the same
GAAAGGA
>LY341259.1 KR 1020170009812-A/3: METHODS AND PHARMACEUTICAL COMPOSITIONS FOR EXPRESSING A POLYNUCLEOTIDE OF INTEREST IN THE RETINAL PIGMENT EPITHELIUM OF A SUBJECT
TAGTTCT
>LG264368.1 KR 1020160081724-A/6: Composition for soaking syrup and use of the same
TTACAAA
>LG264367.1 KR 1020160081724-A/5: Composition for soaking syrup and use of the same
GAAAGGA
>LG264351.1 KR 1020160081640-A/6: Composition for preparing frozen food using the culture product of lactic acid bacteria, and frozen food using the culture product
TTACAAA
>LG264350.1 KR 1020160081640-A/5: Composition for preparing frozen food using the culture product of lactic acid bacteria, and frozen food using the culture product
GAAAGGA
>LG264207.1 KR 1020160081049-A/6: Freeze-dried food using the culture product of lactic acid bacteria and method of preparing the same
TTACAAA
>LG264206.1 KR 1020160081049-A/5: Freeze-dried food using the culture product of lactic acid bacteria and method of preparing the same
GAAAGGA
>LG263416.1 KR 1020160072736-A/6: Cookie with an improved quality and method of preparing the same
TTACAAA
>LG263415.1 KR 1020160072736-A/5: Cookie with an improved quality and method of preparing the same
GAAAGGA
>LY404411.1 KR 1020160113276-A/3: EXPRESSION AND PURIFICATION OF CRM197 AND RELATED PROTEINS
GATATAC
>LY404238.1 KR 1020160104105-A/6: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
TGACTCA
>LY404235.1 KR 1020160104105-A/3: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
TGASTCA
>LY404234.1 KR 1020160104105-A/2: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
HGGAASR
>LX251246.1 WO 2017111166-A/25: Therapeutic agent for disease associated with the amount of TDP-43 present in the cell
GTGTTTG
>LX251240.1 WO 2017111166-A/19: Therapeutic agent for disease associated with the amount of TDP-43 present in the cell
CGACCAA
>LX251239.1 WO 2017111166-A/18: Therapeutic agent for disease associated with the amount of TDP-43 present in the cell
CCACCAT
>LX251238.1 WO 2017111166-A/17: Therapeutic agent for disease associated with the amount of TDP-43 present in the cell
ATCCCTG
>LX251225.1 WO 2017111166-A/4: Therapeutic agent for disease associated with the amount of TDP-43 present in the cell
TTGGTCG
>LX251224.1 WO 2017111166-A/3: Therapeutic agent for disease associated with the amount of TDP-43 present in the cell
ATGGTGG
>LX251223.1 WO 2017111166-A/2: Therapeutic agent for disease associated with the amount of TDP-43 present in the cell
CAGGGAT
>LX155650.1 JP 2017510296-A/45: COMPOSITIONS AND METHODS FOR ENHANCED GENE EXPRESSION IN CONE CELLS
ACCATGG
>LX153761.1 JP 2017510290-A/1: EXPRESSION AND PURIFICATION OF CRM197 AND RELATED PROTEINS
GATATAC
>MS654589.1 Sequence 69 from Patent EP3101129
AGAGAGA
>MS654586.1 Sequence 66 from Patent EP3101129
AGATAGA
>MS654585.1 Sequence 65 from Patent EP3101129
AGAGATA
>MS654584.1 Sequence 64 from Patent EP3101129
TGAGTGA
>MS654583.1 Sequence 63 from Patent EP3101129
TGTGTGA
>MS654582.1 Sequence 62 from Patent EP3101129
AGTGAGA
>MS654581.1 Sequence 61 from Patent EP3101129
ATATAGA
>MS654580.1 Sequence 60 from Patent EP3101129
TGTGAGA
>MS654572.1 Sequence 52 from Patent EP3101129
TCTCTCT
>MS654571.1 Sequence 51 from Patent EP3101129
AGAGAGA
>MS653938.1 Sequence 3 from Patent EP3099800
GATATAC
>MS936675.1 Sequence 72 from Patent EP3119798
ACCATGG
>MS870353.1 Sequence 351 from Patent EP3173092
GGTTTGG
>MS837793.1 Sequence 2 from Patent WO2017014762
CAGCAGG
>MS835650.1 Sequence 12 from Patent EP3112465
AAAAGTA
>MS817513.1 Sequence 8 from Patent EP3160478
AAAAAAA
>LX058189.1 JP 2013544816-A/28: Immune Regulatory Oligonucleotide (IRO) Compounds To Modulate Toll-like Receptor Based Immune Response
TGTCGTT
>LX058164.1 JP 2013544816-A/3: Immune Regulatory Oligonucleotide (IRO) Compounds To Modulate Toll-like Receptor Based Immune Response
TGTCGTT
>LX057142.1 JP 2015528282-A/20: METHOD AND KIT FOR NUCLEIC ACID SEQUENCING
ACCTTGA
>LX057132.1 JP 2015528282-A/10: METHOD AND KIT FOR NUCLEIC ACID SEQUENCING
TAGCCTT
>LX076771.1 WO 2017047102-A/93: BIOMARKER FOR CANCER AND USE THEREOF
GTGGCAA
>LX074568.1 JP 2017060485-A/116: Single-Chain Multivalent Binding Proteins
CTCGAGT
>LX074567.1 JP 2017060485-A/115: Single-Chain Multivalent Binding Proteins
TGATCAG
>LX073229.1 JP 2017051190-A/20: RATIONALLY-DESIGNED SINGLE-CHAIN MEGANUCLEASES WITH NON-PALINDROMIC RECOGNITION SEQUENCES
GGCCGTT
>LX073228.1 JP 2017051190-A/19: RATIONALLY-DESIGNED SINGLE-CHAIN MEGANUCLEASES WITH NON-PALINDROMIC RECOGNITION SEQUENCES
AACGGCC
>LX062490.1 JP 2015533510-A/35: RETROVIRAL VECTOR WITH MINI-PROMOTER CASSETTE
CATTGGG
>LX062493.1 JP 2015533510-A/38: RETROVIRAL VECTOR WITH MINI-PROMOTER CASSETTE
RCCATGG
>LV580302.1 JP 2015221049-A/1: Stabilization method of functional nucleic acid
GCGAAGC
>LV579827.1 JP 2015214570-A/6: Composition for Designing and Developing Universal Cancer Drugs and Vaccines
TACTWAY
>LV578856.1 JP 2017500060-A/3: METHODS AND PHARMACEUTICAL COMPOSITIONS FOR EXPRESSING A POLYNUCLEOTIDE OF INTEREST IN THE RETINAL PIGMENT EPITHELIUM OF A SUBJECT
TAGTTCT
>LV507462.1 JP 2017014252-A/1: ARYL HYDROCARBON RECEPTOR (AHR) MODIFIERS AS NOVEL CANCER THERAPEUTICS
TNGCGTG
>LG143471.1 KR 1020160019223-A/126: Expression Vector and Method of Preparing a Polypeptide of Interest Using the Same
GACTCTA
>LG167527.1 KR 1020150141987-A/14: TARGETED MODIFICATION OF RAT GENOME
TGCTGAG
>LG149055.1 KR 1020160055652-A/6: Beverage with improved taste including fragment of fruit or plant and method of preparing the same
TTACAAA
>LG149054.1 KR 1020160055652-A/5: Beverage with improved taste including fragment of fruit or plant and method of preparing the same
GAAAGGA
>LG149028.1 KR 1020160054997-A/6: Cream composition for bakery and confectionery including psicose
TTACAAA
>LG149027.1 KR 1020160054997-A/5: Cream composition for bakery and confectionery including psicose
GAAAGGA
>LG148696.1 KR 1020160051084-A/6: composition for increasing the storage stability of culture product of lactic acid bacteria
TTACAAA
>LG148695.1 KR 1020160051084-A/5: composition for increasing the storage stability of culture product of lactic acid bacteria
GAAAGGA
>LG147709.1 KR 1020160050569-A/19: Expression system for psicose epimerase and production for psicose using the same
TTACAAA
>LG147708.1 KR 1020160050569-A/18: Expression system for psicose epimerase and production for psicose using the same
GAAAGGA
>LG178017.1 KR 1020160011670-A/5: Detection of hydroxymethylcytosine bases
GCTCTTC
>LF782668.1 JP 2016525355-A/85: METHODS AND SYSTEMS FOR MICROBIOME CHARACTERIZATION, MONITORING AND TREATMENT
GCTCTTC
>LF782653.1 JP 2016525355-A/70: METHODS AND SYSTEMS FOR MICROBIOME CHARACTERIZATION, MONITORING AND TREATMENT
CCTCAGC
>LF715922.1 WO 2016143700-A/24: Method for stabilizing DNA aptamer
GCGNAGC
>LQ664062.1 Sequence 71 from Patent EP3090064
GCTTCTG
>LQ664061.1 Sequence 70 from Patent EP3090064
CGTTCTG
>LQ664008.1 Sequence 17 from Patent EP3090064
GGGGGGG
>LQ664000.1 Sequence 9 from Patent EP3090064
TTTTTTT
>LQ638933.1 Sequence 351 from Patent WO2016170176
GGTTTGG
>LQ620942.1 Sequence 35 from Patent WO2016177682
GTTTTTG
>LQ620921.1 Sequence 14 from Patent WO2016177682
ATTTGAG
>LQ620920.1 Sequence 13 from Patent WO2016177682
TTTGAGG
>LQ620911.1 Sequence 4 from Patent WO2016177682
ATTTGAG
>LF636404.1 JP 2016519076-A/178: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS
TGACCTA
>LF636402.1 JP 2016519076-A/176: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS
TGTGTGG
>LF636401.1 JP 2016519076-A/175: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS
CGTACCG
>LF636400.1 JP 2016519076-A/174: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS
TAAGGCA
>LF636399.1 JP 2016519076-A/173: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS
GGCAGTG
>LF629322.1 JP 2016127850-A/2387: COMBINATORIAL ANTIBODY LIBRARIES AND USES THEREOF
GGTCTCN
>LF397972.1 JP 2014528713-A/1: METHODS FOR TAGGING DNA-ENCODED LIBRARIES
GTGCTGC
>LF404676.1 JP 2015504858-A/17: Targeting EN2, PAX2, and/or DEFB1 for Treatment of Prostate Conditions
VCCTTGW
>LF393205.1 JP 2014520813-A/34: COMPOSITIONS AND METHODS FOR TREATING SKELETAL MYOPATHY
TGGTCCC
>LF393204.1 JP 2014520813-A/33: COMPOSITIONS AND METHODS FOR TREATING SKELETAL MYOPATHY
GGGACCA
>LQ283559.1 Sequence 16 from Patent WO2016034611
TCYRYGA
>LQ283609.1 Sequence 66 from Patent WO2016034611
ATTTTAT
>LQ283608.1 Sequence 65 from Patent WO2016034611
ATTTTAA
>LQ283607.1 Sequence 64 from Patent WO2016034611
TTTTATT
>LQ283606.1 Sequence 63 from Patent WO2016034611
AATTTTT
>LQ283605.1 Sequence 62 from Patent WO2016034611
AAATTTT
>LQ283604.1 Sequence 61 from Patent WO2016034611
TATTTTT
>LQ283603.1 Sequence 60 from Patent WO2016034611
ATTTTTT
>LQ283602.1 Sequence 59 from Patent WO2016034611
TTTTTTT
>LQ283601.1 Sequence 58 from Patent WO2016034611
TTTTTTA
>LQ283600.1 Sequence 57 from Patent WO2016034611
TTTAAAA
>LQ283599.1 Sequence 56 from Patent WO2016034611
TTTTGTT
>LQ283598.1 Sequence 55 from Patent WO2016034611
GGTATAT
>LQ283597.1 Sequence 54 from Patent WO2016034611
CTGAACC
>LQ283596.1 Sequence 53 from Patent WO2016034611
TATTTAT
>LQ283595.1 Sequence 52 from Patent WO2016034611
TTTTCTT
>LQ283594.1 Sequence 51 from Patent WO2016034611
TTATTTT
>LQ283593.1 Sequence 50 from Patent WO2016034611
TTTATTT
>LQ283592.1 Sequence 49 from Patent WO2016034611
TTTTAAA
>LQ283591.1 Sequence 48 from Patent WO2016034611
TTTTTAA
>LQ263679.1 Sequence 35 from Patent EP3011974
GCATGCT
>LQ490955.1 Sequence 537 from Patent WO2016087625
GTACCTT
>LQ490947.1 Sequence 529 from Patent WO2016087625
AACGTTC
>LQ438621.1 Sequence 2 from Patent EP3055431
CGTGCAT
>LQ438620.1 Sequence 1 from Patent EP3055431
TTTTTTT
>LQ576552.1 Sequence 93 from Patent EP3017043
CACAACT
>LQ576551.1 Sequence 92 from Patent EP3017043
ACAACTC
>LQ574249.1 Sequence 31 from Patent WO2016094607
AATAAAT
>LQ450306.1 Sequence 6 from Patent EP3066219
TGACTGA
>LQ450305.1 Sequence 5 from Patent EP3066219
GAAGTCA
>LQ498113.1 Sequence 10 from Patent WO2016075204
GAAGACG
>LQ498112.1 Sequence 9 from Patent WO2016075204
GCTCTTC
>LQ405906.1 Sequence 37 from Patent WO2016142948
CCAACCC
>LQ405900.1 Sequence 31 from Patent WO2016142948
TTTGGTT
>LQ405871.1 Sequence 2 from Patent WO2016142948
CACAGGA
>LQ405870.1 Sequence 1 from Patent WO2016142948
CGCAGGA
>LQ403260.1 Sequence 55 from Patent EP3036260
AGATTGG
>LQ466357.1 Sequence 3 from Patent WO2016113544
CCTTTCA
>LQ522125.1 Sequence 59 from Patent EP3040417
AAGGAGA
>LQ291945.1 Sequence 6 from Patent WO2016059241
AATGGGT
>LQ291944.1 Sequence 5 from Patent WO2016059241
ACCCATT
>LQ291943.1 Sequence 4 from Patent WO2016059241
ACCCATT
>LF169975.1 JP 2016512682-A/26: KIR3DL1 Allele Classification Kit and Method
CAGAACG
>LF169965.1 JP 2016512682-A/16: KIR3DL1 Allele Classification Kit and Method
GATAGGA
>LF158975.1 WO 2016098595-A/5: Probe and SNP Detection Method
GTCCAGA
>LF158974.1 WO 2016098595-A/4: Probe and SNP Detection Method
GACCAGA
>LF152925.1 JP 2016106077-A/13: TARGETING MICRORNAS FOR METABOLIC DISORDERS
ATGCTGC
>LF152924.1 JP 2016106077-A/12: TARGETING MICRORNAS FOR METABOLIC DISORDERS
TGCTGCT
>LF152923.1 JP 2016106077-A/11: TARGETING MICRORNAS FOR METABOLIC DISORDERS
ATGCTGC
>LF152397.1 JP 2016104006-A/81: COMPOSITIONS AND METHODS FOR PRODUCING ISOPRENE FREE OF C5 HYDROCARBONS UNDER DECOUPLING CONDITIONS AND/OR SAFE OPERATING RANGES
AAGGAGG
>LF152396.1 JP 2016104006-A/80: COMPOSITIONS AND METHODS FOR PRODUCING ISOPRENE FREE OF C5 HYDROCARBONS UNDER DECOUPLING CONDITIONS AND/OR SAFE OPERATING RANGES
AGGAGGT
>LF178166.1 JP 2016515401-A/13: Targeted Modification of Rat Genome
TGCTGAG
>LQ220125.1 Sequence 14 from Patent EP2986729
TGCTGAG
>LF140317.1 JP 2016088909-A/16: Prophylactic and therapeutic drug for cartilaginous hyperplasia and method of screening therefor
TGAGTCA
>LF140316.1 JP 2016088909-A/15: Prophylactic and therapeutic drug for cartilaginous hyperplasia and method of screening therefor
TTTTCCA
>LF140312.1 JP 2016088909-A/11: Prophylactic and therapeutic drug for cartilaginous hyperplasia and method of screening therefor
GCTTCTC
>LF140311.1 JP 2016088909-A/10: Prophylactic and therapeutic drug for cartilaginous hyperplasia and method of screening therefor
TAGCTAG
>LG067868.1 KR 1020150095349-A/6: Composition and method for treating neurodegenerative diseases targeting miRNA
CTACCTC
>LG135144.1 KR 1020150126739-A/6: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
TGACTCA
>LG135141.1 KR 1020150126739-A/3: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
TGASTCA
>LG135140.1 KR 1020150126739-A/2: COMPOSITIONS AND METHODS FOR REGULATING CELL OSMOLARITY
HGGAASR
>LG134561.1 KR 1020150131312-A/179: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS
TGACCTA
>LG134559.1 KR 1020150131312-A/177: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS
TGTGTGG
>LG134558.1 KR 1020150131312-A/176: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS
CGTACCG
>LG134557.1 KR 1020150131312-A/175: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS
TAAGGCA
>LG134556.1 KR 1020150131312-A/174: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS
GGCAGTG
>LG098584.1 KR 1020150110562-A/58: LNA OLIGONUCLEOTIDE CARBOHYDRATE CONJUGATES
ACACTCC
>LG098574.1 KR 1020150110562-A/48: LNA OLIGONUCLEOTIDE CARBOHYDRATE CONJUGATES
ATGTAGC
>LG098569.1 KR 1020150110562-A/43: LNA OLIGONUCLEOTIDE CARBOHYDRATE CONJUGATES
ATAAGCT
>LG098564.1 KR 1020150110562-A/38: LNA OLIGONUCLEOTIDE CARBOHYDRATE CONJUGATES
CAATGCA
>HZ782307.1 JP 2016028585-A/6: Compositions and Methods for Regulating Cell Osmolarity
TGACTCA
>HZ782304.1 JP 2016028585-A/3: Compositions and Methods for Regulating Cell Osmolarity
TGASTCA
>HZ782303.1 JP 2016028585-A/2: Compositions and Methods for Regulating Cell Osmolarity
HGGAASR
>HZ492999.1 JP 2016019523-A/60: NICKED OR GAPPED NUCLEIC ACID MOLECULES AND USES THEREOF
CGGAGTT
>HZ492992.1 JP 2016019523-A/53: NICKED OR GAPPED NUCLEIC ACID MOLECULES AND USES THEREOF
CGGAGTT
>HZ492970.1 JP 2016019523-A/31: NICKED OR GAPPED NUCLEIC ACID MOLECULES AND USES THEREOF
GATTTTT
>HZ492919.1 JP 2016027800-A/51: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
AGTTAGG
>HZ492916.1 JP 2016027800-A/48: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
GAAGGCG
>HZ492914.1 JP 2016027800-A/46: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
NAGCGAN
>HZ492910.1 JP 2016027800-A/42: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
GAAGGCG
>HZ492907.1 JP 2016027800-A/39: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
GAAGGCG
>HZ492906.1 JP 2016027800-A/38: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
ACAGCGC
>HZ492901.1 JP 2016027800-A/33: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
CAGCGAG
>HZ492894.1 JP 2016027800-A/26: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
AGTTAGG
>HZ492874.1 JP 2016027800-A/6: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
GCCTCCA
>HZ531316.1 JP 2016502527-A/38: miRNAs AS NOVEL THERAPEUTIC ADJUVANTS AND BIOMARKERS FOR THE PROGNOSIS AND TREATMENT OF DRUG RESISTANT BREAST CANCERS
GATGTTC
>HZ466122.1 JP 2015532587-A/69: POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF FOR TREATMENT OF IMMUNE RELATED DISORDERS AND CANCER
AGAAAKA
>HZ456485.1 JP 2015221035-A/20: RATIONALLY-DESIGNED SINGLE-CHAIN MEGANUCLEASES WITH NON-PALINDROMIC RECOGNITION SEQUENCES
GGCCGTT
>HZ456484.1 JP 2015221035-A/19: RATIONALLY-DESIGNED SINGLE-CHAIN MEGANUCLEASES WITH NON-PALINDROMIC RECOGNITION SEQUENCES
AACGGCC
>LP722086.1 Sequence 45 from Patent EP2882859
TACTTAT
>LP722085.1 Sequence 44 from Patent EP2882859
TACTAAC
>LP722081.1 Sequence 40 from Patent EP2882859
CTRAYNG
>LP722079.1 Sequence 38 from Patent EP2882859
GTAGAGT
>LP722047.1 Sequence 6 from Patent EP2882859
TACTWAY
>LP720195.1 Sequence 1 from Patent EP2872680
GTGCTGC
>LP716923.1 Sequence 57 from Patent EP2886664
CGCNGCG
>LQ069381.1 Sequence 9 from Patent WO2015153757
GGCAGTG
>LQ067424.1 Sequence 2 from Patent EP2964017
GTTTCTT
>LP055192.1 Sequence 489 from Patent EP2839005
TGGAGGA
>LP055085.1 Sequence 382 from Patent EP2839005
CACTCAG
>LP055084.1 Sequence 381 from Patent EP2839005
CACTCAG
>LP055083.1 Sequence 380 from Patent EP2839005
CACTCAG
>LP055082.1 Sequence 379 from Patent EP2839005
CACTCAG
>LP055081.1 Sequence 378 from Patent EP2839005
CACTCAG
>LP054792.1 Sequence 89 from Patent EP2839005
CACTCAG
>LQ106901.1 Sequence 48 from Patent WO2015135935
TACTACT
>LQ104595.1 Sequence 38 from Patent EP2919817
GATGTTC
>LP042949.1 Sequence 6 from Patent EP2770054
GCGAAGC
>LP724060.1 Sequence 3 from Patent WO2015082690
TAGTTCT
>LQ014545.1 Sequence 7 from Patent EP2975036
WWWWWCW
>LQ014544.1 Sequence 6 from Patent EP2975036
WGWWWWW
>LQ014543.1 Sequence 5 from Patent EP2975036
GCWWWWW
>LQ014542.1 Sequence 4 from Patent EP2975036
WWWWWGC
>LQ014541.1 Sequence 3 from Patent EP2975036
WCWGCWW
>LQ014540.1 Sequence 2 from Patent EP2975036
WWGCWGW
>HZ437820.1 JP 2015530988-A/45: Production and Utilization of A Novel Anti-Cancer Drug In Therapy
TACTTAT
>HZ437819.1 JP 2015530988-A/44: Production and Utilization of A Novel Anti-Cancer Drug In Therapy
TACTAAC
>HZ437815.1 JP 2015530988-A/40: Production and Utilization of A Novel Anti-Cancer Drug In Therapy
CTRAYNG
>HZ437813.1 JP 2015530988-A/38: Production and Utilization of A Novel Anti-Cancer Drug In Therapy
GTAGAGT
>HZ437781.1 JP 2015530988-A/6: Production and Utilization of A Novel Anti-Cancer Drug In Therapy
TACTWAY
>HZ451794.1 JP 2015529220-A/20: Tetrabranched peptides and analogues as a new class of antimicrobials and their preparation thereof
GRKVVRR
>HZ433525.1 JP 2015211674-A/82: METHODS OF PRODUCING ISOPRENE AND A CO-PRODUCT
AAGGAGG
>HZ433524.1 JP 2015211674-A/81: METHODS OF PRODUCING ISOPRENE AND A CO-PRODUCT
AGGAGGT
>HZ431891.1 JP 2014221834-A/16: COMPOSITIONS AND METHODS RELATING TO miR-31
GGTAGGC
>HZ431890.1 JP 2014221834-A/15: COMPOSITIONS AND METHODS RELATING TO miR-31
ATCTTGC
>HZ431889.1 JP 2014221834-A/14: COMPOSITIONS AND METHODS RELATING TO miR-31
TCCACCA
>HZ431888.1 JP 2014221834-A/13: COMPOSITIONS AND METHODS RELATING TO miR-31
CTTGCCA
>HZ431887.1 JP 2014221834-A/12: COMPOSITIONS AND METHODS RELATING TO miR-31
CAAACAG
>HZ431886.1 JP 2014221834-A/11: COMPOSITIONS AND METHODS RELATING TO miR-31
CTTGCCA
>HZ431885.1 JP 2014221834-A/10: COMPOSITIONS AND METHODS RELATING TO miR-31
ATCGGCG
>HZ431884.1 JP 2014221834-A/9: COMPOSITIONS AND METHODS RELATING TO miR-31
ATCTTGC
>HZ431883.1 JP 2014221834-A/8: COMPOSITIONS AND METHODS RELATING TO miR-31
CAAAAGA
>HZ431882.1 JP 2014221834-A/7: COMPOSITIONS AND METHODS RELATING TO miR-31
CTTGCCA
>HZ423606.1 JP 2014166187-A/40: Generation of Tumor-Free Embryonic Stem-Like Pluripotent Cells Using Inducible Recombinant RNA Agents
GTAGAGT
>HZ423572.1 JP 2014166187-A/6: Generation of Tumor-Free Embryonic Stem-Like Pluripotent Cells Using Inducible Recombinant RNA Agents
TACTWAY
>HZ409704.1 JP 2015528002-A/2301: CHIRAL CONTROL
CAGGTAA
>HZ407434.1 JP 2015528002-A/31: CHIRAL CONTROL
CAACGTT
>HZ407505.1 JP 2015528002-A/102: CHIRAL CONTROL
TGTCGYT
>LG053038.1 KR 1020150036642-A/2304: CHIRAL CONTROL
CAGGTAA
>LG050768.1 KR 1020150036642-A/31: CHIRAL CONTROL
CAACGTT
>LG050839.1 KR 1020150036642-A/102: CHIRAL CONTROL
TGTCGYT
>LG049269.1 KR 1020150030260-A/1: DNA-ENCODED LIBRARIES HAVING ENCODING OLIGONUCLEOTIDE LINKAGES NOT READABLE BY POLYMERASES
GTGCTGC
>LG047609.1 KR 1020150023811-A/167: LSR ANTIBODIES, AND USES THEREOF FOR TREATMENT OF CANCER
AGAAAKA
>HZ390578.1 JP 2015522292-A/47: COOPERATIVE PRIMERS, PROBES, AND APPLICATIONS THEREOF
ATGGACG
>HZ184875.1 JP 2015143222-A/37: Therapeutic and diagnostic molecules
TCACAGT
>HZ273819.1 JP 2015518485-A/489: MIRNA MODULATORS OF THERMOGENESIS
TGGAGGA
>HZ273712.1 JP 2015518485-A/382: MIRNA MODULATORS OF THERMOGENESIS
CACTCAG
>HZ273711.1 JP 2015518485-A/381: MIRNA MODULATORS OF THERMOGENESIS
CACTCAG
>HZ273710.1 JP 2015518485-A/380: MIRNA MODULATORS OF THERMOGENESIS
CACTCAG
>HZ273709.1 JP 2015518485-A/379: MIRNA MODULATORS OF THERMOGENESIS
CACTCAG
>HZ273708.1 JP 2015518485-A/378: MIRNA MODULATORS OF THERMOGENESIS
CACTCAG
>HZ273419.1 JP 2015518485-A/89: MIRNA MODULATORS OF THERMOGENESIS
CACTCAG
>HZ189125.1 WO 2015115619-A/68: Microorganism with regulated R-specific enoyl coenzyme A hydratase gene expression and method of producing polyhydroxyalkanoate copolymer
AGAGAGA
>HZ189122.1 WO 2015115619-A/65: Microorganism with regulated R-specific enoyl coenzyme A hydratase gene expression and method of producing polyhydroxyalkanoate copolymer
AGATAGA
>HZ189121.1 WO 2015115619-A/64: Microorganism with regulated R-specific enoyl coenzyme A hydratase gene expression and method of producing polyhydroxyalkanoate copolymer
AGAGATA
>HZ189120.1 WO 2015115619-A/63: Microorganism with regulated R-specific enoyl coenzyme A hydratase gene expression and method of producing polyhydroxyalkanoate copolymer
TGAGTGA
>HZ189119.1 WO 2015115619-A/62: Microorganism with regulated R-specific enoyl coenzyme A hydratase gene expression and method of producing polyhydroxyalkanoate copolymer
TGTGTGA
>HZ189118.1 WO 2015115619-A/61: Microorganism with regulated R-specific enoyl coenzyme A hydratase gene expression and method of producing polyhydroxyalkanoate copolymer
AGTGAGA
>HZ189117.1 WO 2015115619-A/60: Microorganism with regulated R-specific enoyl coenzyme A hydratase gene expression and method of producing polyhydroxyalkanoate copolymer
ATATAGA
>HZ189116.1 WO 2015115619-A/59: Microorganism with regulated R-specific enoyl coenzyme A hydratase gene expression and method of producing polyhydroxyalkanoate copolymer
TGTGAGA
>HZ189108.1 WO 2015115619-A/51: Microorganism with regulated R-specific enoyl coenzyme A hydratase gene expression and method of producing polyhydroxyalkanoate copolymer
TCTCTCT
>HZ189107.1 WO 2015115619-A/50: Microorganism with regulated R-specific enoyl coenzyme A hydratase gene expression and method of producing polyhydroxyalkanoate copolymer
AGAGAGA
>HZ160963.1 JP 2015130862-A/3787: Micromirs
AGCTGGG
>HZ160962.1 JP 2015130862-A/3786: Micromirs
ATACCCA
>HZ160961.1 JP 2015130862-A/3785: Micromirs
CGCGCCT
>HZ160960.1 JP 2015130862-A/3784: Micromirs
TGGGATC
>HZ160959.1 JP 2015130862-A/3783: Micromirs
GCTGCTG
>HZ160958.1 JP 2015130862-A/3782: Micromirs
AACCATC
>HZ160957.1 JP 2015130862-A/3781: Micromirs
GCATCCT
>HZ160956.1 JP 2015130862-A/3780: Micromirs
GTTTAGC
>HZ160955.1 JP 2015130862-A/3779: Micromirs
GTATTCT
>HZ160954.1 JP 2015130862-A/3778: Micromirs
GACCGCG
>HZ160953.1 JP 2015130862-A/3777: Micromirs
GAATGTG
>HZ160952.1 JP 2015130862-A/3776: Micromirs
CTACAGT
>HZ160951.1 JP 2015130862-A/3775: Micromirs
GGCCTGG
>HZ160950.1 JP 2015130862-A/3774: Micromirs
AGCATTA
>HZ160949.1 JP 2015130862-A/3773: Micromirs
CAACACC
>HZ160948.1 JP 2015130862-A/3772: Micromirs
CAACACT
>HZ160947.1 JP 2015130862-A/3771: Micromirs
CCTGTAA
>HZ160946.1 JP 2015130862-A/3770: Micromirs
GGGAAGT
>HZ160945.1 JP 2015130862-A/3769: Micromirs
TCTCTGA
>HZ160944.1 JP 2015130862-A/3768: Micromirs
ACTCTAC
>HZ160943.1 JP 2015130862-A/3767: Micromirs
CAGGCAA
>HZ160942.1 JP 2015130862-A/3766: Micromirs
AGTCCCA
>HZ160941.1 JP 2015130862-A/3765: Micromirs
GCGTGCG
>HZ160940.1 JP 2015130862-A/3764: Micromirs
GGCTCAG
>HZ160939.1 JP 2015130862-A/3763: Micromirs
TCCTTCC
>HZ160938.1 JP 2015130862-A/3762: Micromirs
CGAGCTT
>HZ160937.1 JP 2015130862-A/3761: Micromirs
TACGGGT
>HZ160936.1 JP 2015130862-A/3760: Micromirs
CGAGCTT
>HZ160935.1 JP 2015130862-A/3759: Micromirs
TACGGGT
>HZ160934.1 JP 2015130862-A/3758: Micromirs
CTACCTC
>HZ160933.1 JP 2015130862-A/3757: Micromirs
ACATGAT
>HZ160932.1 JP 2015130862-A/3756: Micromirs
GTGCCAA
>HZ160931.1 JP 2015130862-A/3755: Micromirs
CCGTTGA
>HZ160930.1 JP 2015130862-A/3754: Micromirs
AATAATT
>HZ160929.1 JP 2015130862-A/3753: Micromirs
ACAGTCA
>HZ160928.1 JP 2015130862-A/3752: Micromirs
AGAGAAG
>HZ160927.1 JP 2015130862-A/3751: Micromirs
GCCGGGT
>HZ160926.1 JP 2015130862-A/3750: Micromirs
CCTGCCT
>HZ160925.1 JP 2015130862-A/3749: Micromirs
GCTCCCC
>HZ160924.1 JP 2015130862-A/3748: Micromirs
TAAGGGC
>HZ160923.1 JP 2015130862-A/3747: Micromirs
GCGCGGA
>HZ160922.1 JP 2015130862-A/3746: Micromirs
TCTACTG
>HZ160921.1 JP 2015130862-A/3745: Micromirs
GTAACTG
>HZ160920.1 JP 2015130862-A/3744: Micromirs
AGTAGAC
>HZ160919.1 JP 2015130862-A/3743: Micromirs
TGCGCAC
>HZ160918.1 JP 2015130862-A/3742: Micromirs
TCAGCAG
>HZ160917.1 JP 2015130862-A/3741: Micromirs
GCACTTT
>HZ160916.1 JP 2015130862-A/3740: Micromirs
CCGTCCC
>HZ160915.1 JP 2015130862-A/3739: Micromirs
GTGCAAT
>HZ160914.1 JP 2015130862-A/3738: Micromirs
CCCCACC
>HZ160913.1 JP 2015130862-A/3737: Micromirs
CCCAACC
>HZ160912.1 JP 2015130862-A/3736: Micromirs
GTGCAAT
>HZ160911.1 JP 2015130862-A/3735: Micromirs
AAGACTC
>HZ160910.1 JP 2015130862-A/3734: Micromirs
CCGCTGA
>HZ160909.1 JP 2015130862-A/3733: Micromirs
TCTGCTG
>HZ160908.1 JP 2015130862-A/3732: Micromirs
CTCACTA
>HZ160907.1 JP 2015130862-A/3731: Micromirs
AGCTCCC
>HZ160906.1 JP 2015130862-A/3730: Micromirs
AGCTTTA
>HZ160905.1 JP 2015130862-A/3729: Micromirs
ACCAAAG
>HZ160904.1 JP 2015130862-A/3728: Micromirs
AGCCAGT
>HZ160903.1 JP 2015130862-A/3727: Micromirs
ACACAGT
>HZ160902.1 JP 2015130862-A/3726: Micromirs
AAGTTGC
>HZ160901.1 JP 2015130862-A/3725: Micromirs
TCGTTGC
>HZ160900.1 JP 2015130862-A/3724: Micromirs
TCCAAGT
>HZ160899.1 JP 2015130862-A/3723: Micromirs
GATATTA
>HZ160898.1 JP 2015130862-A/3722: Micromirs
TGTCAGT
>HZ160897.1 JP 2015130862-A/3721: Micromirs
TTTGAGT
>HZ160896.1 JP 2015130862-A/3720: Micromirs
CCGTTCA
>HZ160895.1 JP 2015130862-A/3719: Micromirs
CCGACCC
>HZ160894.1 JP 2015130862-A/3718: Micromirs
CACCCGC
>HZ160893.1 JP 2015130862-A/3717: Micromirs
GTAATGG
>HZ160892.1 JP 2015130862-A/3716: Micromirs
CGCTGCC
>HZ160891.1 JP 2015130862-A/3715: Micromirs
GAAGAGG
>HZ160890.1 JP 2015130862-A/3714: Micromirs
TCCTCTA
>HZ160889.1 JP 2015130862-A/3713: Micromirs
GAAATCC
>HZ160888.1 JP 2015130862-A/3712: Micromirs
AACCACC
>HZ160887.1 JP 2015130862-A/3711: Micromirs
GAGGTAT
>HZ160886.1 JP 2015130862-A/3710: Micromirs
TTTCCAG
>HZ160885.1 JP 2015130862-A/3709: Micromirs
CAGGGCA
>HZ160884.1 JP 2015130862-A/3708: Micromirs
GTTCCTG
>HZ160883.1 JP 2015130862-A/3707: Micromirs
TGTTACT
>HZ160882.1 JP 2015130862-A/3706: Micromirs
GTACTGG
>HZ160881.1 JP 2015130862-A/3705: Micromirs
AGGTCTC
>HZ160880.1 JP 2015130862-A/3704: Micromirs
GATCCCA
>HZ160879.1 JP 2015130862-A/3703: Micromirs
ATGGTGC
>HZ160878.1 JP 2015130862-A/3702: Micromirs
TGAGCAG
>HZ160877.1 JP 2015130862-A/3701: Micromirs
GCTGGAG
>HZ160876.1 JP 2015130862-A/3700: Micromirs
CTCCTCC
>HZ160875.1 JP 2015130862-A/3699: Micromirs
CAGAGCC
>HZ160874.1 JP 2015130862-A/3698: Micromirs
GTCACAA
>HZ160873.1 JP 2015130862-A/3697: Micromirs
GGCAACA
>HZ160872.1 JP 2015130862-A/3696: Micromirs
GCCCCGC
>HZ160871.1 JP 2015130862-A/3695: Micromirs
CAGCGAG
>HZ160870.1 JP 2015130862-A/3694: Micromirs
TCTAGTT
>HZ160869.1 JP 2015130862-A/3693: Micromirs
AGCTCCT
>HZ160868.1 JP 2015130862-A/3692: Micromirs
ATTTGTT
>HZ160867.1 JP 2015130862-A/3691: Micromirs
ATTTGTT
>HZ160866.1 JP 2015130862-A/3690: Micromirs
GTCTTCC
>HZ160865.1 JP 2015130862-A/3689: Micromirs
GCATACA
>HZ160864.1 JP 2015130862-A/3688: Micromirs
CCGCACC
>HZ160863.1 JP 2015130862-A/3687: Micromirs
GGCTTCC
>HZ160862.1 JP 2015130862-A/3686: Micromirs
GAACCGG
>HZ160861.1 JP 2015130862-A/3685: Micromirs
GAGTGAC
>HZ160860.1 JP 2015130862-A/3684: Micromirs
CTCCTGG
>HZ160859.1 JP 2015130862-A/3683: Micromirs
TAGCCAG
>HZ160858.1 JP 2015130862-A/3682: Micromirs
AATGAAT
>HZ160857.1 JP 2015130862-A/3681: Micromirs
GGGCCAC
>HZ160856.1 JP 2015130862-A/3680: Micromirs
CCCCGCC
>HZ160855.1 JP 2015130862-A/3679: Micromirs
ACGTGGG
>HZ160814.1 JP 2015130862-A/3638: Micromirs
TTCCCCC
>HZ160813.1 JP 2015130862-A/3637: Micromirs
TGGTACT
>HZ160812.1 JP 2015130862-A/3636: Micromirs
ACCTTGT
>HZ160811.1 JP 2015130862-A/3635: Micromirs
CAAGGGA
>HZ160810.1 JP 2015130862-A/3634: Micromirs
CAGACTG
>HZ160809.1 JP 2015130862-A/3633: Micromirs
TGCTAGC
>HZ160808.1 JP 2015130862-A/3632: Micromirs
ATCTCCA
>HZ160807.1 JP 2015130862-A/3631: Micromirs
TCCAGGT
>HZ160806.1 JP 2015130862-A/3630: Micromirs
TAGAGTT
>HZ160805.1 JP 2015130862-A/3629: Micromirs
GGAAGTC
>HZ160804.1 JP 2015130862-A/3628: Micromirs
TTTTGAG
>HZ160803.1 JP 2015130862-A/3627: Micromirs
CAATGAC
>HZ160802.1 JP 2015130862-A/3626: Micromirs
GGACCCC
>HZ160801.1 JP 2015130862-A/3625: Micromirs
GGCTCGG
>HZ160800.1 JP 2015130862-A/3624: Micromirs
AGGCGTT
>HZ160799.1 JP 2015130862-A/3623: Micromirs
ACATTCC
>HZ160798.1 JP 2015130862-A/3622: Micromirs
TGCCCAG
>HZ160797.1 JP 2015130862-A/3621: Micromirs
GTCCTCG
>HZ160796.1 JP 2015130862-A/3620: Micromirs
TTAGCTC
>HZ160795.1 JP 2015130862-A/3619: Micromirs
AACACCC
>HZ160794.1 JP 2015130862-A/3618: Micromirs
CCACCCC
>HZ160793.1 JP 2015130862-A/3617: Micromirs
ATTTGAA
>HZ160792.1 JP 2015130862-A/3616: Micromirs
AGTAGTT
>HZ160791.1 JP 2015130862-A/3615: Micromirs
GGGATTT
>HZ160790.1 JP 2015130862-A/3614: Micromirs
CGCAGCC
>HZ160789.1 JP 2015130862-A/3613: Micromirs
AGTGTGT
>HZ160788.1 JP 2015130862-A/3612: Micromirs
CCCGTGT
>HZ160787.1 JP 2015130862-A/3611: Micromirs
CTAGACC
>HZ160786.1 JP 2015130862-A/3610: Micromirs
CTGTAAG
>HZ160785.1 JP 2015130862-A/3609: Micromirs
GACACAA
>HZ160784.1 JP 2015130862-A/3608: Micromirs
ATGACGT
>HZ160783.1 JP 2015130862-A/3607: Micromirs
GTGACAC
>HZ160782.1 JP 2015130862-A/3606: Micromirs
GCAGGCT
>HZ160781.1 JP 2015130862-A/3605: Micromirs
CACACTT
>HZ160780.1 JP 2015130862-A/3604: Micromirs
TGGTGCC
>HZ160779.1 JP 2015130862-A/3603: Micromirs
CAGAGAC
>HZ160778.1 JP 2015130862-A/3602: Micromirs
TGACACA
>HZ160777.1 JP 2015130862-A/3601: Micromirs
CATGGTC
>HZ160776.1 JP 2015130862-A/3600: Micromirs
ATAAGCT
>HZ160775.1 JP 2015130862-A/3599: Micromirs
TAAAATT
>HZ160774.1 JP 2015130862-A/3598: Micromirs
TGTTCTG
>HZ160773.1 JP 2015130862-A/3597: Micromirs
GGTTCTC
>HZ160772.1 JP 2015130862-A/3596: Micromirs
GTGGCCA
>HZ160771.1 JP 2015130862-A/3595: Micromirs
TATGGAA
>HZ160770.1 JP 2015130862-A/3594: Micromirs
AATGCAT
>HZ160769.1 JP 2015130862-A/3593: Micromirs
TACGCCC
>HZ160768.1 JP 2015130862-A/3592: Micromirs
AACCATA
>HZ160767.1 JP 2015130862-A/3591: Micromirs
CCTCTTT
>HZ160766.1 JP 2015130862-A/3590: Micromirs
AACTGTA
>HZ160765.1 JP 2015130862-A/3589: Micromirs
ACCAGTT
>HZ160764.1 JP 2015130862-A/3588: Micromirs
ACACAAG
>HZ160763.1 JP 2015130862-A/3587: Micromirs
ATTCTCA
>HZ160762.1 JP 2015130862-A/3586: Micromirs
CAAATGA
>HZ160761.1 JP 2015130862-A/3585: Micromirs
ACAAGAA
>HZ160760.1 JP 2015130862-A/3584: Micromirs
TTTATCT
>HZ160759.1 JP 2015130862-A/3583: Micromirs
ATTAGAA
>HZ160758.1 JP 2015130862-A/3582: Micromirs
CACATCT
>HZ160757.1 JP 2015130862-A/3581: Micromirs
ACTGGCT
>HZ160756.1 JP 2015130862-A/3580: Micromirs
CACACTC
>HZ160755.1 JP 2015130862-A/3579: Micromirs
TGAGCGT
>HZ160754.1 JP 2015130862-A/3578: Micromirs
CACTTCA
>HZ160753.1 JP 2015130862-A/3577: Micromirs
GAGCGGA
>HZ160752.1 JP 2015130862-A/3576: Micromirs
CCAACTC
>HZ160751.1 JP 2015130862-A/3575: Micromirs
TGTTTTC
>HZ160750.1 JP 2015130862-A/3574: Micromirs
CATTAAC
>HZ160749.1 JP 2015130862-A/3573: Micromirs
TTATACA
>HZ160748.1 JP 2015130862-A/3572: Micromirs
AACATAC
>HZ160747.1 JP 2015130862-A/3571: Micromirs
AGGCGCC
>HZ160746.1 JP 2015130862-A/3570: Micromirs
CCGTGCC
>HZ160745.1 JP 2015130862-A/3569: Micromirs
GTCAACC
>HZ160744.1 JP 2015130862-A/3568: Micromirs
GCTACTT
>HZ160743.1 JP 2015130862-A/3567: Micromirs
AAACTTT
>HZ160742.1 JP 2015130862-A/3566: Micromirs
TTACTTT
>HZ160741.1 JP 2015130862-A/3565: Micromirs
GCAGCTC
>HZ160740.1 JP 2015130862-A/3564: Micromirs
GTGCAAA
>HZ160739.1 JP 2015130862-A/3563: Micromirs
AGCTCAT
>HZ160738.1 JP 2015130862-A/3562: Micromirs
GGTAATA
>HZ160737.1 JP 2015130862-A/3561: Micromirs
CTTACCC
>HZ160736.1 JP 2015130862-A/3560: Micromirs
GGACTAG
>HZ160735.1 JP 2015130862-A/3559: Micromirs
ACCGTTT
>HZ160734.1 JP 2015130862-A/3558: Micromirs
CACCTGT
>HZ160733.1 JP 2015130862-A/3557: Micromirs
TTGATTT
>HZ160732.1 JP 2015130862-A/3556: Micromirs
TGGGTCG
>HZ160731.1 JP 2015130862-A/3555: Micromirs
TGGGTCG
>HZ160730.1 JP 2015130862-A/3554: Micromirs
GTAAGAC
>HZ160729.1 JP 2015130862-A/3553: Micromirs
CAGGCAC
>HZ160728.1 JP 2015130862-A/3552: Micromirs
AGTTGTC
>HZ160727.1 JP 2015130862-A/3551: Micromirs
TTTTGCT
>HZ160726.1 JP 2015130862-A/3550: Micromirs
AGTTTTG
>HZ160725.1 JP 2015130862-A/3549: Micromirs
TACTTTT
>HZ160724.1 JP 2015130862-A/3548: Micromirs
TACCTTT
>HZ160723.1 JP 2015130862-A/3547: Micromirs
ATACTTT
>HZ160722.1 JP 2015130862-A/3546: Micromirs
GTACTTT
>HZ160721.1 JP 2015130862-A/3545: Micromirs
TTACTTT
>HZ160720.1 JP 2015130862-A/3544: Micromirs
TTACTTT
>HZ160719.1 JP 2015130862-A/3543: Micromirs
TTACTTT
>HZ160718.1 JP 2015130862-A/3542: Micromirs
ACAGTTT
>HZ160717.1 JP 2015130862-A/3541: Micromirs
CAGTTTT
>HZ160716.1 JP 2015130862-A/3540: Micromirs
CAGTTTT
>HZ160715.1 JP 2015130862-A/3539: Micromirs
TTACTTT
>HZ160714.1 JP 2015130862-A/3538: Micromirs
GGTTTTT
>HZ160713.1 JP 2015130862-A/3537: Micromirs
TTACTTT
>HZ160712.1 JP 2015130862-A/3536: Micromirs
GATTTTT
>HZ160711.1 JP 2015130862-A/3535: Micromirs
TTACTTT
>HZ160710.1 JP 2015130862-A/3534: Micromirs
GGTTCTT
>HZ160709.1 JP 2015130862-A/3533: Micromirs
TTACTTT
>HZ160708.1 JP 2015130862-A/3532: Micromirs
CAGTTTT
>HZ160707.1 JP 2015130862-A/3531: Micromirs
TTTACTG
>HZ160706.1 JP 2015130862-A/3530: Micromirs
TTTGCTG
>HZ160705.1 JP 2015130862-A/3529: Micromirs
TGCAGAA
>HZ160704.1 JP 2015130862-A/3528: Micromirs
GAATGTT
>HZ160703.1 JP 2015130862-A/3527: Micromirs
ATCCCCG
>HZ160702.1 JP 2015130862-A/3526: Micromirs
CTGTCAC
>HZ160701.1 JP 2015130862-A/3525: Micromirs
AATCCTT
>HZ160700.1 JP 2015130862-A/3524: Micromirs
GCCCACC
>HZ160699.1 JP 2015130862-A/3523: Micromirs
ATTTCTC
>HZ160698.1 JP 2015130862-A/3522: Micromirs
AAGGCAT
>HZ160697.1 JP 2015130862-A/3521: Micromirs
GTGGGAG
>HZ160696.1 JP 2015130862-A/3520: Micromirs
CTTTGCA
>HZ160695.1 JP 2015130862-A/3519: Micromirs
GCACTTT
>HZ160694.1 JP 2015130862-A/3518: Micromirs
CTCAAGA
>HZ160693.1 JP 2015130862-A/3517: Micromirs
CTCTGGA
>HZ160692.1 JP 2015130862-A/3516: Micromirs
GCGCCTT
>HZ160691.1 JP 2015130862-A/3515: Micromirs
CTTTGTA
>HZ160690.1 JP 2015130862-A/3514: Micromirs
GCGCCTT
>HZ160689.1 JP 2015130862-A/3513: Micromirs
GCGCGTT
>HZ160688.1 JP 2015130862-A/3512: Micromirs
ACCATTT
>HZ160687.1 JP 2015130862-A/3511: Micromirs
AGTGCGT
>HZ160686.1 JP 2015130862-A/3510: Micromirs
CACTTTG
>HZ160685.1 JP 2015130862-A/3509: Micromirs
CACTTTG
>HZ160684.1 JP 2015130862-A/3508: Micromirs
AAGCACT
>HZ160683.1 JP 2015130862-A/3507: Micromirs
AGCACTT
>HZ160682.1 JP 2015130862-A/3506: Micromirs
CTTTGTA
>HZ160681.1 JP 2015130862-A/3505: Micromirs
AGCACTT
>HZ160680.1 JP 2015130862-A/3504: Micromirs
AGCACTT
>HZ160679.1 JP 2015130862-A/3503: Micromirs
AGCACTT
>HZ160678.1 JP 2015130862-A/3502: Micromirs
CTCTGGA
>HZ160677.1 JP 2015130862-A/3501: Micromirs
AGCACTT
>HZ160676.1 JP 2015130862-A/3500: Micromirs
TTGGAGA
>HZ160675.1 JP 2015130862-A/3499: Micromirs
AGGCACT
>HZ160674.1 JP 2015130862-A/3498: Micromirs
GCACTTT
>HZ160673.1 JP 2015130862-A/3497: Micromirs
TGCACTT
>HZ160672.1 JP 2015130862-A/3496: Micromirs
TGCACTT
>HZ160671.1 JP 2015130862-A/3495: Micromirs
CTCTAGA
>HZ160670.1 JP 2015130862-A/3494: Micromirs
TGCACTT
>HZ160669.1 JP 2015130862-A/3493: Micromirs
CTCTAGA
>HZ160668.1 JP 2015130862-A/3492: Micromirs
GCGCTTT
>HZ160667.1 JP 2015130862-A/3491: Micromirs
AGCGCTT
>HZ160666.1 JP 2015130862-A/3490: Micromirs
CTCTAGA
>HZ160665.1 JP 2015130862-A/3489: Micromirs
GCGCTTT
>HZ160664.1 JP 2015130862-A/3488: Micromirs
TCCAGAG
>HZ160663.1 JP 2015130862-A/3487: Micromirs
GCGCTTT
>HZ160662.1 JP 2015130862-A/3486: Micromirs
GCGCTTT
>HZ160661.1 JP 2015130862-A/3485: Micromirs
GCGCTTT
>HZ160660.1 JP 2015130862-A/3484: Micromirs
TGCACGA
>HZ160659.1 JP 2015130862-A/3483: Micromirs
ATGCACG
>HZ160658.1 JP 2015130862-A/3482: Micromirs
TGCACGA
>HZ160657.1 JP 2015130862-A/3481: Micromirs
TCTAGAG
>HZ160656.1 JP 2015130862-A/3480: Micromirs
CTCCAGA
>HZ160655.1 JP 2015130862-A/3479: Micromirs
CTCGAGA
>HZ160654.1 JP 2015130862-A/3478: Micromirs
AGGAAGC
>HZ160653.1 JP 2015130862-A/3477: Micromirs
TTGGAGA
>HZ160652.1 JP 2015130862-A/3476: Micromirs
AGGCACT
>HZ160651.1 JP 2015130862-A/3475: Micromirs
GTGTCAA
>HZ160650.1 JP 2015130862-A/3474: Micromirs
CTTGAGA
>HZ160649.1 JP 2015130862-A/3473: Micromirs
CTTGTGA
>HZ160648.1 JP 2015130862-A/3472: Micromirs
CCTGTGA
>HZ160647.1 JP 2015130862-A/3471: Micromirs
GAAATTT
>HZ160646.1 JP 2015130862-A/3470: Micromirs
GCTGAGT
>HZ160645.1 JP 2015130862-A/3469: Micromirs
CAGCACT
>HZ160644.1 JP 2015130862-A/3468: Micromirs
AAAGACA
>HZ160643.1 JP 2015130862-A/3467: Micromirs
CCTGAGT
>HZ160642.1 JP 2015130862-A/3466: Micromirs
CTGCAGT
>HZ160641.1 JP 2015130862-A/3465: Micromirs
ACCAATC
>HZ160640.1 JP 2015130862-A/3464: Micromirs
CTGCAGT
>HZ160639.1 JP 2015130862-A/3463: Micromirs
CTGGAGT
>HZ160638.1 JP 2015130862-A/3462: Micromirs
TACAATC
>HZ160637.1 JP 2015130862-A/3461: Micromirs
GTGCAAA
>HZ160636.1 JP 2015130862-A/3460: Micromirs
GTGCCTT
>HZ160635.1 JP 2015130862-A/3459: Micromirs
TGGCTCC
>HZ160634.1 JP 2015130862-A/3458: Micromirs
TGTTGAC
>HZ160633.1 JP 2015130862-A/3457: Micromirs
CAGGGTC
>HZ160632.1 JP 2015130862-A/3456: Micromirs
CGCTGCT
>HZ160631.1 JP 2015130862-A/3455: Micromirs
GCAAGGA
>HZ160630.1 JP 2015130862-A/3454: Micromirs
GGTGCAT
>HZ160629.1 JP 2015130862-A/3453: Micromirs
AAAGGAT
>HZ160628.1 JP 2015130862-A/3452: Micromirs
GGTGCAT
>HZ160627.1 JP 2015130862-A/3451: Micromirs
AGGTGCA
>HZ160626.1 JP 2015130862-A/3450: Micromirs
AAGGATT
>HZ160625.1 JP 2015130862-A/3449: Micromirs
AGTCTTA
>HZ160624.1 JP 2015130862-A/3448: Micromirs
GTGATGT
>HZ160623.1 JP 2015130862-A/3447: Micromirs
GCTTGAA
>HZ160622.1 JP 2015130862-A/3446: Micromirs
GTGGTTT
>HZ160621.1 JP 2015130862-A/3445: Micromirs
TGCTGCT
>HZ160620.1 JP 2015130862-A/3444: Micromirs
AATACTC
>HZ160619.1 JP 2015130862-A/3443: Micromirs
GTTTGTT
>HZ160618.1 JP 2015130862-A/3442: Micromirs
ATGTTTC
>HZ160617.1 JP 2015130862-A/3441: Micromirs
ATGTACA
>HZ160616.1 JP 2015130862-A/3440: Micromirs
GACCTTC
>HZ160615.1 JP 2015130862-A/3439: Micromirs
CAGGTCC
>HZ160614.1 JP 2015130862-A/3438: Micromirs
TCCCCAC
>HZ160613.1 JP 2015130862-A/3437: Micromirs
TGCATAA
>HZ160612.1 JP 2015130862-A/3436: Micromirs
ATCCATG
>HZ160611.1 JP 2015130862-A/3435: Micromirs
CCAGGTT
>HZ160610.1 JP 2015130862-A/3434: Micromirs
GATGTCA
>HZ160609.1 JP 2015130862-A/3433: Micromirs
TATCTGG
>HZ160608.1 JP 2015130862-A/3432: Micromirs
CCTTTCA
>HZ160607.1 JP 2015130862-A/3431: Micromirs
GTACGAT
>HZ160606.1 JP 2015130862-A/3430: Micromirs
GTATGAT
>HZ160605.1 JP 2015130862-A/3429: Micromirs
GTACAGG
>HZ160604.1 JP 2015130862-A/3428: Micromirs
CTGCCCC
>HZ160603.1 JP 2015130862-A/3427: Micromirs
CAGCCTC
>HZ160602.1 JP 2015130862-A/3426: Micromirs
TGTATGA
>HZ160601.1 JP 2015130862-A/3425: Micromirs
GAGCCTG
>HZ160600.1 JP 2015130862-A/3424: Micromirs
CCCGTCT
>HZ160599.1 JP 2015130862-A/3423: Micromirs
AGGAGTG
>HZ160598.1 JP 2015130862-A/3422: Micromirs
GGCACAT
>HZ160597.1 JP 2015130862-A/3421: Micromirs
TGGACTG
>HZ160596.1 JP 2015130862-A/3420: Micromirs
GATAGGG
>HZ160595.1 JP 2015130862-A/3419: Micromirs
TTGCACT
>HZ160594.1 JP 2015130862-A/3418: Micromirs
GACAACC
>HZ160593.1 JP 2015130862-A/3417: Micromirs
CAGATGA
>HZ160592.1 JP 2015130862-A/3416: Micromirs
AAACAGT
>HZ160591.1 JP 2015130862-A/3415: Micromirs
AACGGTT
>HZ160590.1 JP 2015130862-A/3414: Micromirs
TTGCAAA
>HZ160589.1 JP 2015130862-A/3413: Micromirs
GATCCCA
>HZ160588.1 JP 2015130862-A/3412: Micromirs
TCGCAAA
>HZ160587.1 JP 2015130862-A/3411: Micromirs
CACTGCC
>HZ160586.1 JP 2015130862-A/3410: Micromirs
CACTGCC
>HZ160585.1 JP 2015130862-A/3409: Micromirs
ATATGCA
>HZ160584.1 JP 2015130862-A/3408: Micromirs
ATCATGA
>HZ160583.1 JP 2015130862-A/3407: Micromirs
CCATCCA
>HZ160582.1 JP 2015130862-A/3406: Micromirs
CTCCAAG
>HZ160581.1 JP 2015130862-A/3405: Micromirs
ACGACCT
>HZ160580.1 JP 2015130862-A/3404: Micromirs
GCAAGAC
>HZ160579.1 JP 2015130862-A/3403: Micromirs
CAGTATT
>HZ160578.1 JP 2015130862-A/3402: Micromirs
TTCCCGA
>HZ160577.1 JP 2015130862-A/3401: Micromirs
GTGTCAT
>HZ160576.1 JP 2015130862-A/3400: Micromirs
ACGTTTT
>HZ160575.1 JP 2015130862-A/3399: Micromirs
TGCTGCT
>HZ160574.1 JP 2015130862-A/3398: Micromirs
GCCCCTC
>HZ160573.1 JP 2015130862-A/3397: Micromirs
ACCGAGC
>HZ160572.1 JP 2015130862-A/3396: Micromirs
AGTCCAG
>HZ160571.1 JP 2015130862-A/3395: Micromirs
CTGTTGA
>HZ160570.1 JP 2015130862-A/3394: Micromirs
GGTGAAG
>HZ160569.1 JP 2015130862-A/3393: Micromirs
GTTACAT
>HZ160568.1 JP 2015130862-A/3392: Micromirs
GTCTACT
>HZ160567.1 JP 2015130862-A/3391: Micromirs
GTTATAT
>HZ160566.1 JP 2015130862-A/3390: Micromirs
GGTAACC
>HZ160565.1 JP 2015130862-A/3389: Micromirs
CAACATT
>HZ160564.1 JP 2015130862-A/3388: Micromirs
CTAGGAA
>HZ160563.1 JP 2015130862-A/3387: Micromirs
TCTGATC
>HZ160562.1 JP 2015130862-A/3386: Micromirs
ACAACTT
>HZ160561.1 JP 2015130862-A/3385: Micromirs
CTTGTAT
>HZ160560.1 JP 2015130862-A/3384: Micromirs
GTCAACC
>HZ160559.1 JP 2015130862-A/3383: Micromirs
ATTACAT
>HZ160558.1 JP 2015130862-A/3382: Micromirs
GTTACAT
>HZ160557.1 JP 2015130862-A/3381: Micromirs
GTCTACC
>HZ160556.1 JP 2015130862-A/3380: Micromirs
GTCAGGA
>HZ160555.1 JP 2015130862-A/3379: Micromirs
AGTCCAG
>HZ160554.1 JP 2015130862-A/3378: Micromirs
CAACCTC
>HZ160553.1 JP 2015130862-A/3377: Micromirs
TGTGTGA
>HZ160552.1 JP 2015130862-A/3376: Micromirs
TCTATGT
>HZ160551.1 JP 2015130862-A/3375: Micromirs
TCTATGA
>HZ160550.1 JP 2015130862-A/3374: Micromirs
GAATCTA
>HZ160549.1 JP 2015130862-A/3373: Micromirs
TCTATGA
>HZ160548.1 JP 2015130862-A/3372: Micromirs
CGAACAA
>HZ160547.1 JP 2015130862-A/3371: Micromirs
CTGCTAA
>HZ160546.1 JP 2015130862-A/3370: Micromirs
TATTATA
>HZ160545.1 JP 2015130862-A/3369: Micromirs
CTGATAA
>HZ160544.1 JP 2015130862-A/3368: Micromirs
TATTATA
>HZ160543.1 JP 2015130862-A/3367: Micromirs
TTTTGAG
>HZ160542.1 JP 2015130862-A/3366: Micromirs
AGCACTT
>HZ160541.1 JP 2015130862-A/3365: Micromirs
AGCACTT
>HZ160540.1 JP 2015130862-A/3364: Micromirs
GTTTGAG
>HZ160539.1 JP 2015130862-A/3363: Micromirs
CGGCACT
>HZ160538.1 JP 2015130862-A/3362: Micromirs
CAGCAGG
>HZ160537.1 JP 2015130862-A/3361: Micromirs
GTCGATC
>HZ160536.1 JP 2015130862-A/3360: Micromirs
GTATTAT
>HZ160535.1 JP 2015130862-A/3359: Micromirs
GCAACAG
>HZ160534.1 JP 2015130862-A/3358: Micromirs
GTGCAAT
>HZ160533.1 JP 2015130862-A/3357: Micromirs
GGGCATT
>HZ160532.1 JP 2015130862-A/3356: Micromirs
TCCACCC
>HZ160531.1 JP 2015130862-A/3355: Micromirs
GTGCAAT
>HZ160530.1 JP 2015130862-A/3354: Micromirs
CAAGGAT
>HZ160529.1 JP 2015130862-A/3353: Micromirs
GGTGTGT
>HZ160528.1 JP 2015130862-A/3352: Micromirs
TCTGATA
>HZ160527.1 JP 2015130862-A/3351: Micromirs
CTGGGGG
>HZ160526.1 JP 2015130862-A/3350: Micromirs
CACTGCC
>HZ160525.1 JP 2015130862-A/3349: Micromirs
TAGTGAT
>HZ160524.1 JP 2015130862-A/3348: Micromirs
ACTGCCT
>HZ160523.1 JP 2015130862-A/3347: Micromirs
AGTGATT
>HZ160522.1 JP 2015130862-A/3346: Micromirs
GCTGATT
>HZ160521.1 JP 2015130862-A/3345: Micromirs
CACTGCC
>HZ160520.1 JP 2015130862-A/3344: Micromirs
GGCAGAC
>HZ160519.1 JP 2015130862-A/3343: Micromirs
GAGTCAG
>HZ160518.1 JP 2015130862-A/3342: Micromirs
GCACCCC
>HZ160517.1 JP 2015130862-A/3341: Micromirs
GTGTGAG
>HZ160516.1 JP 2015130862-A/3340: Micromirs
GAGACGG
>HZ160515.1 JP 2015130862-A/3339: Micromirs
CTTTATA
>HZ160514.1 JP 2015130862-A/3338: Micromirs
AGGCACT
>HZ160513.1 JP 2015130862-A/3337: Micromirs
CAATGCA
>HZ160512.1 JP 2015130862-A/3336: Micromirs
AAACATT
>HZ160511.1 JP 2015130862-A/3335: Micromirs
CAATGCA
>HZ160510.1 JP 2015130862-A/3334: Micromirs
GACAGGG
>HZ160509.1 JP 2015130862-A/3333: Micromirs
GGCGCTC
>HZ160508.1 JP 2015130862-A/3332: Micromirs
ATATTGT
>HZ160507.1 JP 2015130862-A/3331: Micromirs
ATGCTGG
>HZ160506.1 JP 2015130862-A/3330: Micromirs
AGCCGTT
>HZ160505.1 JP 2015130862-A/3329: Micromirs
TATAGGA
>HZ160504.1 JP 2015130862-A/3328: Micromirs
ATGAAAA
>HZ160503.1 JP 2015130862-A/3327: Micromirs
GCTCTTG
>HZ160502.1 JP 2015130862-A/3326: Micromirs
ATACCTA
>HZ160501.1 JP 2015130862-A/3325: Micromirs
CCAGGGG
>HZ160500.1 JP 2015130862-A/3324: Micromirs
CCCAGAG
>HZ160499.1 JP 2015130862-A/3323: Micromirs
TGCTTTG
>HZ160498.1 JP 2015130862-A/3322: Micromirs
GGTGTGT
>HZ160497.1 JP 2015130862-A/3321: Micromirs
AGGGCCA
>HZ160496.1 JP 2015130862-A/3320: Micromirs
CCCAGAG
>HZ160495.1 JP 2015130862-A/3319: Micromirs
CTACTAG
>HZ160494.1 JP 2015130862-A/3318: Micromirs
GGGATGC
>HZ160493.1 JP 2015130862-A/3317: Micromirs
GGGGCAG
>HZ160492.1 JP 2015130862-A/3316: Micromirs
GACCACC
>HZ160491.1 JP 2015130862-A/3315: Micromirs
GTAATGT
>HZ160490.1 JP 2015130862-A/3314: Micromirs
CAGCTTT
>HZ160489.1 JP 2015130862-A/3313: Micromirs
CAGCTTT
>HZ160488.1 JP 2015130862-A/3312: Micromirs
CAGCTTT
>HZ160487.1 JP 2015130862-A/3311: Micromirs
CAGCTTT
>HZ160486.1 JP 2015130862-A/3310: Micromirs
CTAAATT
>HZ160485.1 JP 2015130862-A/3309: Micromirs
GTGCAAT
>HZ160484.1 JP 2015130862-A/3308: Micromirs
GCATAGC
>HZ160483.1 JP 2015130862-A/3307: Micromirs
TCTTGCC
>HZ160482.1 JP 2015130862-A/3306: Micromirs
ACTGAAA
>HZ160481.1 JP 2015130862-A/3305: Micromirs
TGTTTAC
>HZ160480.1 JP 2015130862-A/3304: Micromirs
ACTGAAA
>HZ160479.1 JP 2015130862-A/3303: Micromirs
TGTTTAC
>HZ160478.1 JP 2015130862-A/3302: Micromirs
TCTCCCA
>HZ160477.1 JP 2015130862-A/3301: Micromirs
TCTCCCA
>HZ160476.1 JP 2015130862-A/3300: Micromirs
TGTTTAC
>HZ160475.1 JP 2015130862-A/3299: Micromirs
CCTCCCA
>HZ160474.1 JP 2015130862-A/3298: Micromirs
TGTTTAC
>HZ160473.1 JP 2015130862-A/3297: Micromirs
ACTGAAA
>HZ160472.1 JP 2015130862-A/3296: Micromirs
TGTTTAC
>HZ160471.1 JP 2015130862-A/3295: Micromirs
AGCAATT
>HZ160470.1 JP 2015130862-A/3294: Micromirs
AGCACTT
>HZ160469.1 JP 2015130862-A/3293: Micromirs
GTTAAAG
>HZ160468.1 JP 2015130862-A/3292: Micromirs
AGCACTT
>HZ160467.1 JP 2015130862-A/3291: Micromirs
ATGTTAA
>HZ160466.1 JP 2015130862-A/3290: Micromirs
AGCACTT
>HZ160465.1 JP 2015130862-A/3289: Micromirs
GTTAAAG
>HZ160464.1 JP 2015130862-A/3288: Micromirs
AGCACTT
>HZ160463.1 JP 2015130862-A/3287: Micromirs
GTTTAAG
>HZ160462.1 JP 2015130862-A/3286: Micromirs
AGCACTT
>HZ160461.1 JP 2015130862-A/3285: Micromirs
TTGCACT
>HZ160460.1 JP 2015130862-A/3284: Micromirs
TTGCACT
>HZ160459.1 JP 2015130862-A/3283: Micromirs
CTTGTAT
>HZ160458.1 JP 2015130862-A/3282: Micromirs
ATCGGTC
>HZ160457.1 JP 2015130862-A/3281: Micromirs
TGGTGCT
>HZ160456.1 JP 2015130862-A/3280: Micromirs
GAAACCA
>HZ160455.1 JP 2015130862-A/3279: Micromirs
AAACCAG
>HZ160454.1 JP 2015130862-A/3278: Micromirs
TGGTGCT
>HZ160453.1 JP 2015130862-A/3277: Micromirs
AAATCAG
>HZ160452.1 JP 2015130862-A/3276: Micromirs
TGGTGCT
>HZ160451.1 JP 2015130862-A/3275: Micromirs
GTAAACC
>HZ160450.1 JP 2015130862-A/3274: Micromirs
CCCACAT
>HZ160449.1 JP 2015130862-A/3273: Micromirs
CTTCTGC
>HZ160448.1 JP 2015130862-A/3272: Micromirs
ACATACA
>HZ160447.1 JP 2015130862-A/3271: Micromirs
GGGGCCC
>HZ160446.1 JP 2015130862-A/3270: Micromirs
CAACCCT
>HZ160445.1 JP 2015130862-A/3269: Micromirs
AGCTCCT
>HZ160444.1 JP 2015130862-A/3268: Micromirs
ATCTAGT
>HZ160443.1 JP 2015130862-A/3267: Micromirs
TAAGCTC
>HZ160442.1 JP 2015130862-A/3266: Micromirs
ACTGTGA
>HZ160441.1 JP 2015130862-A/3265: Micromirs
TAAGCCC
>HZ160440.1 JP 2015130862-A/3264: Micromirs
ACTGTGA
>HZ160439.1 JP 2015130862-A/3263: Micromirs
AGAACAG
>HZ160438.1 JP 2015130862-A/3262: Micromirs
TACTTGA
>HZ160437.1 JP 2015130862-A/3261: Micromirs
AGAATAG
>HZ160436.1 JP 2015130862-A/3260: Micromirs
AGAATAG
>HZ160435.1 JP 2015130862-A/3259: Micromirs
TACTTGA
>HZ160434.1 JP 2015130862-A/3258: Micromirs
CTCCGCC
>HZ160433.1 JP 2015130862-A/3257: Micromirs
GTGCAAT
>HZ160432.1 JP 2015130862-A/3256: Micromirs
AGTAGGC
>HZ160431.1 JP 2015130862-A/3255: Micromirs
AGTAGGC
>HZ160430.1 JP 2015130862-A/3254: Micromirs
CTGAGCC
>HZ160429.1 JP 2015130862-A/3253: Micromirs
GGAACCC
>HZ160428.1 JP 2015130862-A/3252: Micromirs
AATGTGA
>HZ160427.1 JP 2015130862-A/3251: Micromirs
GGAACCC
>HZ160426.1 JP 2015130862-A/3250: Micromirs
AATGTGA
>HZ160425.1 JP 2015130862-A/3249: Micromirs
GTGACTT
>HZ160424.1 JP 2015130862-A/3248: Micromirs
AATACAC
>HZ160423.1 JP 2015130862-A/3247: Micromirs
AACTGAC
>HZ160422.1 JP 2015130862-A/3246: Micromirs
CTACTGA
>HZ160421.1 JP 2015130862-A/3245: Micromirs
ATGTAGC
>HZ160420.1 JP 2015130862-A/3244: Micromirs
TGCCAGG
>HZ160419.1 JP 2015130862-A/3243: Micromirs
ATGTAGC
>HZ160418.1 JP 2015130862-A/3242: Micromirs
CCCTGTG
>HZ160417.1 JP 2015130862-A/3241: Micromirs
GGTGGTG
>HZ160416.1 JP 2015130862-A/3240: Micromirs
CGGTGTG
>HZ160415.1 JP 2015130862-A/3239: Micromirs
GAAGAAC
>HZ160414.1 JP 2015130862-A/3238: Micromirs
GGCAGCT
>HZ160413.1 JP 2015130862-A/3237: Micromirs
GACAATC
>HZ160412.1 JP 2015130862-A/3236: Micromirs
ACAATTC
>HZ160411.1 JP 2015130862-A/3235: Micromirs
TCAACTC
>HZ160410.1 JP 2015130862-A/3234: Micromirs
GAACCAT
>HZ160409.1 JP 2015130862-A/3233: Micromirs
GGAACCA
>HZ160408.1 JP 2015130862-A/3232: Micromirs
AAGCACA
>HZ160407.1 JP 2015130862-A/3231: Micromirs
ATGCAGT
>HZ160406.1 JP 2015130862-A/3230: Micromirs
AGAGATT
>HZ160405.1 JP 2015130862-A/3229: Micromirs
TGAGATT
>HZ160404.1 JP 2015130862-A/3228: Micromirs
TAGGTCA
>HZ160403.1 JP 2015130862-A/3227: Micromirs
GACAGGC
>HZ160402.1 JP 2015130862-A/3226: Micromirs
CCTGCTG
>HZ160401.1 JP 2015130862-A/3225: Micromirs
GACTGTT
>HZ160400.1 JP 2015130862-A/3224: Micromirs
AAAGGGA
>HZ160399.1 JP 2015130862-A/3223: Micromirs
ACGCACA
>HZ160398.1 JP 2015130862-A/3222: Micromirs
TGGTGTT
>HZ160397.1 JP 2015130862-A/3221: Micromirs
ATAAGCT
>HZ160396.1 JP 2015130862-A/3220: Micromirs
ACTACAG
>HZ160395.1 JP 2015130862-A/3219: Micromirs
GCACTTT
>HZ160394.1 JP 2015130862-A/3218: Micromirs
AATGCAG
>HZ160393.1 JP 2015130862-A/3217: Micromirs
GCACTTT
>HZ160392.1 JP 2015130862-A/3216: Micromirs
CGTCTTA
>HZ160391.1 JP 2015130862-A/3215: Micromirs
CGTCTTA
>HZ160390.1 JP 2015130862-A/3214: Micromirs
ACATTCC
>HZ160389.1 JP 2015130862-A/3213: Micromirs
ATGAAGG
>HZ160388.1 JP 2015130862-A/3212: Micromirs
AAAGGGA
>HZ160387.1 JP 2015130862-A/3211: Micromirs
CATTTCA
>HZ160386.1 JP 2015130862-A/3210: Micromirs
CATAGGA
>HZ160385.1 JP 2015130862-A/3209: Micromirs
ATACCTC
>HZ160384.1 JP 2015130862-A/3208: Micromirs
GTAAGAC
>HZ160383.1 JP 2015130862-A/3207: Micromirs
CAGTATT
>HZ160382.1 JP 2015130862-A/3206: Micromirs
GTAAGAT
>HZ160381.1 JP 2015130862-A/3205: Micromirs
CAGTATT
>HZ160380.1 JP 2015130862-A/3204: Micromirs
GTAAGAT
>HZ160379.1 JP 2015130862-A/3203: Micromirs
CAGTGTT
>HZ160378.1 JP 2015130862-A/3202: Micromirs
GCAAAAC
>HZ160377.1 JP 2015130862-A/3201: Micromirs
GCAAAAC
>HZ160376.1 JP 2015130862-A/3200: Micromirs
TTTGCAC
>HZ160375.1 JP 2015130862-A/3199: Micromirs
GCAAAAC
>HZ160374.1 JP 2015130862-A/3198: Micromirs
TTTGCAC
>HZ160373.1 JP 2015130862-A/3197: Micromirs
ACACTGG
>HZ160372.1 JP 2015130862-A/3196: Micromirs
ACTACTG
>HZ160371.1 JP 2015130862-A/3195: Micromirs
ACACTGG
>HZ160370.1 JP 2015130862-A/3194: Micromirs
TCTGGAC
>HZ160369.1 JP 2015130862-A/3193: Micromirs
GTGGTGA
>HZ160368.1 JP 2015130862-A/3192: Micromirs
ACTACCT
>HZ160367.1 JP 2015130862-A/3191: Micromirs
TGTTGCC
>HZ160366.1 JP 2015130862-A/3190: Micromirs
ACTACCT
>HZ160365.1 JP 2015130862-A/3189: Micromirs
AATATTG
>HZ160364.1 JP 2015130862-A/3188: Micromirs
TGCTGCT
>HZ160363.1 JP 2015130862-A/3187: Micromirs
CCCACTG
>HZ160362.1 JP 2015130862-A/3186: Micromirs
CTGTTAC
>HZ160361.1 JP 2015130862-A/3185: Micromirs
AAACCCC
>HZ160360.1 JP 2015130862-A/3184: Micromirs
GGCCAGT
>HZ160359.1 JP 2015130862-A/3183: Micromirs
AAGACCC
>HZ160358.1 JP 2015130862-A/3182: Micromirs
GGCCAGT
>HZ160357.1 JP 2015130862-A/3181: Micromirs
ATTGGCA
>HZ160356.1 JP 2015130862-A/3180: Micromirs
TAGGTCA
>HZ160355.1 JP 2015130862-A/3179: Micromirs
GGCAAGG
>HZ160354.1 JP 2015130862-A/3178: Micromirs
CCCTGGG
>HZ160353.1 JP 2015130862-A/3177: Micromirs
ACCCCTC
>HZ160352.1 JP 2015130862-A/3176: Micromirs
GCACAGG
>HZ160351.1 JP 2015130862-A/3175: Micromirs
GGGGCAG
>HZ160350.1 JP 2015130862-A/3174: Micromirs
TCTGGGT
>HZ160349.1 JP 2015130862-A/3173: Micromirs
GCCTGGT
>HZ160348.1 JP 2015130862-A/3172: Micromirs
GGTACTC
>HZ160347.1 JP 2015130862-A/3171: Micromirs
AGGACTG
>HZ160346.1 JP 2015130862-A/3170: Micromirs
AGCGCAG
>HZ160345.1 JP 2015130862-A/3169: Micromirs
TTCCGTT
>HZ160344.1 JP 2015130862-A/3168: Micromirs
ACATATC
>HZ160343.1 JP 2015130862-A/3167: Micromirs
GGCACTC
>HZ160342.1 JP 2015130862-A/3166: Micromirs
CCCCTGC
>HZ160341.1 JP 2015130862-A/3165: Micromirs
CCCCGCC
>HZ160340.1 JP 2015130862-A/3164: Micromirs
ACATATC
>HZ160339.1 JP 2015130862-A/3163: Micromirs
TTAGGGC
>HZ160338.1 JP 2015130862-A/3162: Micromirs
GCACCTT
>HZ160337.1 JP 2015130862-A/3161: Micromirs
AGGGCAG
>HZ160336.1 JP 2015130862-A/3160: Micromirs
GCACCTT
>HZ160335.1 JP 2015130862-A/3159: Micromirs
AAGGGAT
>HZ160334.1 JP 2015130862-A/3158: Micromirs
TGTGGGA
>HZ160333.1 JP 2015130862-A/3157: Micromirs
TTGTAGC
>HZ160191.1 JP 2015130862-A/3015: Micromirs
CAGTCCA
>HZ160190.1 JP 2015130862-A/3014: Micromirs
CACGCCC
>HZ160189.1 JP 2015130862-A/3013: Micromirs
TCAACAG
>HZ160188.1 JP 2015130862-A/3012: Micromirs
CCCTGAG
>HZ160187.1 JP 2015130862-A/3011: Micromirs
ACATCCT
>HZ160186.1 JP 2015130862-A/3010: Micromirs
AAGACTT
